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ABSTRACT 
 
 
The innate immune system, also known as natural or non-specific immune system, 
is conserved from insects to humans. The insect innate immune system is composed of 
humoral and cellular components. Insect humoral responses mainly include synthesis of 
antimicrobial peptides (AMPs) and activation of the prophenoloxidase (PPO) system. 
Expression of AMPs is regulated by two signaling pathways, the Toll-Spätzle (Spz) and 
immune deficiency (IMD) pathways, in Drosophila melanogaster. My research has been 
focusing on pattern recognition receptors (PRRs) and regulation of AMP genes in the 
tobacco hornworm, Manduca sexta.  
In chapter 2, I showed direct interaction between M. sexta MsToll and MsSpz-
C108 by Co-immunoprecipitation (Co-IP), and demonstrated that co-expression of 
MsToll and MsSpz-C108 can activate AMP gene promoters in S2 cells by dual luciferase 
assays. My results confirm a Toll-Spz pathway in an insect other than Drosophila. 
In chapter 3, a Toll-ML (MD2 (myeloid differentiation protein 2) - related lipid-
recognition)-LPS signaling pathway was identified in M. sexta. The Co-IP assay showed 
that MsToll, MsML-1 and lipopolysaccharide (LPS) could form a receptor complex. 
More importantly, I showed that co-expression of MsToll and MsML-1 could up-regulate 
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AMP genes activated by LPS. My results for the first time showed that a Toll-ML-LPS 
signaling pathway is conserved from insects to humans. 
In chapter 4, I identified Relish short isoforms and Dorsal in M. sexta. Dorsal and 
Relish belong to the nuclear factor-κB (NF-κB)/Rel family. I showed that M. sexta Dorsal 
and Rel2 (Relish) isoforms could regulate AMP genes differently, and Dorsal and Rel2 
could form heterodimers, which negatively regulated AMP genes. This is a novel finding 
about NF-κB factors in regulation of AMP gene expression. 
Characterization of a new member (βGRP3) of the β-1, 3-glucan recognition 
proteins in M. sexta was presented in chapter 5. I discovered novel functions of M. sexta 
βGRP3 in the βGRP family proteins: (1) calcium-dependent agglutination of bacterial 
cells, and (2) antibacterial (bacteriostatic) activity. 
In Chapter 6, I characterized function of M. sexta gloverin. I showed that M. sexta 
gloverin can bind to different microbial cell wall components and has activity against 
different microorganisms. My results suggested that gloverin’s broad spectrum of activity 
may be related to its binding ability to microbial cell wall components. 
In Chapter 7, I summarized my discoveries in insect innate immune signaling 
pathways and proposed future research directions.  
My research has contributed to a better understanding of innate immunity in 
insects and vertebrates, regulation of gene expression by NF-κB factors, and evolution of 
the innate immune signaling pathways.  
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CHAPTER 1 
GENERAL INTRODUCTION OF INSECT INNATE IMMUNE SIGNALING 
PATHWAYS 
 
The innate and adaptive immune systems are two major branches of the defense 
system in multicellular organisms.  The innate immune system, also known as natural or 
non-specific immune system, is the first line of defense against pathogens, such as 
bacteria and fungi. The innate immune system of insects is similar to that of vertebrates 
(Ferrandon et al., 2007; Lemaitre and Hoffmann, 2007; Muller et al., 2008). The generic 
recognition of pathogens by components of the innate immune system provides 
immediate defense against infection, which is conserved from insects to humans. On the 
other hand, adaptive immunity that is found in vertebrates but not insects develops over 
longer time periods, for example, the generation of antibody molecules may take up to 
one week. In innate immune responses, a group of germline-encoded pattern recognition 
receptors (PRRs) can recognize and bind to conserved pathogen-associated molecular 
patterns (PAMPs), such as lipopolysaccharides (LPS), peptidoglycans (PG), lipoteichoic 
acid (LTA), β-1,3-glucan, and mannan present on the invading microorganisms but not 
on the host cells. The receptors on the cell surface convey the information to the interior 
of the cell by series of adaptor proteins.  
The innate immune system is composed of humoral and cellular components. 
Cellular responses mainly include blood cells (called hemocytes in insects) mediated 
immune responses such as nodule formation, phagocytosis and melanotic encapsulation, 
whereas synthesis of antimicrobial peptides (AMPs) and activation of the 
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prophenoloxidase (PPO) system are major components of humoral responses (Medzhitov 
and Janeway, 2000b). In this chapter, I focus on general introduction of insect humoral 
immunity. I will begin with recognition proteins in the host, which specifically recognize 
cell wall components of pathogens. Then, I will introduce two major pathways that have 
been well-studied in the Drosophila melanogaster: the Toll-Spätzle pathway and the 
immune deficiency (IMD) pathway. The two pathways regulate synthesis of most AMPs. 
I will also compare the difference between mammalian Toll-like receptor (TLR) pathway 
and D. melanogaster Toll pathway. Then I will discuss the family of nuclear factor kappa 
B (NF-κB) transcription factors that control the Toll and IMD pathways. Finally, I will 
present several AMPs as the targets of the Toll and IMD pathways.  
 
Beta-1,3-Glucan Recognition Proteins (BGRP)/Gram-Negative Binding Proteins 
(GNBPs) 
GNBPs are a class of immune recognition proteins, which share a conserved C-
terminal β-glucanase-like domain (Werner et al., 2000). They were initially shown to 
recognize and bind to Gram-negative, but not Gram-positive, bacteria in Bombyx mori 
(Lee et al., 1996). These proteins are found only in invertebrate animals, and do not exist 
in mammals (Medzhitov and Janeway Jr, 2000). Members of the GNBPs were also 
discovered to recognize Gram-positive bacteria (Choe et al., 2002; Pili-Floury et al., 
2004). GNBPs can bind to β-1, 3-glucans on fungi and therefore are also named β-1, 3-
glucan recognition proteins (βGRPs or BGRPs) (Hughes, 2012; Jiang et al., 2004; Ma 
and Kanost, 2000; Wang et al., 2011). Based on their catalytic activity, GNBPs can be 
divided into two groups; one group possesses glucanase activity (Lee et al., 1996), while 
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another group has no catalytic activity due to lacking the critical cysteines required for 
the activity (Kim et al., 2000). In Drosophila, at least three GNBPs have been identified; 
however, only functions of DmGNBP-1 and DmGNBP-3 were characterized. Both 
contain an N-terminal GNBP homology domain and an evolutionarily conserved β-
glucanase domain at the C-terminus (Hetru and Hoffmann, 2009) (Figure 1). DmGNBP-1 
exists as soluble and glycosylphosphatidylinositol (GIP)-anchored forms and can 
recognize LPS or β-1, 3-glucans (Kim et al., 2000). DmGNBP-1 interacts with PGRP-SA 
to recognize the diaminopimelic acid (DAP)-type PG (Ferrandon et al., 2004). DmGNBP-
3 is crucial for the recognition of yeast (Buchon et al., 2009; Gottar et al., 2006). Both 
DmGNBPs can initiate the Toll pathway (Ferrandon et al., 2004) (Table 1).  
In M. sexta, three βGRPs and one GNBP have been identified. MsβGRP-1 
agglutinates yeast, Gram-negative and positive bacteria, and activates PPO, which 
triggers melanization in the presence of laminiarin (Ma and Kanost, 2000). MsβGRP-2 
aggregates yeast, Gram-negative and Gram-positive bacteria, and stimulates PPO 
activation after binding to the laminarin (Jiang et al., 2004). M. sexta microbe binding 
protein (MsMBP) alone enhances phenoloxidase (PO) activity at low concentration; 
however it dramatically inhibits PO activity when present at high concentration. PO 
activity is highly activated by MsMBP via binding to a variety of cell wall components 
(Wang et al., 2011) (Table 2).  
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Figure 1. GNBP1 and GNBP3 in D. melanogaster 
DmGNBP1 and DmGNBP3 contain an N-terminal GNBP homology domain and highly 
evolutional conserved β-glucanase domain at the C-terminus. 
 
 
(Hetru, C., Hoffmann, J. A., 2009. NF-kappaB in the immune response of Drosophila. 
Cold Spring Harb Perspect Biol. 1, a000232.) 
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The Drosophila Toll Pathway 
After PPRs detect and bind PAMPs to initiate immune responses, the signaling 
needs to be transmitted into cells to trigger the host defense mechanisms. There are two 
major pathways to integrate the extracellular signaling in Drosophila melanogaster, the 
Toll and IMD pathways. First, I introduce the Drosophila Toll pathway. Either in 
embryonic development or immune recognition, initiation of the Drosophila Toll 
pathway occurs through cleavage of the Toll receptor ligand Spätzle (or Spaetzle) (Spz) 
(Morisato and Anderson, 1994; Schneider et al., 1994). Spz, similar to other common 
secreted protein, is synthesized as an inactive precursor. Extracellular cleavage of the 
full-length Spz by a protease cascade into an active carboxyl-terminal fragment is 
required for activation of the Toll pathway. During early Drosophila embryogenesis, a 
Dorsal-Ventral (DV) signal initiates a serine protease (SP) cascade. In this cascade, 
Gastrulation Defective cleaves Snake, which activates the protease Easter (Chasan et al., 
1992; Hong and Hashimoto, 1995). In another branch of the DV pattern, sulfotransferase 
Pipe also processes and activates Easter (Cho et al., 2010). The active form of Easter 
cleaves the full-length Spz (Mulnix and Dunn, 1994). In pathogen recognition, the cell 
wall components β-glucan from fungi and Lysine (LYS)-type PG from Gram-positive 
bacteria initiate two protease cascades, which activate a Gram-positive-specific serine 
protease (Grass) (Royet and Dziarski, 2007). β-glucan and LYS-type PGs are recognized 
by GNBP3 and PGRP-SA, respectively (Kurokawa et al., 2011; Schleifer and Kandler, 
1972). PGRP-SA physically interacts with GNBP1 to form a heterodimer (Gobert et al., 
2003; Michel et al., 2001; Pili-Floury et al., 2004). New glycan reducing ends generated 
from the Lys-type PGs after proteolysis by active GNBP1 are captured by PGRP-SA 
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(Wang et al., 2006). LYS-type PG also can be recognized by PGRP-SD, which is a 
partially complementary pathway to the PGRP-SA-GNBP1 pathway (Bischoff et al., 
2004). A modular serine protease (ModSP), which is highly conserved in insects, accepts 
the signals from GNBP3 and PGRP-SA (Buchon et al., 2009). ModSP converges the 
signal to Grass, which recruits another four serine proteases, named spirit, spheroide, 
and sphinx1/2 (El Chamy et al., 2008; Kambris et al., 2006). In immune response, there is 
a parallel proteolytic cascade mediated by the protease Persephone (PSH), which is 
activated by the secreted fungal virulence factor PR1 and Gram-positive bacterial 
virulence factors (El Chamy et al., 2008; Gottar et al., 2006). 
In immune responses, all three proteolytic processes finally activate a Spz-
processing enzyme (SPE), a serine protease that is responsible for Spz cleavage (Jang et 
al., 2006). Spz consists of a prodomain at the N-terminus and a carboxyl-terminal 
fragment (C-106), which includes 7 of the 9 Cysteine residues (DeLotto and DeLotto, 
1998). The prodomain contains a conserved motif, which is an amphipathic helix. 
However, the C-terminal region is dominantly hydrophobic. In non-signaling conditions, 
the amphipathic domain masks the hydrophobic region, the determinant that is crucial for 
binding to the Toll receptor. The proteolysis by Easter or SPE leads to a conformational 
change, which releases and exposes the C-terminal 106 amino acids from the prodomain 
(Arnot et al., 2010). The active form of Spz dimerizes through three intrachain disulfide 
bridges. One Spz dimer binds to the N-terminus of one Toll receptor, triggering a 
conformational change that causes Toll receptor dimerization and the formation of an 
oligomer: 4Spz-2Toll. The complex initiates the intracellular signaling pathway 
(Gangloff et al., 2008). The activated Toll dimer interacts with the adaptor protein 
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Myeloid differentiation primary response gene 88 (MyD88) through their intracellular 
Toll/Interleukin-1 receptor (TIR) domains (Horng and Medzhitov, 2001; Sun et al., 2002; 
Xiao et al., 1999). MyD88 is a death domain (DD)-containing adaptor, which comes into 
contact with another DD adaptor Tube that in turn recruits kinase Pelle. MyD88, Tube, 
and Pelle associate to form a heterotrimeric complex through the death domains. MyD88 
does not directly interact with Pelle, but the two distinct DD surfaces of Tube bind to 
MyD88 and Pelle (Sun et al., 2002). The MyD88-Tube-Pelle heterotrimer is critical for 
proceeding to the phosphorylation and degradation of Drosophila IκB factor Cactus. In 
non-signaling conditions, Cactus associates with the transcription factors of the Rel/NF-
κB family Dorsal or a Dorsal-related immunity gene (Dif), retaining their cytoplasmic 
retention and inhibiting their nuclear localization (Wu and Anderson, 1998). During 
immune response, the active kinase Pelle phosphorylates and degrades Cactus (Towb et 
al., 2001). Dorsal or Dif is released from Cactus-Dorsal or Cactus-Dif complex, and 
translocates into the nucleus to activate the transcription of several target genes (Figure 2). 
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Figure 2. Drosophila Toll Pathway 
Both early embryogenesis and immune recognition activate the Toll-Spz pathway via 
proteolytic processing.  In the development and immune response, the protease Easter 
and SPE cleave full-length Spz, exposing the C-terminal Spz fragment, which is critical 
for the binding to Toll. One Spz dimer binds to one Toll receptor and triggers the 
conformation change leading to formation of a 4Spz:2Toll heteromultimer. The complex 
initiates the intracellular signal. Finally, kinase Pelle phosphorylates and degrades Cactus, 
which keeps Dif or Dorsal in the cytoplasm. Then Dif or Dorsal translocates to the 
nucleus and up-regulates target genes. 
 
(Valanne, S., Wang, J. H., Ramet, M., 2011. The Drosophila Toll signaling pathway. J 
Immunol. 186, 649-56.) 
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Toll Receptors 
Nine Toll receptors and eleven Toll-like-Receptors (TLRs) have been identified in 
D. melanogaster and mammals, respectively. Both Drosophila Toll and mammalian 
TLRs contain a highly conserved extracellular domain called the Leucine-Rich Repeats 
(LRRs) and an intracellular motif named the Toll-IL-1-resistence (TIR) domain. In 
mammals, with the help of co-receptor proteins, TLRs directly detect, recognize, and 
bind to different PAMPs. These bindings trigger a conformation change, which induces 
the formation of TLR homo or heterodimers, to initiate the intracellular signal. In contrast, 
Drosophila Toll does not directly detect and bind to the PAMPs; however, similar to the 
TLR dimers, Drosophila Toll homodimers are crucial for activating the downstream 
cascades. It has been shown that Drosophila Toll-1 is necessary for the Toll-Spätzle 
pathway in both immune recognition and embryogenesis (Lemaitre et al., 1996). 
Drosophila Toll-6 and Toll-7 are expressed in central nervous system (CNS) and regulate 
the mature and formation of CNS (McIlroy et al., 2013). Drosophila Toll-7 is activated 
by virus infection (Nakamoto et al., 2012). One of Drosophila AMPs, drosomycin is up-
regulated by Toll-9 in D. melanogaster Schneider 2 (S2) cell lines (Bettencourt et al., 
2004b; Ooi et al., 2002). The active Drosophila Toll receptors form dimers, which bind 
to the intracellular adaptor protein MyD88 via a TIR domain, to initiate the downstream 
signaling pathway (Horng and Medzhitov, 2001). The functions of different Drosophila 
Toll are summarized in Table 1. 
Previously, a Toll receptor in M. sexta, which can be induced by some of Gram-
positive/negative bacteria or fungi, was reported, and the TIR domain of MsToll has high 
similarity to that of vertebrate TLR4 (Ao et al., 2008b) (Table 2).  
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Table 1 GRP/GNBPs and Toll Receptors in D. melanogaster 
Gene Type of Protein Putative ligand Evidence References 
GNBP1 Gram-negative 
binding protein 
Potentially G
+
 
bacterial 
determinants 
Hydrolyzes G
+
 PGs. 
Acts in complex with 
PGRP-SA to activate 
the Toll pathway. 
(Filipe et al., 
2005; Gobert et 
al., 2003; Pili-
Floury et al., 
2004) 
GNBP3 Gram-negative 
binding protein 
Fungi GNBP3 recognizes 
β-1, 3-glucan and 
activates the Toll 
pathway. 
(Buchon et al., 
2009; Gottar et 
al., 2006) 
18 
wheeler, 
Toll-2 
Toll-like 
Receptor 
Unknown Expression of attacin 
affected in mutant 
flies 
(Eldon et al., 
1994; 
Ligoxygakis et 
al., 2002; 
Williams et al., 
1997) 
Toll-6 Toll-like 
Receptor 
Unknown Toll-6 regulates the 
formation of 
Drosophila CNS 
(McIlroy et al., 
2013) 
Toll-7 Toll-like 
Receptor 
Unknown Loss of Toll-7 leads 
to increased 
vesicular stomatitis 
virus (VSV) 
replication and 
mortality 
(Nakamoto et al., 
2012) 
Toll-9 Toll-like 
Receptor 
Unknown Protein activates 
drosomycin in S2 
cells through MyD88 
(Bettencourt et 
al., 2004b; Ooi et 
al., 2002) 
 
(Pal, S., Wu, L. P., 2009. Lessons from the fly: pattern recognition in Drosophila 
melanogaster. Adv Exp Med Biol. 653, 162-74.) 
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Table 2 GRP/GNBPs and Toll Receptors in M. sexta 
Gene Type of 
Protein 
Putative ligand Evidence References 
MsToll Toll-like 
Receptor 
Active Spätzle Messenger ribonucleic 
acid (mRNA) was 
induced by yeast and 
Gram-positive bacteria 
(Ao et al., 
2008b) 
MsPGRP Peptidoglycan 
recognition 
protein 
 The mRNA level is 
rapidly increased at 2h 
post-injection and 
decreased after 24h 
injection  
(Zhu et al., 
2003) 
MsβGRP-1 β-1, 3-glucan 
recognition 
proteins 
Fungi, G
+
/G
-
 
bacteria 
MsβGRP-1 activates 
PPO in the presence of 
Laminarin 
(Ma and 
Kanost, 
2000) 
MsβGRP-2 β-1, 3-glucan 
recognition 
proteins 
Fungi, G
+
/G
-
 
bacteria 
MsβGRP-2 stimulates 
PO activity after 
binding to Laminarin 
(Jiang et al., 
2004) 
MsMBP microbe 
binding protein 
Fungi, G
+
/G
-
 
bacteria 
MsMBP enhances PO 
activity at low 
concentration and 
inhibit PO at high 
concentration 
(Wang et 
al., 2011) 
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The Drosophila IMD Pathway 
Gram-positive bacterial and fungal infections are mostly recognized by the 
Drosophila Toll pathway. In contrast, the IMD signaling pathway plays a key role in the 
recognition of Gram-negative bacteria. IMD signaling is triggered by DAP-type PG from 
Gram-negative and some Gram-positive bacteria. PGRP-LC, which encodes three 
alternative splice variants PGRP-LCa, PGRP-LCx and PGRP-LCy, is critical for the 
initiation of the IMD pathway (Werner et al., 2003). The PGRP-LCa and PGRP-LCx 
proteins contain a transmembrane domain and can recognize tracheal cytotoxin (TCT) in 
DAP-type PG (Chang et al., 2006; Chang et al., 2005; Kaneko et al., 2004; Kaneko and 
Silverman, 2005; Mellroth et al., 2005). The function of PGRP-LCy is partially redundant. 
DAP-type PG triggers the formation of the heterodimer of PGRP-LCa and PGRP-LCx or 
the homodimer of PGRP-LCx (Werner et al., 2000). PGRP-LE lacks the transmembrane 
domain. In the cell, PGRP-LE as the receptor recognizes PG; however, outside the cell, 
PGRP-LE is the co-receptor for PGRP-LC (Kaneko et al., 2006; Yano et al., 2008). Other 
PGRP family members play either negative or positive roles (Stenbak et al., 2004). For 
example, PGRP-SC1b inhibits the activation of AMPs in Drosophila blood cell lines 
(Mellroth et al., 2003). 
Signal from extracellular region triggers the formation of PGRP-LC receptors 
hetero- or homo-dimers and the cytoplasmic domains of receptors interact with IMD. 
IMD is a DD-containing protein, which recruits an adaptor protein Fas-associated death 
domain-containing protein (FADD) (Georgel et al., 2001). FADD is connected to a 
caspase Death-related ced-3/Nedd2-like protein (DREDD). DREDD proteolytically 
cleaves IMD and the transcription factor NF-κB protein Relish (Leulier et al., 2000; 
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Paquette et al., 2010; Stoven et al., 2000). Cleaved IMD binds to the E3-ligase Inhibitor 
of apoptosis proteins 2 (IAP2), E2-ubiquitin-conjugating enzymes variant 1a (UEV1a), 
Bendless Uncoordinated protein 13 (Unc13), and Effete ubiquitin-conjugating enzyme 5 
(Ubc5), which polyubiquitinate the cleaved IMD for degradation. The ubiquitin signaling 
activates the downstream Transforming growth factor-β activated kinase 1 (Tak1).  In 
Drosophila, the N-terminal kinase (JNK) pathway is a branch of the IMD pathway, and 
Tak1 phosphorylates and activates transcription factor activator protein 1 (AP-1), which 
up-regulates the transcription of stress response or wound repair genes (Riesgo-Escovar 
et al., 1996; Sluss et al., 1996). In the IMD signaling pathway, Tak1 activates Drosophila 
inhibitor NF-κB proteins kinase (IKK) complex, which consists of two subunits, the 
kinase called Immune response deficient 5 (Ird5) and the regulatory subunit Kenney (Lu 
et al., 2001; Rutschmann et al., 2000; Silverman et al., 2003; Silverman et al., 2000; 
Vidal et al., 2001). Both IKK complex and DREDD are required for the cleavage of 
transcription factor Relish (Silverman et al., 2000). Relish contains an N-terminal Rel 
homology domain (RHD) and a C-terminal inhibitor NF-κB (IκB) part. In non-signaling 
condition, the IκB part inhibits RHD activity and nuclear localization. In immune 
challenge, Relish is phosphorylated and cleaved by kinase Ird5 and caspase DREDD. The 
IκB region is degraded and releases the NF-κB part, which translocates to the nucleus and 
activates the transcripts of AMPs (Stoven et al., 2000; Stoven et al., 2003) (Figure 3).  
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Figure 3. Drosophila IMD Pathway 
The IMD pathway is initiated by the binding of PGRP-LC dimer to the DAP-type PG. 
The dimer recruits IMD protein, which connects to the caspase DREDD through the 
adaptor protein FADD. DREDD cleaves IMD, which is polyubiquitinated and degraded. 
DREDD also cleaves Relish and releases the C-terminus of Relish. The N-terminal RHD 
region translocates into the nucleus and activates the transcription of downstream genes 
(Kleino, 2010).   
 
(Kleino, A., The Imd Pathway-mediated Immune Response) 
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The Mammalian Toll-like Receptors (TLRs) Pathways 
In vertebrate animals, TLRs, which are type I transmembrane receptors, serve in 
innate immune response to recognize a variety of PAMPs. The TLRs contain an 
evolutionarily conserved leucine-rich repeat (LRR) domain in the extracellular region and 
a TIR domain in the cells. Individual TLRs can distinguish different pathogens from self 
and directly bind to the conserved motifs found in distinct microorganisms, but not in 
hosts (Bischoff et al., 2004). TLR2, TLR1, TLR6, TLR5, and TLR11 localize to the 
plasma membrane. TLR4 localizes to both cell membrane and endosomes, while TLR3, 
TLR7, TLR8, and TLR13 localize to endosomes. The location of TLRs is dependent on 
the site of their ligands. TLRs localizing at the cell membrane detect specific cell wall 
components as ligands in blood; however, TLRs in the endosomes recognize microbial 
nucleic acid. The binding of ligands to the receptors triggers the formation of TLR dimers, 
which initiate the intracellular signaling pathway. TLR2 associates with TLR1 or TLR6 
to form heterodimers that recognize a variety of microbial cell wall components, 
including LYS-type PG, lipoprotein/lipopeptides from several bacteria (Akira et al., 2001; 
Medzhitov, 2001). Diacylated and Triacylated lipopetides are recognized by TLR2-TLR6 
and TLR2-TLR1, respectively (Takeuchi et al., 2001; Takeuchi et al., 2002). The 
proinflammatory signaling initiated by the bacterial flagellin is mediated by TLR5 
(Hayashi et al., 2001). TLR11 plays an important role to detect uropathogenic bacteria 
(Zhang et al., 2004). In endosomes, homodimer TLR3 is involved in the recognition of 
double-stranded RNA (dsRNA) originating from viral replication within infected cells 
(Alexopoulou et al., 2001). The TLR7-TLR8 heterodimer recognizes many synthetic 
chemicals, like imiquimod, that is a potential antiviral chemical, and single-stranded viral 
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RNA (Diebold et al., 2004; Heil et al., 2004; Hemmi et al., 2002; Lund et al., 2004). 
Bacterial ribosomal RNA is recognized by the homodimer TLR13 (Hidmark et al., 2012; 
Li and Chen, 2012; Oldenburg et al., 2012). Homodimer TLR9 is crucial for the 
recognition of bacterial or viral nucleotides with rich hypomethylated CpG-
deoxyribonucleic acid (DNA) motifs (Hemmi et al., 2000). LPS can be recoginzed by 
TLR4. The target PAMPs of all mammalian TLRs, specific immune cells expression, 
signal adaptors, and downstream effectors are summarized in Table 3. 
Extracellular signals trigger the dimerization of receptors, which initiate the 
intracellular pathway. There are also two basic intracellular pathways, the MyD88-
dependent and MyD88-independent pathways. TLR2, TLR1, TLR6, TLR5, TLR11, 
TLR7, TLR8, and TLR13 trigger a MyD88-dependent pathway in the cell. In contrast, 
TLR3 lead to a MyD88-independent pathway. Only TLR4 dimers can activate both 
pathways. 
In the MyD88-dependent pathway, the dimers of TLRs recruit MyD88, an adaptor 
protein with the help of another adaptor protein MyD88-adaptor-like protein (MAL). 
TLRs interact with MyD88 via their intracellular TIR domain. MyD88 contains a death 
domain, which recruits the IL-1R-assocaited protein kinases (IRAKs) through DD 
domain interaction (Wesche et al., 1997). The interaction induces the recruitment of 
tumor necrosis factor receptor-associated factor 6 (TRAF6) and then triggers the 
formation of IRAKs/TRAF6 heterocomplex. IRAKs/TRAF6 heterodimer causes 
conformational changes and leaves the receptor dimers. The complex recruits kinase 
complex TAK1-binding proteins 2 (TAB2)/TAK1/TAK1-binding proteins 1 (TAB1). 
The TAB2/TAK1/TAB1/TRAF activates the mitogen-activated protein kinases (MAPKs), 
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which induce JNK and p38 pathways to up-regulate the proinflammatory cytokines 
(Flannery and Bowie, 2010; Wong et al., 1999). The complex also activates IKK, which 
phosphorylates and degrades IκBs. In nonsignaling conditions, IκBs sequester the 
transcription factor NF-κB in the cytoplasm. In immune recognition, IκBs are degraded 
and release NF-κB, which translocates into the nucleus and activates the transcription of 
effector genes (Silverman and Maniatis, 2001). In endosome signals, there is another 
pathway that can be activated. IRAKs/TRAF3 directly recruits IKK, which activates 
interferon-regulatory factor 7 (IRF7) translocating into the nucleus to induce the 
transcription of Type I interferons (IFNs) (O'Neill et al., 2013). 
In the MyD88-independent pathway, also called the TRIF-dependent pathway, the 
dimer of TLRs recruits TIR domain-containing adaptor protein inducing interferon-β 
(TRIF) with the help of TRIF-related adaptor molecule (TRAM) via their TIR domain 
interaction (Fitzgerald et al., 2003; Oshiumi et al., 2003a; Yamamoto et al., 2003; 
Yamamoto et al., 2002). TRIF interacts with tumor necrosis factor receptor-associated 
factor 3 (TRAF3), which activates IKK. IKK leads to the translocation of transcription 
factor interferon-regulatory factor 3 (IRF3) into the nucleus and activates the expression 
of Type I IFNs (Oshiumi et al., 2003b).  
Now I will interpret the TLR4-MD2-LPS pathway in more detail. In mammals, 
the TLR4-MD2-LPS pathway is elicited by a soluble acute-phase protein, LPS-binding 
protein (LBP), that rapidly responds to bacterial LPS. LBP contains two bactericidal 
permeability-increasing domains (BPI), which recoginze and bind to LPS in the blood 
(Kirkland et al., 1990). LBP transfers LPS to a pattern recogition protein called cluster of 
differentiation 14 (CD14), which exists as glycosylphosphatidylinositol (GPI)-anchored 
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and soluble forms (Ferrero et al., 1990; Pugin et al., 1994). CD14 forms a dimer via its C-
terminal domain, and accepts LPS at each N-termial domain (Kim et al., 2005). 
Membrane-bound CD14 increases the local concentration of LPS and transfers LPS to a 
soluble myeloid differentiation factor 2 (MD2), which is a chaperone and co-receptor for 
TLR4 (Shimazu et al., 1999). The binding triggers a conformation change, which induces 
the formation of LPS-MD2-TLR4 complex (Schromm et al., 2001). The multimer 
triggers TLR4 dimerization, which initiates the intracellular siganling. TLR4 dimer leads 
to the translocation of transcription factors cyclic AMP-responsive element-binding 
proteins (CREB), AP1, and NF-κB to the nucleus via MyD88-dependent pathway and 
activates the transcription of traget genes (Han et al., 1993; Kawai et al., 1999; Sen and 
Baltimore, 1986). Another transcription factor IRF3 can be activated by TLR4 dimer via 
MyD88-independent pathway (Hoebe et al., 2003). The active IRF3 translocates into the 
nucleus, then binds to the promoters of IFNβ genes. The general story of TLRs is 
summerized in Figure 4. 
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Figure 4. Mammalian TLRs Signaling Pathways 
In mammalian systems, TLRs as PRRs recognize and directly bind to pathogens and 
initiate the intracellular signaling pathway (Bischoff et al., 2004). TLR2, TLR1, TLR6, 
TLR5, and TLR11 in the plasma membrane detect the cell wall components of 
microorganisms in the blood. TLR4 locating to both cell membrane and endosomes 
recognizes LPS from Gram-negative bacteria. Instead, TLR3, TLR7, TLR8, and TLR13 
in endosomes bind to microbial nucleic acid. The binding of ligands to the receptors 
triggers the formation of TLR hetero- or homo-dimers. TLR2, TLR1, TLR6, TLR5, 
TLR11, TLR7, TLR8, and TLR13 activate a MyD88-dependent pathway in the cell. In 
contrast, TLR3 leads to a TRIF-dependent pathway. Only TLR4 initiates both pathways. 
In the two pathways, MyD88 or TRIF recruits a serial of adaptor proteins, kinases, or 
caspases. Activation of signaling pathways releases the transcription factors in the 
cytoplasm such as NF-κB, IRF7, IRF3, CREB, and AP1, which translocate into the 
nuclues and activate the transcription of target genes, such as AMPs, IFNβ gene, IFNs, 
Type I IFNs.  
 
(O'Neill, L. A., Golenbock, D., Bowie, A. G., 2013. The history of Toll-like receptors - 
redefining innate immunity. Nat Rev Immunol. 13, 453-60.) 
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Table 3 TLR-Targeted Therapeutics 
TLR 
Immune Cell 
Expression 
PAMPs 
Signal 
Adaptor 
Production 
TLR1+ 
TLR2 
Cell surface 
Mo, MΦ, DC, 
B 
Triacylated lipoproteins 
(Pam3CSK4) 
PG,LPS 
TIRAP, 
MyD88, 
Mal 
IC 
TLR2+ 
TLR6 
Cell surface 
Mo, MΦ, MC, 
B 
Diacylated lipoproteins 
(FSL-1) 
TIRAP, 
MyD88, 
Mal 
IC 
TLR3 
Endosomes 
B, T, NK, DC 
dsRNA (poly (I:C)) 
tRNA, siRNA 
TRIF 
IC, 
type1 IFN 
TLR4 
Cell surface/ 
endosomes 
Mo, MΦ, DC, 
MC, 
IE 
LPS 
Paclitaxel 
TRAM, 
TRIF 
TIRAP, 
MyD88 
Mal 
IC, 
type1 IFN 
TLR5 
Cell surface 
Mo, MΦ, DC, 
IE 
Flagellin  MyD88 IC 
TLR7 
Endosomes 
Mo, MΦ, DC. 
B 
ssRNA 
Imidazoquinolines (R848) 
Guanosine analogs (Loxoribine) 
MyD88 
IC, 
type1 IFN 
TLR8 
Endosomes 
Mo, MΦ, DC, 
MC 
ssRNA, 
Imidazoquinolines (R848) 
MyD88 
IC, 
type1 IFN 
TLR9 
Endosomes 
Mo, MΦ, DC, 
B,T 
CpG DNA 
CpG ODNs 
MyD88 
IC, 
type1 IFN 
TLR10 
Endosomes 
Mo, MΦ, DC 
profilin-like proteins MyD88 IC 
 
Mo: monocytes, MΦ: macrophages, DC: dendritic cells, MC: Mast cells, B: B cells, T: T 
cells, IE: Intestinal epithelium, IC: Inflammatory cytokines 
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NF-κB Transcription Factors 
Nuclear factor kappa B (NF-κB), which consists of a family of transcription 
factors in insects and mammals, but not in bacteria, fungi, plants, or C. elegans, plays a 
crucial role in apoptosis, inflammation, immunity, cell proliferation, differentiation, and 
survival. In humans, there are five NF-κB members (Figure 5); and the Drosophila 
genome codes for three homologs (Figure 6). Based on the different regulatory 
mechanisms, secondary structure, and transactivation potential, NF-κB transcription 
factors are divided into four groups. 
Class I NF-κB factors contain human RelA (p65), RelB, c-Rel, Drosophila Dorsal 
and Dif. They share a conserved 300 amino acids long RHD motif at the N-terminal 
region, which is critical for formation of homo- or hetero-dimers, binding to promoters, 
interaction with IκB, and nuclear translocation. They also contain a C-terminal 
transactivation domain (TAD) (Baldwin, 1996; Ghosh et al., 1998) (Figures 5 and 6). In 
this group, only RelB includes an N-terminal Leucine zipper motif (Dobrzanski et al., 
1993). The primary mechanism for regulating class I NF-κB factors is phosphorylation-
induced proteolysis. In un-stimulated conditions, RHD is sequestered in the cell 
cytoplasm via interacting with ankyrin (ANK) repeats in IκB. In immune recognition, the 
IKK complex phosphorylates, ubiquitinates, and degrades IκB to release NF-κB. The 
active NF-κB translocates into the nucleus to activate the transcript of target genes 
(Brown et al., 1995). Drosophila Dorsal and Dif are 45% identical to the mammalian c-
Rel, RelA, and RelB. Dorsal and Dif are retained in the cytosol via binding to Cactus, 
which is homologous to mammalian IκBa (Geisler et al., 1992; Huguet et al., 1997). 
Cactus contains an IκB conserved domain, ANK repeats, an N-terminal acidic domain 
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(Ac), and C-terminal proline, glutamic acid, serine, and threonine-rich segment (PEST) 
(Figure 6) (Oeckinghaus and Ghosh, 2009). 
The class II NF-κB factors include human p100 and p105, which are the 
precursors of p52 and p50, respectively. Proteolysis is required for activation of the class 
II NF-κB factors. They contain a RHD at the N-terminal region, followed by a glycine 
rich region (GRR) and multiple copies of ANK, and a DD at the C-terminal region. C-
terminal ANK is characteristic of IκB, which inhibits nuclear translocation and 
transcriptional activity of the N-terminal RHD domain. Under the immune challenge, 
p100 and p105 are proteolytic cleaved after phosphorylation and ubiquitination to remove 
ANK repeats, then the active p52 and p50 are released (Huguet et al., 1997; Hultmark, 
2003). 
The class III NF-κB factor is Drosophila Relish, which contains an N-terminal 
RHD and C-terminal ANK repeats typical of mammalian IκB and Drosophila Cactus. 
Drosophila Relish requires caspase-mediated cleavage to degrade ANK repeats and 
release RHD region, which translocates to the nucleus and activates the transcript of 
target genes (Stoven et al., 2003). 
Class IV NF-κB factors consists of a family of nuclear factors of activated T-cells 
(NF-AT) transcription factors, and induce the downstream genes in the adaptive immune 
system. 
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Figure 5. Mammalian members of the NF-κB, IκB, and IKK protein families 
ANK, ankyrin repeats; CC, coiled-coil; DD, death domain; GRR, glycine-rich region; 
HLH, helix-loop-helix; IKK, IκB kinase; LZ, leucine-zipper; NBD, NF-kappaB essential 
modulator (NEMO)-binding domain; PEST, proline-, glutamic acid-, serine-, and 
threonine-rich region; TAD, transactivation domain; ZF, zinc finger  
 
(Oeckinghaus, A., Ghosh, S., 2009. The NF-kappaB family of transcription factors and 
its regulation. Cold Spring Harb Perspect Biol. 1, a000034.) 
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Figure 6. The NF-κB and IκB proteins in Drosophila. 
REL, Rel-homology domain; NLS, nuclear localization sequence; PEST, proline, 
glutamic acid, serine, and threonine-rich segment; Ac, acidic domain. 
 
(Hetru, C., Hoffmann, J. A., 2009. NF-kappaB in the immune response of Drosophila. 
Cold Spring Harb Perspect Biol. 1, a000232.) 
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Insect AMPs 
Insects produce a battery of antimicrobial peptides (AMPs) and the synthesis of 
AMPs is controlled by the Toll and Imd pathways in Drosophila. If there is no microbial 
infection, the level of AMPs is non-detectable in the insect body. Once the hosts are 
infected by microorganisms, AMPs are rapidly synthesized within hours in the insect fat 
body, the functional analog of the mammalian liver. To defend the intruder from midgut 
or epidermis, AMPs are secreted and accumulated in the insect hemolymph. AMPs, 
which normally contain between 12 and 50 amino acids, are small cationic proteins. 
AMPs are synthesized as inactive precursors, which require proteolysis to form the active 
proteins/peptides. According to their secondary structures, AMPs can be classified into 
four groups: (i) alpha-helix proteins (Bulet et al., 1999; Dimarcq et al., 1998), (ii) 
Cysteine-rich AMPs (Barbault F, 2003), (iii) proline-rich peptides, (iv) glycine-rich 
peptides (Bulet and Stocklin, 2005; Otvos, 2000). AMPs include several positive charge 
residues, such as Arginine, Lysine, or Histidine and more than 50% hydrophobic residues. 
In solution, the AMPs are randomly folded. When AMPs detect and bind to bacteria, 
amphipathicity allows AMPs to partition into the bacterial membrane and form pores to 
change the permeability of the cell wall and lyze bacteria (Dathe and Wieprecht, 1999; 
Durr et al., 2006; Hancock and Lehrer, 1998; Oren and Shai, 1998; Papagianni, 2003; 
Pieters et al., 2009; Sitaram and Nagaraj, 2002; Wang, 2006). 
In Drosophila, AMPs can be classified into seven families, including Attacin 
(Kockum et al., 1984), Diptericin (Dimarcq et al., 1988; Wicker et al., 1990), Cecropin 
(Boman et al., 1991), Drosocin (Bulet et al., 1993) that inhibits Gram-negative bacteria; 
Defensin (Hoffmann and Hetru, 1992) with activities against Gram-positive bacteria; 
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Drosomycin (Fehlbaum et al., 1994) and Metchnikowin (Levashina et al., 1995) with 
activities against fungi (Table 4). 
In M. sexta, many AMPs were identified, including Lysozyme with bacteriolytic 
activity (Mulnix and Dunn, 1994; Russell and Dunn, 1991), Cecropin that can inhibit 
Gram-negative bacteria (Dickinson et al., 1988), Moricin with antimicrobial activity 
against Gram-negative and Gram-positive bacteria (Dai et al., 2008), Lebocin A, B, C 
and Gloverin, which can inhibit Gram-negative and Gram-positive bacteria, and fungi 
(Rao et al., 2012; Rayaprolu et al., 2010; Xu et al., 2012). Many AMPs are common in 
insects and have been identified in several insect orders; however, Moricin and Gloverin 
are only found in Lepidoptera so far (Table 5). 
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Table 4 Antimicrobial Peptides in Drosophila 
Peptides Main Activity concent
ration 
3-D structure Reference 
Diptericin Gram-negative 
bacteria 
0.5 μM nd (Dimarcq et 
al., 1988; 
Wicker et al., 
1990) 
Attacin Gram-negative 
bacteria 
nd nd (Kockum et 
al., 1984) 
Drosocin Gram-negative 
bacteria 
40 μM 
 
(Bulet et al., 
1993) 
Cecropin Gram-positive 
and Gram-
negative 
bacteria, 
Fungi 
20 μM 
 
(Boman et 
al., 1991; 
Ekengren and 
Hultmark, 
1999) 
Defensin Gram-positive 
bacteria 
1 μM 
 
(Hoffmann 
and Hetru, 
1992; Imler 
and Bulet, 
2005) 
Drosomycin Fungi 100 μM 
 
(Fehlbaum et 
al., 1994; 
Landon et al., 
1997) 
Metchnikowin Fungi 10 μM nd (Levashina et 
al., 1995) 
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Table 5 Antimicrobial Peptides in M. sexta 
Peptides Main Activity 3-D structure Reference 
Lysozyme Bacteriolytic nd (Mulnix and Dunn, 
1994; Russell and 
Dunn, 1991) 
Cecropin Gram-negative 
bacteria 
nd (Dickinson et al., 
1988) 
Attacin nd nd  
Moricin Gram-positive 
and Gram-
negative 
bacteria 
 
 
(Dai et al., 2008) 
Lebocin A, B, C Gram-positive 
and Gram-
negative 
bacteria, 
Fungi 
nd (Rao et al., 2012; 
Rayaprolu et al., 
2010) 
Gloverin Gram-positive 
and Gram-
negative 
bacteria, 
Fungi 
nd (Xu et al., 2012) 
Defensin nd nd  
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Questions and Hypotheses 
Based on the previous research, the best models to investigate the innate immune 
pathways are Drosophila melanogaster and Manduca sexta both in vivo and in vitro 
experiments. In my research, I identified several components of innate immunity in M. 
sexta and also demonstrated the synthesis of AMPs is mediated by highly conserved 
mechanism, Toll and Imd pathways in invertebrates. 
As introduced above, the Toll pathway was initially identified for its role in the 
early dorsal – ventral (DV) patterning of the Drosophila embryo. The pathway has been 
well studied in D. melanogaster, but less characterized in other insect species. Although 
Toll and Spz genes have been identified in other insects, interactions between a Toll 
receptor and a Spz from the same insect species other than D. melanogaster have not 
been demonstrated. In chapter 2, I will propose that there is a Toll-Spz pathway in M. 
sexta and this pathway is conserved in insects.    
In mammals, Toll-like receptor 4 (TLR4) is the receptor that recognizes LPS. 
MD2 is required for the recognition of LPS and binding to TLR4. In insects, the IMD and 
Toll signaling pathways have been identified; however receptors that can recognize LPS 
have not been discovered in invertebrates. In chapter 3, I hypothesize that insects have a 
similar Toll-ML-LPS pathway and the recognition of LPS is highly evolutionary 
conserved from insects to humans. 
NF-κB transcription factors play essential roles in the regulation of innate 
immune responses. In Drosophila, Relish containing both a Rel-homology domain and an 
inhibitor κB (IκB)-like domain has well been studied. However, how the short isoforms 
of Relish containing only RHD or IκB-like domain regulate the gene expression is not 
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clear. In chapter 4, I investigated the functions of two short isoforms of Relish and Dorsal 
from M. sexta and the role of MsDorsal and MsRel2 heterodimer in the activation of 
AMP production. 
Recognition of pathogens by insect pattern recognition receptors (PRRs) is critical 
to mount effective immune responses. Identifying new members of surveillance 
molecules and investigating functions of new members can advance our understanding on 
how the PRRs recognize pathogen-associated molecular patterns (PAMPs) and their 
crucial roles in immune responses. In chapter 5, I aim to characterize and functional 
analyze βGRP3, a new member of the M. sexta βGRP/BGRP family. 
Insects can synthesize a variety of AMPs with activities against bacteria, fungi, 
viruses and some parasites. Some AMPs, such as Cecropin, Attacin and Defensin, are 
common and present in most insect species, while others like Moricin, Gloverin and 
Lebocin have been identified only in lepidopteran insects so far. Gloverin is a glycine-
rich and heat stable antimicrobial protein. In chapter 6, I will investigate the expression 
profile, binding ability and antimicrobial activity of M. sexta Gloverin (MsGlv). 
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CHAPTER 2 
A TOLL-SPÄTZLE PATHWAY IN THE TOBACCO HORNWORM, MANDUCA 
SEXTA 
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Abstract 
Insects synthesize a battery of antimicrobial peptides (AMPs) and expression of 
AMP genes is regulated by the Toll and Imd (immune deficiency) pathways 
in Drosophila melanogaster. The Drosophila Toll pathway is activated after Spätzle (Spz) 
is cleaved by Spätzle processing enzyme (SPE) to release the active C-terminal C106 
domain (DmSpz-C106), which then binds to the Toll receptor to initiate the signaling 
pathway and regulate expression of AMP genes such as drosomycin. Toll and Spz genes 
have been identified in other insects, but interaction between Toll and Spz and direct 
evidence for a Toll-Spz pathway in other insect species have not been demonstrated. Our 
aim is to investigate a Toll-Spz pathway in Manduca sexta, and compare M. sexta and D. 
melanogaster Toll-Spz pathways. Co-immunoprecipitation (Co-IP) assays showed 
that MsToll
ecto
 (the ecto-domain of M. sexta Toll) could interact with MsSpz-C108 (the 
active C-terminal C108 domain of M. sexta Spz), but not with full-length MsSpz 
and DmToll
ecto
 could interact with DmSpz-C106 but not DmSpz, suggesting that the Toll 
receptor only binds to the active C-terminal domain of Spz. Co-expression of MsToll-
MsSpz-C108, but not MsToll-MsSpz, could up-regulate expression of drosomycin gene 
in Drosophila S2 cells, indicating that MsToll-MsSpz-C108 complex can activate the Toll 
signaling pathway. In vivo assays showed that activation of AMP genes, 
including cecropin, attacin, moricin and lebocin, in M. sexta larvae by purified 
recombinant MsSpz-C108 could be blocked by pre-injection of antibody to MsToll, 
further confirming a Toll-Spz pathway in M. sexta, a lepidopteran insect. 
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Introduction 
The innate and adaptive immune systems are two major branches of the defense 
system in multicellular organisms. Innate immunity is the first defensive line that controls 
initial steps of immune responses. It can also profoundly impact the establishment of 
adaptive immune responses (Medzhitov and Janeway, 2000a; Medzhitov and Janeway, 
1997). In innate immune responses, a group of germline-encoded pattern recognition 
receptors (PRRs) can recognize and bind to conserved pathogen-associated molecular 
patterns (PAMPs) present on the invading microorganisms, such as bacteria and fungi, 
but not on the host cells (Janeway, 1989; Medzhitov and Janeway, 1997). The innate 
immune system is composed of humoral and cellular components. Cellular responses 
mainly include blood cells (hemocytes)-mediated immune responses such as nodule 
formation, phagocytosis and melanotic encapsulation, whereas synthesis of antimicrobial 
peptides (AMPs) and activation of the prophenoloxidase system are major components of 
humoral responses (Kanost et al., 2004; Rao et al., 2010). Expression of AMP genes in 
Drosophila melanogaster is regulated by the Toll and immune deficiency (Imd) pathways 
(Choe et al., 2002; De Gregorio et al., 2002; Lemaitre et al., 1995; Lemaitre et al., 1996; 
Ramet et al., 2002). The Drosophila Toll pathway is activated by Gram-positive bacteria 
and fungi, resulting in systemic production of AMPs (Aggarwal and Silverman, 2008; 
Hetru and Hoffmann, 2009). Moreover, the Toll signaling pathway and other pathways 
are involved in controlling hemocyte proliferation and density (Sorrentino et al., 2004; 
Zettervall et al., 2004), as well as melanization (Bettencourt et al., 2004a).  
The Toll pathway was initially identified in early Drosophila embryonic 
development as, the dorsal – ventral (DV) patterning of the embryo, and the dorsal group 
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of genes includes Toll, tube, pelle, cactus, the NF-kB homolog dorsal, and seven genes 
up-stream of the Toll (Belvin and Anderson, 1996; Morisato and Anderson, 1995). Tolls 
and Toll-like receptors (TLRs) have been identified in many animal species, including 
mammals (Shinkai et al., 2006; Takeuchi and Akira, 2010), chicken (Fukui et al., 2001), 
fish (Tsujita et al., 2004), insects (Ao et al., 2008b; Christophides et al., 2002; Evans et 
al., 2006; Imamura and Yamakawa, 2002; Kanzok et al., 2004; Luna et al., 2002; 
Yamagata et al., 1994), shrimp (Yang et al., 2007), and sponge (Wiens et al., 2007). 
However, mammalian TLRs function as pattern recognition receptors but do not have a 
role in development (Kimbrell and Beutler, 2001), whereas the Drosophila Toll pathway 
is involved in both immunity (Lemaitre et al., 1996) and developmental processes (Belvin 
and Anderson, 1996; Halfon et al., 1995; Qiu et al., 1998).  
Activation of the Drosophila Toll pathway is preceded by activation of Spätzle 
(Spz), the Toll receptor ligand (Morisato and Anderson, 1994; Schneider et al., 1994). 
Under non-signaling conditions, a predominantly hydrophobic C-terminal domain of Spz 
is masked by a prodomain of Spz. Embryonic dorsal-ventral patterning, Gram-positive 
bacterial and fungal cell wall components, and virulence factors can activate Spz 
(Valanne et al., 2011). Spz is processed into its active C-terminal C-106 domain in a 
process that involves activation of a cascade of serine proteinases. Proteolysis of Spz 
causes a conformational change, which exposes determinants of C-106 domain that are 
critical for binding to the Toll receptor (Arnot et al., 2010). Two Spz-C106 dimers bind to 
two Toll receptors. Then, the binding triggers a conformational change in the Toll 
receptors to form stable dimers (Hu et al., 2004). The dimeric Toll complexes interact 
with an adaptor protein MyD88 via intracellular TIR (Toll-interleukin 1 resistance) 
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domains (Horng and Medzhitov, 2001; Sun et al., 2002; Tauszig-Delamasure et al., 2002). 
Tube and kinase Pelle are recruited by MyD88 to form a MyD88-Tube-Pelle 
heterotrimeric complex through their death domain (DD)-mediated interactions 
(Moncrieffe et al., 2008; Sun et al., 2002; Xiao et al., 1999). Intracellular signaling leads 
to phosphorylation and degradation of Cactus, which in turn releases Dorsal-related 
immunity factor (Dif) and/or Dorsal to translocate to the nucleus and activate 
transcription of AMP genes (Imler and Hoffmann, 2001; Wu and Anderson, 1998). 
The Toll signaling pathway has been well studied in D. melanogaster, but less 
characterized in other insect species. Although Toll and Spz genes have been identified in 
other insects, including Anopheles gambiae (Christophides et al., 2002; Luna et al., 2002), 
Aedes aegypti (Kanzok et al., 2004), Apis mellifera (Evans et al., 2006), Bombyx mori 
(Imamura and Yamakawa, 2002; Wang et al., 2007), and Manduca sexta (An et al., 2010; 
Ao et al., 2008b), interaction between a Toll receptor and a Spz from the same insect 
species other than D. melanogaster has not been demonstrated. Previously a Toll receptor 
from M. sexta was discovered (Ao et al., 2008b), and Spz-1 gene has also been identified 
(An et al., 2010). M. sexta Spz-1A (MsSpz) was cleaved and activated by proteinase HP8 
to release the active C-terminal domain MsSpz-C108 (An et al., 2010). Injection of 
MsSpz-C108 into M. sexta larvae up-regulates several AMP genes (An et al., 2010), 
suggesting that there is a Toll pathway in M. sexta. In this study, we showed direct 
interaction between M. sexta Toll (MsToll) and MsSpz-C108 and further confirmed a 
Toll-Spz pathway in M. sexta by both in vitro and in vivo assays. We established stable 
Drosophila S2 cell lines expressing M. sexta and D. melanogaster Tolls (MsToll and 
DmToll) and their ecto-domains (MsToll
ecto
 and DmToll
ecto
), Spz proteins (MsSpz and 
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DmSpz) and their active C-terminal domains (MsSpz-C108 and DmSpz-C106). Co-
immunoprecipitation (Co-IP) assays showed that MsToll
ecto
 and DmToll
ecto
 could interact 
with MsSpz-C108 and DmSpz-C106, but not MsSpz and DmSpz, respectively. Co-
expression of MsToll-MsSpz-C108 and DmToll-DmSpz-C106 in S2 cells could up-
regulate drosomycin but not diptericin gene. Activation of AMP genes, including 
cecropin-6, attacin-1, attacin-2, moricin and lebocin, by recombinant MsSpz-C108 in M. 
sexta larvae could be blocked by pre-injection of antibody to MsToll. Our results 
demonstrated a Toll-Spz pathway in M. sexta, a Lepidopteran insect.  
 
Materials and Method 
 
Insect rearing and cell line 
M. sexta eggs were originally purchased from Carolina Biological Supplies 
(Burlington, NC, USA). Larvae were reared on an artificial diet at 25°C (Dunn, 1983), 
and the fifth instar larvae were used for the experiments. D. melanogaster Schneider S2 
cells were purchased from the American Type Culture Collection (ATCC). 
 
Construction of recombinant pMT⁄BiP⁄V5-His A expression vectors 
Complementary DNA (cDNA) fragments encoding MsToll (residues 13-963), 
MsToll
ecto
 (residues 13-718), MsTIR (residues 766-963), MsSpz (residues 20-295), 
MsSpz-C108 (residues 188-295), DmToll (residues 28-1097), DmToll
ecto
 (residues 28-
805), DmTIR (residues 858-1097), DmSpz (residues 26-244), and DmSpz-C106 (residues 
139-244) were amplified by polymerase chain reaction (PCR) using forward and reverse 
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primers listed in Table 6. Forward primers for MsSpz, MsSpz-C108, DmSpz and DmSpz-
C106 contain codons for an in-frame Flag sequence and a KpnI site, while reverse 
primers contain a stop codon followed by a PmeI site. Forward primers for MsToll, 
MsToll
ecto
, MsTIR, DmToll, DmToll
ecto 
and DmTIR contain a KpnI site, while reverse 
primers contain an ApaI site. PCR reactions were performed with the following 
conditions: 94°C for 3 min, 35 cycles of 94°C for 30 s, Tm-5°C for 30 s, 72°C for 30 s to 
4 min, followed by a final extension at 72°C for 10 min. The PCR products were 
recovered by agarose gel electrophoresis-Wizard® SV Gel and PCR Clean-Up System 
(A9285, Promega) and subcloned into T-Easy vectors (A1360, Promega). Plasmid DNAs 
in T-vectors were purified using PureYield™ Plasmid Miniprep System (A1222, 
Promega) according to the manufacturer’s instruction and digested with KpnI/PmeI or 
KpnI/ApaI, DNA fragments were recovered and inserted into KpnI/PmeI or KpnI/ApaI 
digested pMT⁄BiP⁄V5-His A vector (V413020, Invitrogen) using T4 DNA ligase 
(M0202L, New England Biolabs). Recombinant expression vectors were then purified 
and sequenced by an Applied Biosystems 3730 DNA Analyzer in the DNA Sequencing 
and Genotyping Facility at University of Missouri – Kansas City, and used to generate 
stable S2 cell lines. 
 
Cell culture and establishment of stable S2 cell lines 
D. melanogaster S2 cells were maintained at 27°C in Insect Cell Culture Media 
(SH30610.02, Hyclone), supplemented with 10% heat-inactivated fetal bovine serum 
(catalog #10082063, Invitrogen) containing 1% penicillin-streptomycin solution (G6784, 
Sigma-Aldrich). For DNA transfection, cells were seeded overnight in serum-free 
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medium (SH30278.01, Hyclone). GenCarrier-1
TM
 transfection reagent (#31-00110, 
Epoch Biolabs) was used for transient transfection based on the manufacturer’s 
instructions. Cells in culture dishes or plates were grown to 70% confluence prior to 
transfection. DES
®–Inducible⁄Secreted Kit with pCoBlast (K5130-01, Invitrogen) was 
used to construct stable S2 cell lines. To select stable S2 cells expressing recombinant 
proteins, pCoBlast (Invitrogen) was cotransfected with recombinant pMT⁄BiP⁄V5-His A 
vectors. After 48h transfection, S2 cells were centrifuged and resuspended in complete 
growth medium containing 25 μg/ml Blasticidine S hydrochloride (No.15205, Sigma-
Aldrich). Resistant colonies appeared 1 week later.  
 
Western blot analysis and immunoprecipitation (Co-IP) assay 
For Western blot analysis, copper sulfate (final concentration of 250 μM) was 
added to the stable S2 cell lines (2×10
6
 cells/well) in 6-well plates, and protein expression 
was induced for 48 h. Cell culture medium (2 ml each) was collected, stable S2 cells were 
homogenized in 400 μl lysis buffer [50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM 
EDTA, 1% NP-40, 0.5 mM PMSF, protease inhibitor cocktail (P8340, Sigma-Aldrich)]. 
The cell homogenates were incubated on ice for 15 min and sonicated briefly several 
times, and then centrifuged at 15,000 g for 15 min at 4°C. The supernatants were 
collected as cell extracts for Western blot analysis. The cell culture media (10 μl each) 
and cell extracts (10 μl each, equivalent to ~5×104 cells) were separated on 10%, 12%, or 
15% Sodium dodecyl sulfate (SDS) - Polyacrylamide Gel Electrophoresis (PAGE) and 
proteins were transferred to nitrocellulose membranes (162-0097, Bio-Rad). The 
membrane was blocked with 5% BSA in Tris-buffered saline (10 mM Tris-HCl, pH7.6, 
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150 mM NaCl) containing 0.05% Tween-20 (Tris buffered saline (TBS)-T) at room 
temperature for at least 3 h and then incubated overnight with primary antibody at 4°C in 
5% BSA in TBS-T with gentle rocking. Then, the membrane was washed four times with 
TBS-T and incubated with secondary antibody in 5% BSA in TBS-T for 2 h at room 
temperature. After washing four times with TBS-T (10 min each time), the signal was 
developed by using ECL Chemiluminescence Detection Kit (RPN2134, GE Healthcare) 
or alkaline phosphatase (AP)-conjugate color development Kit (#170-6432, Bio-Rad). 
Anti-Flag M2 antibody (F-1804, Sigma-Aldrich, 1:5000 dilution) and anti-V5 antibody 
(V-8012, Sigma-Aldrich, 1:5000 dilution) were used as primary antibodies, horseradish 
peroxidase-conjugate anti-mouse antibody (SC-2005, Santa Cruz Biotechnology, 
1:10,000) was used as secondary antibody for chemiluminescence, and alkaline 
phosphatase-conjugate anti-mouse antibody (A4312, Sigma-Aldrich, 1:10,000) was used 
as secondary antibody for color development. 
Immunoprecipitation (Co-IP) assay was performed by using 300 μl of cell extract, 
which is equivalent to approximately 10
6
 cells, or equivalent cell culture medium 
containing recombinant proteins. The cell extracts or cell culture media were pre-cleared 
for 30 min with 30 μl Protein G Sepharose (50% slurry, No.17-0618-01, GE Healthcare) 
in a total volume of 500 μl. After centrifugation, the supernatant was incubated with anti-
Flag M2 or anti-V5 antibody (final concentration of 10 μg/ml) at 4°C for 10 h with gentle 
rocking. Then, 30 μl Protein G Sepharose (50% slurry) in lysis buffer was added to the 
protein-antibody mixture and incubated at 4°C overnight with gentle rocking. The 
Sepharose beads containing immunoprecipitated proteins were collected after 
centrifugation, washed three times with lysis buffer, re-suspended in 50 μl of 1×SDS 
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sample buffer, boiled at 95°C for 5 min, and used for subsequent immunoblotting 
analysis. 
 
Purification of recombinant MsSpz and MsSpz-C108 
To purify recombinant proteins, stable S2 cells expressing MsSpz or MsSpz-C108 
in 75-cm
2
 flasks were induced for protein expression after addition of copper sulfate 
(final concentration of 250 μM). Cell culture medium was collected continuously for 10 
days starting at 24 h after protein expression by collecting culture medium every day and 
re-suspending the cells with fresh medium. To purify recombinant proteins, cell culture 
medium was combined, cell debris was removed by centrifugation at 1000 g for 10 min at 
room temperature, and cell-free medium was incubated overnight at 4°C with 500 μl of 
Anti-Flag M2 agarose beads (A2220, Sigma-Aldrich) equilibrated with initial buffer (50 
mM Tris-HCl, 150 mM NaCl, pH7.4). Anti-Flag M2 agarose beads were then packed 
into a column (1.5 cm × 1 cm) and cell-free medium was reloaded to the column several 
times at a flow rate of 0.05 ml/min. Then, the column was washed with the initial buffer 
until A280 of the effluent was near zero. The bound proteins were sequentially eluted 
with one ml aliquots of the elution buffer (0.1 M glycine-HCl, pH 3.5, 1% Triton X-100) 
into vials containing 100 μl of 1 M Tris-base, pH 8.0. Fractions were analyzed by 12% or 
15% SDS-PAGE. Fractions containing recombinant MsSpz or MsSpz-C108 were de-
salted with D-salt
TM
 Excellulose
TM
 GF-5 desalting column (#1851850, Pierce) pre-
equilibrated with deionized water (dH2O), and fractions containing recombinant proteins 
were pooled and concentrated. 
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Cleavage of recombinant MsSpz by M. sexta larval plasma 
To test whether MsSpz can be activated by M. sexta larval plasma, induced cell-
free plasma was collected from immunized M. sexta larvae injected with a mixture of 
heat-killed yeast (Saccharomyces cerevisiae, 1.7×10
7
 cells), dry Micrococcus luteus (33 
μg) and heat-killed Escherichia coli XL-1 blue (3.3×107 cells) at 24 h post-injection, and 
the control plasma was collected from naïve larvae. Purified MsSpz (50 μl of 100 ng/μl, 5 
μg) was incubated with 10 μl induced or control plasma in a total of 75 μl at room 
temperature for 2 h. Then 25 μl 4×SDS loading buffer was added to the reaction mixture. 
The reaction mixture was heated to 95°C for 5 min and aliquots (10 μl, an equivalent of 1 
μl original plasma and 0.5 μg recombinant protein) were analyzed by 15 % SDS-PAGE 
and immunoblotting using mouse monoclonal anti-Flag M2 antibody (F-1804, Sigma-
Aldrich, 1:5000 dilution) or rabbit polyclonal anti-MsSpz-C108 antibody (a gift from Dr. 
Michael Kanost, Kansas State University) (1:1000 dilution) as primary antibody. 
 
Dual-Luciferase Reporter Assay 
For Dual-luciferase reporter assays, S2 cells were plated in 96-well culture plates 
(10
4
 cells/well) overnight in serum-free medium. These S2 cells were then transiently co-
transfected with recombinant pMT⁄BiP⁄V5-His A expression plasmid (0.3 μg), pGL3B, 
pGL3B-drosomycin, pGL3B-diptericin or pGL3B-attacin firefly luciferase reporter 
plasmid (0.15 μg) (Rao et al., 2011), and renilla luciferase reporter plasmid (0.015 μg) (as 
an internal standard) (pRL-TK, Promega). After overnight transfection, serum-free 
medium was replaced with complete growth medium containing 250 μM copper sulfate 
(final concentration) for protein expression, and firefly luciferase and renilla luciferase 
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activities were measured 48 h after protein expression using the Dual-Luciferase Reporter 
Assay System (E1980, Promega) in the GloMax
®
 Multi Microplate Luminometer 
(Promega). Relative luciferase activity (RLA) was obtained as the ratio of firefly 
luciferase activity to renilla luciferase activity. RLA from S2 cells co-transfected with 
empty pMT⁄BiP⁄V5-His A and pGL3B (empty reporter vector) plasmids was used as the 
calibrator. These experiments were repeated at least three times (three independent 
biological samples, or three independent cell cultures), and a representative set of data 
was used to make figures.  
 
Real-time PCR analysis 
S2 cells were cultured in 6-well culture plates (10
5 
cells/well) overnight in serum-
free medium, and transiently transfected with recombinant pMT⁄BiP⁄V5-His A expression 
vectors (3 μg each vector). After overnight transfection, serum-free medium was replaced 
with complete growth medium containing 250 μM copper sulfate to induce expression of 
recombinant proteins. After protein expression for 48 h, total RNAs were extracted from 
these S2 cells using TRIzol
®
 Reagent (T9424, Sigma-Aldrich) according to the 
manufacturer’s instructions. Residual genomic DNA was digested by RQ1 RNase-free 
DNase (M6101, Promega). cDNA was prepared from 1 μg total RNA in a 25 μl reaction 
using moloney murine leukemia virus (M-MLV) reverse transcriptase (M1701, Promega) 
with an anchor-oligo(dT)18 primer following the manufacturer’s instructions. Each cDNA 
sample (diluted 1:50) was used as template for quantitative real-time PCR analysis. The 
Drosophila ribosomal protein 49 (rp49) gene was used as an internal standard to 
normalize the amount of RNA template. The primer pairs (Table 6) were designed based 
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on the sequences of rp49, drosomycin and diptericin. The real-time PCR was performed 
in 20 μl reactions containing 10 μl 2×SYBR® GreenERTM qPCR SuperMix Universal (No. 
204141, Qiagen), 4 μl dH2O, 4 μl diluted cDNA template, and 1 μl forward and reverse 
primers (10 pmol each). Real-time PCR program was 2 min at 50°C, 10 min at 95°C, 
followed by 40 cycles of 95°C for 15 s, 60°C for 1 min and the dissociation curve 
analysis. Data from three replicas of each sample were analyzed by the ABI 7500 SDS 
software (Applied Biosystems) using a comparative method (2
−∆∆CT
). The baseline was 
set automatically by the software to maintain the consistency. cDNA sample from S2 
cells transfected with empty pMT⁄BiP⁄V5-His A plasmid was used as the calibrator. The 
expression levels of drosomycin and diptericin transcripts in other cDNA samples were 
calculated by the 2
−∆∆CT 
method, which stands for the n-fold difference in relative 
expression to the calibrator. All the data were presented as relative mRNA expression. 
These experiments were repeated at least three times. 
 
Injection of MsSpz and MsSpz-C108 into M. sexta larvae 
Day 1 fifth instar M. sexta naïve larvae were injected with water (as a negative 
control), purified recombinant MsSpz (3 μg /larva), or MsSpz-C108 (1 μg /larva). Twenty 
hours later, fat body and hemocyte samples were collected, total RNA was isolated with 
TRIzol
®
 Reagent (Sigma-Aldrich), and cDNA was prepared with ImProm-II reverse 
transcriptase (Promega) as described above. Each cDNA sample (diluted 1:50) was used 
as template for real-time PCR analysis. M. sexta ribosomal protein S3 (rpS3) gene was 
used as an internal standard to normalize the amount of RNA template. AMP genes, 
including cecropin-6 (AY232302.1), attacin-1 (DQ072728.1), attacin-2 (AY232304.1), 
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lebocin-b and lebocin-c (GU563901.1 and GU563900.1), moricin (AY232301.1) and 
lysozyme (S71028.1) were detected with primer pairs (10 pmol each) listed in Table S1. 
cDNA sample from naïve larvae was used as the calibrator. The expression levels of 
AMP genes from other samples were calculated by the 2
−∆∆CT 
method. All the data were 
presented as relative mRNA expression. These experiments were repeated at least three 
times. 
 
Injection of antibody to MsToll into M. sexta larvae 
To test whether MsSpz-C108 binds to MsToll in M. sexta larvae to stimulate 
expression of AMP genes, day 1 fifth instar M. sexta naïve larvae were pre-injected with 
purified IgG to the ecto-domain of MsToll (Toll Ab, 5 μg/larva) or IgG from pre-immune 
rabbit serum (Control Ab, 5 μg/larva), and these larvae were then injected with water, 
purified recombinant MsSpz (3 μg/larva), MsSpz-C108 (1 μg/larva), TLR grade 
peptidoglycan from Staphylococcus aureus (PG-SA) or Escherichia coli (PG-K12) 
(Invivogen), or without second injection (control) at 1 h after pre-injection of antibody. 
Twenty hours later, fat body and hemocyte samples were collected for quantitative real-
time PCR analysis. Total RNA and cDNA samples were prepared as described above. M. 
sexta ribosomal protein S3 (rpS3) gene was used as an internal standard to normalize the 
amount of RNA template. Expression of cecropin-6, attacin-1, lebocin-b/c, moricin and 
lysozyme genes were determined by real-time PCR as described above. These 
experiments were repeated at least three times. 
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Data analysis 
One representative set of data was used to make figures using the Graphpad Prism 
software, and the significance of difference was determined by an unpaired t-test or by 
one way ANOVA followed by a Tukey’s multiple comparison test with the Graphpad 
InStat software (GraphPad, San Diego, CA). 
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Table 6 PCR primers used in this study 
Primers Forward Primer (5’  3’)  Reverse Primer (5’  3’) 
For protein expression   
DmTIR_N_KpnI ATGGTACCAAAGTTCG
ATGCCTTCATCTCG 
DmTIR_C_ApaI ATGGGCCCTACGTCG
CTCTGTTTGGCA 
MsTIR_ N_KpnI ATGGTACCACCGTACG
ACGCGTTTGTGTCTTT
CGCACA 
MsTIR_C_ApaI ATGGGCCCTTTGTAG
CAAGGACTCGCGCCC
GGCGCTGG 
DmToll_N_KpnI ATGGTACCAATGAGTC
GACTAAAGGCC 
DmToll_C_ ApaI ATGGGCCCTACGTCG
CTCTGTTTGGC 
  DmToll
ecto
_C_Ap
aI 
ATGGGCCCGAACAC
GCCCTTTTCCGCCGG 
MsToll_N_ KpnI ATGGTACCAATGCAGA
TGCTGAGCTGGCT 
MsToll_C_ ApaI ATGGGCCCTTTGTAG
CAAGGACTCGCGC 
  MsToll
ecto
_C_ 
ApaI 
ATGGGCCCGAACATC
AGCCCATTGGATGA 
MsSpz_N_ KpnI ATGGTACCCATGGACTACAAGGACGACGATGACAAGGCGGCCGC
ATACAAATGCAAAGACTGCTTCAGTTTCGCATCACA 
MsSpz-
C108_N_ KpnI 
ATGGTACCCATGGACT
ACAAGGACGACGATG
ACAAGGCGGCCGCATT
GGGTCCGCAGGA 
MsSpz_C_PmeI CGGTTTAAACTCATA
TGATTGTCAATTTGG
CC 
DmSpz_N_ 
KpnI 
ATGGTACCCATGGACTACAAGGACGACGATGACAAGGCGGCCGC
TATGATGACGCCCATGTGG 
DmSpz-
C106_N_ KpnI 
ATGGTACCCATGGACT
ACAAGGACGACGATG
ACAAGGCGGCCGCTGT
TGGTGGCTCAGACGA 
DmSpz_C_ PmeI CGGTTTAAACTCACC
CAGTCTTCAACGC 
For Real-time PCR   
Drs_N_19 TTGTTCGCCCTCTTCG
CTGT 
Drs_C_208 ATCCTTCGCACCAGC
ACTT 
Dpt_N_37 GCAATCGCTTCTACTT
TGG 
Dpt_C_306 TCTGTAGGTGTAGGT
GCT 
rp49_N_1 ATGACCATCCGCCCAG
CAT 
rp49_C_317 TTCTTGGAGGAGACG
CCGT 
Cec6_N ATTCTTCGTCTTCGCTT
GC  
Cec6_C ATGTAATACTGTAAT
GACAC 
Mor_N ATAAAGCAGGCTGGC
AAGG 
Mor_C AGAAGATTCCGAAG
GGAGAAC 
Att1_N CAATGGACACGGCGCT
ACTCTTACC  
Att1_C ACGCGCCCACCTTGT
CCTTGAAC 
Leb_N ACGTGCGTAGTGTGAA
CGAG 
Leb_C CGCAGATTATGAGTT
ACGACGA 
Lys_N GTGTGCCTCGTGGAGA
ATG 
Lys_C ATGCCTTGGTGATGT
CGTC 
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Primers Forward Primer (5’  3’)  Reverse Primer (5’  3’) 
Glo_N CCCGCAATACGCTCAG
ATA 
Glo_C TGCTGGAAGAGACCT
TGGA 
Att2_N GCCAACGCTTTCGCCA
CCAG 
Att2_C CTTGCCGCCCACAGA
GTAGTCGTT 
rpS3_N GTTGCGAGGTGGTGGT
TTC 
rpS3_C CCGTTCTTGCCCTGT
TGGTC 
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Results 
 
Expression of recombinant M. sexta and D. melanogaster Toll and Spz proteins in S2 
cells 
The Toll-Spz signaling pathway has been well understood in D. melanogaster, but 
is not well characterized in other insect species. In M. sexta, Toll and Spz-1 genes have 
been identified (An et al., 2010; Ao et al., 2008b). In order to investigate a Toll-Spz 
pathway in M. sexta and compare M. sexta and D. melanogaster Toll pathways in S2 
cells, we established stable S2 cell lines expressing Toll receptors (MsToll and DmToll) 
and their TIR (MsTIR and DmTIR) and ecto-domains (MsToll
ecto
 and DmToll
ecto
), as well 
as Spz proteins (MsSpz and DmSpz) and their active C-terminal domains (MsSpz-C108 
and DmSpz-C106). Immunoblotting results showed that recombinant D. melanogaster 
and M. sexta Spz proteins and their active C-terminal domains were detected in both cell 
culture media and cell lysates (Fig. 7A and B). For the active carboxyl-terminal domains 
of Spz, a single protein band was detected in the cells and the cell culture media (Fig. 7A). 
For the full-length Spz proteins, multiple protein bands were detected (Fig. 7B), 
suggesting differential post-translational modifications of Spz proteins, and different 
modified forms of Spz were present in the cell culture media and cells. For the Toll 
receptors, M. sexta Toll (MsToll), MsToll
ecto
 (the ecto-domain) and MsTIR (Fig. 7C and 
E), as well as D. melanogaster Toll (DmToll) and DmTIR (Fig. 7E and F) were detected 
only in S2 cells but not in cell culture media. However, DmToll
ecto
 (the ecto-domain of 
DmToll) was detected as multiple protein bands in S2 cells and a single protein band in 
the cell culture medium (Fig. 7D), also suggesting differential post-translational 
modifications of DmToll
ecto
. One of the DmToll
ecto
 protein bands was just above the 80 
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kDa marker (Fig. 7D, lane 2), which may be a cleavage product because the calculated 
mass of DmToll
ecto
 is 95.8 kDa. For DmToll, cleavage products with sizes slightly larger 
than DmTIR were also detected (Fig. 7F, lane 4), suggesting that DmToll may be cleaved 
in the ecto-domain at a site close to the transmembrane domain. 
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Figure 7. Expression of recombinant M. sexta and D. melanogaster Toll and Spätzle 
proteins in S2 cells. 
M. sexta and D. melanogaster Toll (MsToll and DmToll) and their TIR (MsTIR and 
DmTIR) and ecto-domains (MsToll
ecto
 and DmToll
ecto
), Spätzle proteins (MsSpz and 
DmSpz) and their active C-terminal domains (MsC108 and DmC106) were expressed in 
Drosophila S2 cells, and recombinant proteins in cell culture media (10 μl each from 2 
ml total) and cell lysates (10 μl each from 400 μl total) were identified by 
immunoblotting using anti-Flag M2 antibody or anti-V5 antibody as the primary antibody, 
alkaline phosphatase-conjugate anti-mouse antibody as the secondary antibody and 
alkaline phosphatase (AP) conjugate color development kit. A: MsSpz-C108 (lanes 1 and 
2) and DmSpz-C106 (lanes 3 and 4); B: MsSpz (lanes 1 and 2) and DmSpz (lanes 3 and 
4); C: MsToll
ecto
 (lanes 1 and 2) and MsToll (lanes 3 and 4); D: DmToll
ecto
; E: MsTIR 
(lanes 1 and 2) and DmTIR (lanes 3 and 4); F: DmTIR (lanes 1 and 2) and DmToll (lanes 
3 and 4). Lanes 1 and 3: culture media; lanes 2 and 4: cell lysates. The calculated masses 
of these recombinant proteins are: MsSpz-C108 (14.6 kDa), DmSpz-C106 (14.1 kDa), 
MsSpz (34.1 kDa), DmSpz (27.2 kDa), MsToll
ecto
 (81.9 kDa), MsToll (109.4 kDa), 
DmToll
ecto
 (95.8 kDa), DmToll (128.5 kDa), MsTIR (26.2 kDa), and DmTIR (30.8 kDa).  
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Recombinant M. sexta Spz is activated by induced larval plasma 
To investigate activation of M. sexta Spz, recombinant MsSpz and MsSpz-C108 
were purified from stable S2 cell lines by antibody affinity chromatography (Fig. 8A and 
B). Both recombinant MsSpz and MsSpz-C108 contain a Flag-tag at the amino-terminus, 
and they were recognized by anti-Flag antibody (Fig. 8B). To determine whether 
recombinant MsSpz can be activated by proteinases in M. sexta larval plasma, purified 
MsSpz was treated with induced M. sexta cell-free plasma at room temperature for 2 h, 
and the cleavage products were detected by monoclonal anti-Flag (Fig. 8C) or polyclonal 
anti-MsSpz-C108 (Fig. 8D) antibody. Purified MsSpz (calculated mass of 34.1 kDa) and 
MsSpz-C108 (calculated mass of 14.6 kDa) could be recognized by anti-Flag and anti-
MsSpz-C108 antibodies (Fig. 8C and D, lanes 2 and 4, respectively). After treating with 
induced M. sexta larval plasma, the MsSpz band disappeared and a major band at ~20 
kDa was recognized by anti-Flag antibody (Fig. 8C, lane 3, arrowhead), which 
corresponded to the N-terminal fragment of MsSpz since the Flag-tag was at the N-
terminus, and a cleavage product at ~12 kDa was recognized by antibody to MsSpz-C108 
(Fig. 8D, lane 3, arrowhead), which corresponded to the C-terminal MsSpz-C108. A 
control experiment using naïve plasma showed that very little MsSpz was cleaved. These 
results suggest that MsSpz can be activated by proteinases in the hemolymph of M. sexta 
larvae, and these proteinases may also be induced by microorganisms. The cleavage 
MsSpz-C108 was smaller than the recombinant MsSpz-C108 (Fig. 8D, comparing lanes 3 
and 4) since recombinant protein contained a Flag-tag at the N-terminus. In the plasma 
sample alone, endogenous MsSpz or MsSpz-C108 was not detected by anti-MsSpz-C108 
antibody (Fig. 8D, lane 1), probably due to low concentration of Spz protein in plasma 
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(An et al., 2010). But a band at ~23 kDa in the plasma sample was recognized by anti-
Flag antibody (Fig. 8C, lane 1, asterisk), and several bands were recognized by anti-
MsSpz-C108 antibody (Fig. 8D, lane 1), indicating non-specific recognition of plasma 
proteins by antibodies. 
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Figure 8. Activation of recombinant M. sexta Spätzle by induced larval plasma. 
Recombinant M. sexta Spätzle (MsSpz) and its active C-terminal domain (MsC108 for 
MsSpz-C108) were purified by antibody affinity chromatography and analyzed by SDS-
PAGE (A) (1 μg MsSpz and 1.5 μg MsSpz-C108) and Western blotting (B) (0.5 μg each 
protein) using anti-Flag antibody. Purified recombinant MsSpz was activated by induced 
cell-free plasma collected at 24 h after larvae were injected with a mixture of S. 
cerevisiae, M. luteus and E. coli, and cleavage products were analyzed by Western 
blotting using anti-Flag (C) or anti-MsSpz-C108 (D) as primary antibody, alkaline 
phosphatase-conjugate anti-mouse antibody as the secondary antibody and alkaline 
phosphatase (AP) conjugate color development kit. Panels A and B: lanes 1 and 2 were 
MsSpz and MsC108, respectively. Panels C and D: lane 1, induced plasma (1 μl); lane 2, 
purified recombinant MsSpz (0.5 μg); lane 3, induced plasma (1 μl) + purified MsSpz 
(0.5 μg); lane 4, purified recombinant MsC108 (MsSpz-C108) (0.5 μg). Arrowhead 
indicates the N-terminal cleavage product of MsSpz (C, lane 3) or C-terminal cleavage 
product of MsSpz (D, lane 3), while arrow indicates purified recombinant MsC108 
(MsSpz-C108) (C and D, lane 4).    
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MsToll
ecto 
interacts with MsSpz-C108 but not with MsSpz 
In D. melanogaster, after Spz is activated by proteolysis, the C-terminal active 
domain (DmSpz-C106) is released from prodomain and recognized by the Toll receptor 
to initiate intracellular signaling pathway (Arnot et al., 2010; Hu et al., 2004; Morisato 
and Anderson, 1994; Schneider et al., 1994; Valanne et al., 2011). To determine whether 
MsSpz or MsSpz-C108 can bind to MsToll receptor, we over-expressed the ecto-domain 
of MsToll (MsToll
ecto
) with a V5-His-tag at the C-terminus, and MsSpz and MsSpz-C108 
with a Flag-tag at the N-terminus in S2 cells (Fig. 7). Co-immunoprecipitation (Co-IP) 
assays were performed by mixing individual cell lysates or using co-expression cell 
lysates. For MsSpz, both cell lysate and cell culture medium were used because different 
modified forms of MsSpz were present in culture medium and cells (Fig. 7B). Our results 
showed that when cell lysates containing MsSpz-C108 and MsToll
ecto
 were mixed, Flag 
antibody could pull down both MsSpz-C108-Flag and MsToll
ecto
-V5 (Fig. 9A and B, lane 
4), whereas V5 antibody could precipitate both MsToll
ecto
-V5 and MsSpz-C108-Flag (Fig. 
9C and D, lane 4). Similar results were obtained when cells co-expressing MsToll
ecto
-V5 
and MsSpz-C108-Flag were used for the Co-IP assay (Fig. 9A-D, lane 5). When cell 
lysates and culture media containing MsSpz and MsToll
ecto
 were mixed, or cells co-
expressing MsToll
ecto
 and MsSpz were used for the Co-IP assays, Flag antibody only 
pulled down MsSpz-Flag but not MsToll
ecto
-V5 (Fig. 9E and F, lanes 5-8), while V5 
antibody could precipitate only MsToll
ecto
-V5 but not MsSpz-Flag (Fig. 9G and H, lanes 
5-8). These results suggest that MsToll
ecto
 can interact with MsSpz-C108 but not with 
full-length MsSpz. We also performed Co-IP assays of DmToll
ecto
 with DmSpz-C106 or 
DmSpz, and the results showed that DmToll
ecto
 could interact with DmSpz-C106 but not 
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with DmSpz (Fig. 10). Together, these results indicate that the Toll receptor only binds to 
active form Spz. 
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Figure 9. M. sexta Toll
ecto
 (the ecto-domain) interacts with MsSpz-C108 but not with 
MsSpz. 
The ecto-domain of M. sexta Toll (MsToll
ecto
), Spätzle-1A (MsSpz) and the active C-
terminal domain of MsSpz (MsSpz-C108) were expressed or co-expressed in Drosophila 
S2 cells for 48 h. Proteins in both culture media and cell lysates were used for co-
immunoprecipitation (Co-IP) assays as described in the Materials and Methods. 
MsToll
ecto
 contained a V5-tag, while MsSpz and MsSpz-C108 contained a Flag-tag. 
Monoclonal antibody (anti-FLAG or anti-V5) was added to combined cell lysates, 
combined culture media with cell lysates, co-expression culture media or cell lysates, and 
immunoprecipitated (IP) proteins or Co-IP proteins were detected by immunoblotting 
using anti-Flag or anti-V5 antibody as the primary antibody, horseradish peroxidase-
conjugate anti-mouse antibody as the secondary antibody and ECL chemiluminescence 
detection kit (A-D), or alkaline phosphatase-conjugate anti-mouse antibody as the 
secondary antibody and alkaline phosphatase (AP) conjugate color development kit (E-F). 
Lanes 1-3 from A-D and lanes 1-4 from E-F were cell lysates or culture media alone 
(protein inputs). In the figure, M is for culture media, C for cell lysates, Co-M for culture 
media from co-expression, and Co-C for cell lysates from co-expression.  
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Figure 10. D. melanogaster Toll
ecto
 (the ecto-domain) interacts with DmSpz-C106 but not 
with DmSpz. 
The ecto-domain of D. melanogaster Toll (DmToll
ecto
), Spätzle-1 (DmSpz) and the active 
C-terminal fragment of DmSpz (DmSpz-C106) were expressed or co-expressed in 
Drosophila S2 cells for 48 h. Proteins in both cell culture media and cell lysates were 
used for co-immunoprecipitation (Co-IP) assays as described in the Materials and 
Methods and in Fig. 9 legend. DmToll
ecto
 contained a V5-tag, while DmSpz and DmSpz-
C106 contained a Flag-tag. Monoclonal antibody (anti-FLAG or anti-V5) was added to 
combined cell lysates, combined culture media with cell lysates, co-expression culture 
media or cell lysates, and immunoprecipitated (IP) proteins or Co-IP proteins were 
detected by immunoblotting using anti-Flag or anti-V5 antibody as the primary antibody, 
alkaline phosphatase-conjugate anti-mouse antibody as the secondary antibody and 
alkaline phosphatase (AP) conjugate color development kit. Lanes 1-4 from A-D and 
lanes 1-5 from E-F were cell lysates or culture media alone (protein inputs). In the figure, 
M is for culture media, C for cell lysates, Co-M for culture media from co-expression, 
and Co-C for cell lysates from co-expression. 
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Co-expression of MsToll with MsSpz-C108, but not MsSpz, in S2 cells induces 
transcriptional of the drosomycin gene 
In D. melanogaster, the Toll-Spz pathway activates NF-κB factors Dorsal and Dif 
to induce expression of the drosomycin gene, while the Imd pathway activates NF-κB 
factor Relish to induce diptericin gene expression (Tanji and Ip, 2005). To investigate 
whether MsToll-MsSpz-C108 can activate expression of drosomycin or diptericin genes, 
Drosophila S2 cell lines expressing or co-expressing MsToll and MsSpz-C108 were 
selected for experiments because no M. sexta cell line is available. We first over-
expressed the TIR domains of MsToll and DmToll to determine whether MsToll can 
activate antimicrobial peptide (AMP) genes in S2 cells. Dual luciferase activity assay 
showed that over-expression of DmTIR and MsTIR could activate drosomycin promoter 
significantly, but did not activate diptericin or attacin promoter (Fig. 11), indicating that 
MsToll can activate drosomycin gene in S2 cells. 
We next over-expressed individual D. melanogaster and M. sexta Toll (Toll and 
Toll
ecto
) and Spz (Spz and the active C-terminal domain) proteins or co-expressed 
different combination of Toll and Spz proteins in S2 cells, and then determined activation 
of drosomycin or diptericin gene by dual luciferase reporter assays. As a positive control, 
co-expression of DmToll-DmSpz-C106, but not DmToll-DmSpz, significantly increased 
relative luciferase activity of drosomycin reporter (~40-fold), but did not activate 
diptericin reporter (Fig. 12). Similarly, co-expression of MsToll-MsSpz-C108, but not 
MsToll-MsSpz, also activated drosomycin reporter to a significantly higher level (~25-
fold) than the control, although the level activated by MsToll-MsSpz-C108 was slightly 
lower than that activated by DmToll-DmSpz-C106. Over-expression of DmSpz-C106 
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alone also activated drosomycin reporter to a significantly higher level than the control. 
However, over-expression of Toll, Toll
ecto
 and Spz proteins or co-expression of other 
combinations of Toll and Spz, particularly DmToll-MsSpz-C108 and MsToll-DmSpz-
C106, did not activate drosomycin reporter (Fig. 12), suggesting that only a correct pair 
of Toll-Spz (DmToll-DmSpz-C106 or MsToll-MsSpz-C108) can activate the Toll 
signaling pathway. 
To confirm the dual luciferase results, we also performed real-time PCR on RNA 
isolated from S2 cells over-expressing or co-expressing Toll and Spz proteins (Fig. 13). 
Over-expression of DmSpz-C106 alone significantly increased drosomycin mRNA level 
(~4-fold) compared to the control. Co-expression of MsToll-MsSpz-C108 and DmToll-
DmSpz-C106 increased drosomycin transcript levels to significantly higher levels (14- 
and 18-fold, respectively) than over-expression of DmSpz-C106 alone (Fig. 13A). 
However, over-expression or co-expression of these proteins did not significantly change 
the diptericin mRNA levels compared to the control (Fig. 13B). These results are 
consistent with those of dual luciferase assays (Fig. 12), and further confirm that MsToll-
MsSpz-C108 can activate the transcription of drosomycin but not diptericin gene in S2 
cells. 
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Figure 11. Over-expression of M. sexta Toll TIR domain (MsTIR) in S2 cells activates 
drosomycin promoter reporter. 
Drosophila S2 cells were transiently co-transfected with a recombinant expression 
plasmid (expressing MsToll TIR or DmToll TIR) and a promoter reporter (pGL3B, 
pGL3B-drosomycin, pGL3B-diptericin, or pGL3B-attacinA). These cells were induced 
for protein expression for 48 h, and relative luciferase activity (RLA) in these cells was 
measured by dual-luciferase assay. Activity in cells co-transfected with empty 
pMT⁄BiP⁄V5-His A and pGL3B plasmids was set as 1 (the calibrator). Bars represent the 
mean of three individual measurements ± SEM. Identical letters are not significant 
difference (p>0.05), while different letters indicate significant difference among groups 
(p<0.05) determined by one way ANOVA followed by a Tukey’s multiple comparison 
test. 
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Figure 12. Co-expression of MsToll with MsSpz-C108 but not MsSpz activates 
drosomycin promoter reporter in S2 cells. 
S2 cells were transiently co-transfected with recombinant expression plasmid(s) 
(expressing MsToll, MsToll
ecto
, DmToll, DmToll
ecto
, MsSpz, MsC108 (MsSpz-C108), 
DmSpz or DmC106 (DmSpz-C106), or co-expressing any combinations of Toll and Spz) 
and a promoter reporter (pGL3B, pGL3B-drosomycin or pGL3B-diptericin). These cells 
were induced for protein expression for 48 h, and relative luciferase activity (RLA) in 
these cells was measured by dual-luciferase assay. Activity in cells co-transfected with 
empty pMT⁄BiP⁄V5-His A and pGL3B plasmids was set as 1 (the calibrator). Bars 
represent the mean of three individual measurements ± SEM. Identical letters are not 
significant difference (p>0.05), while different letters indicate significant difference 
among groups (p<0.05) determined by one way ANOVA followed by a Tukey’s multiple 
comparison test. 
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Figure 13. Co-expression of MsToll with MsSpz-C108 but not MsSpz activates 
endogenous drosomycin gene in S2 cells. 
S2 cells were transiently transfected with recombinant expression plasmid(s) (expressing 
MsToll, MsToll
ecto
, DmToll, DmToll
ecto
, MsSpz, MsC108 (MsSpz-C108), DmSpz or 
DmC106 (DmSpz-C106), or co-expressing any combinations of Toll and Spz), and then 
induced for protein expression for 48 h. Total RNAs were prepared from these cells, and 
expression of endogenous drosomycin (A) and diptericin (B) genes was determined by 
real-time PCR. Ribosomal protein  49 (rps49) gene was used as an internal control. Bars 
represent the mean of three individual measurements ± SEM. Identical letters are not 
significant difference (p>0.05), while different letters indicate significant difference 
among groups (p<0.05) determined by one way ANOVA followed by a Tukey’s multiple 
comparison test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
The Toll-Spz pathway regulates expression of AMP genes in M. sexta larvae 
Several antimicrobial peptide (AMP) genes, including cecropin-6, attacin-1, 
attacin-2, moricin, gloverin, lebocin-b and lebocin-c, and lysozyme have been identified 
in M. sexta (Kanost et al., 2004; Rao et al., 2012). It has been reported that injection of 
MsSpz-C108 but not MsSpz into M. sexta larvae can activate some AMP genes (An et al., 
2010). To further confirm regulation of AMP genes in M. sexta larvae, purified 
recombinant MsSpz, MsSpz-C108, or water (the control) was injected into day 1 fifth 
instar M. sexta naïve larvae, and expression of AMP genes in hemocytes and fat body 
was determined. Quantitative real-time PCR results showed that water injection did not 
activate AMP genes in hemocytes and fat body compared to the naïve larvae, and 
injection of MsSpz activates AMP genes to low levels compared to the naïve larvae or the 
water injection control, probably due to activation of some MsSpz by hemolymph 
proteinases (Fig. 14). However, injection of MsSpz-C108 activated all AMP genes 
(except lysozyme) in hemocytes and fat body to significantly higher levels than the 
control (water-injection) and naïve larvae (Fig. 14). These results suggest that M. sexta 
AMP genes can be regulated by the Toll-Spz pathway. Lysozyme was activated by MsSpz 
and MsSpz-C108 to a similarly low level, which was still significantly higher than that of 
the naïve larvae or the water-injection control. Lysozyme mRNA level was significantly 
lower than that of any other AMP genes.  
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Figure 14. Activation of AMP genes by MsSpz-C108 in M. sexta larvae. 
Day 1 fifth instar M. sexta naïve larvae were injected with purified recombinant MsSpz (3 
μg/larva), MsSpz-C108 (1 μg/larva), or water (control), or left untreated (naïve), 
hemocytes and fat body were then collected at 20 h post-injection for preparation of total 
RNAs. Expression of AMP genes, including cecropin-6, attacin-1, attacin-2, lebocin-b/c 
(primers were for the common regions of the two mRNAs), moricin and lysozyme, in 
hemocytes (A) and fat body (B) was determined by real-time PCR. Ribosomal protein S3 
(rpS3) gene was used as an internal control. The bars represent the mean of three 
individual measurements ± SEM. Relative expression of each AMP gene in naïve larvae 
was set as 1. Identical letters are not significant difference (p>0.05), while different 
letters indicate significant difference (p<0.05) among different treatments for each AMP 
gene determined by one way ANOVA followed by a Tukey’s multiple comparison test. 
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Activation of AMP genes in M. sexta larvae by MsSpz-C108 is blocked by antibody to 
MsToll 
In Drosophila, Gram-positive Lys-type peptidoglycan (PG) activates the Toll 
pathway, while Gram-negative meso-diaminopimelic acid (DAP)-type PG activates the 
Imd pathway (Gottar et al., 2002; Leulier et al., 2003; Michel et al., 2001). In M. sexta, 
both Lys-type and DAP-type PGs can activate expression of M. sexta AMP genes (Rao 
and Yu, 2010). To further confirm a Toll-Spz pathway in M. sexta and to test whether 
activation of AMP genes by Lys-type and DAP-type peptidoglycans in M. sexta is 
regulated by the Toll and/or Imd pathways, an antibody blocking assay was performed 
since attempts to silence MsToll gene by RNAi failed. M. sexta larvae were first injected 
with purified IgG to the ecto-domain of MsToll or control IgG from pre-bleed serum, 
then injected with water, recombinant MsSpz or MsSpz-C108, S. aureus PG (PG-SA, 
Lys-type PG), E. coli PG (PG-K12, DAP-type PG), or without a second injection 
(control), and induced expression of AMP genes in hemocytes and fat body was 
determined. 
Real-time PCR results showed that in the control IgG pre-injected larvae, 
injection of water did not activate AMP genes, and injection of MsSpz could activate 
AMP genes to low levels in both hemocytes and fat body (Fig. 15), probably due to 
activation of some MsSpz in the hemolymph. But injection of MsSpz-C108 and PG-SA 
activated all the AMP genes (except lysozyme) to significantly higher levels in hemocytes 
and fat body compared to the injection of water (Fig. 15), and injection of PG-K12 also 
activated some AMP genes (e.g. moricin in hemocytes and fat body, and lebocin-b/c in 
fat body) to significantly higher levels than the water injection (Fig. 15D, H and I). 
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Among MsSpz-C108, PG-SA and PG-K12, MsSpz-C108 activated most AMP genes to 
significantly higher levels than PG-SA and PG-K12 did, and PG-SA activated most AMP 
genes to significantly higher levels than PG-K12 did, but PG-K12 activated moricin in 
hemocytes (Fig. 15D) and lebocin-b/c in fat body (Fig. 15H) to significantly higher levels 
than PG-SA did.  
In the MsToll IgG pre-injected larvae, activation of AMP genes (except lysozyme) 
by MsSpz-C108, PG-SA and PG-K12 in hemocytes and fat body was all except for 
lebocin-b/c in hemocyte (Fig. 15C) significantly suppressed compared to those of the 
control IgG pre-injected larvae (Fig. 15). These results suggest that MsSpz-C108, PG-SA 
and PG-K12 may all activate AMP genes via the Toll-Spz pathway, and binding of 
MsToll IgG to MsToll blocks MsSpz-C108 from binding to MsToll and thus suppresses 
activation of the downstream AMP genes. Although overall activation level of lysozyme 
by MsSpz-C108, PG-SA and PG-K12 was significantly lower than any of the other AMP 
genes, PG-K12 activated lysozyme to significantly higher levels than MsSpz-C108 and 
PG-SA did, and pre-injection of MsToll antibody did not block PG-K12 activated 
expression of lysozyme in hemocytes and fat body (Fig. 15E and J). Pre-injection of 
MsToll antibody also stimulated activation of lebocin-b/c in hemocytes (Fig. 15C), which 
was different from suppression of lebocin-b/c in fat body (Fig. 15H). These results 
suggest that regulation of lysozyme in fat body and hemocytes and lebocin-b/c in 
hemocytes may not be regulated by the Toll-Spz pathway.    
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Figure 15. Activation of AMP genes in M. sexta larvae by MsSpz-C108 is blocked by 
pre-injection of antibody to MsToll. 
Day 1 fifth instar M. sexta naïve larvae were pre-injected with purified IgG to the ecto-
domain of MsToll (Toll Ab, 5 μg/larva) or IgG from pre-bleed serum (control Ab, 5 
μg/larva). These larvae were then injected with purified recombinant MsSpz (3 μg/larva), 
MsSpz-C108 (1 μg/larva), PG-SA (1 μg/larva), PG-K12 (1 μg/larva), or water, or without 
second injection (control) at 1 h after pre-injection of antibody. Hemocytes and fat body 
were collected at 20 h after second injection for preparation of total RNAs. Expression of 
AMP genes (cecropin-6, attacin-1, lebocin-b/c and moricin) in hemocytes (A-E) and fat 
body (F-J) was determined by real-time PCR. Ribosomal protein S3 (rpS3) gene was 
used as an internal control. The bars represent the mean of three individual measurements 
± SEM. Relative expression of each AMP gene after pre-injection of antibody but 
without second injection (control) was set as 1. Asterisks indicate significant difference 
(p<0.05) between Toll and Control antibody pre-injections for each AMP gene 
determined by an unpaired t-test. 
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Discussion 
 
MsToll
ecto
 can interact with MsSpz-C108, but not with full-length MsSpz 
Invertebrates, such as insects, mainly rely on innate immunity to fight against 
pathogens. Induced expression of antimicrobial peptide (AMP) genes is an important 
defense mechanism in insect innate immunity (Ashida M, 1998; Hancock and Scott, 2000; 
Imler and Bulet, 2005; Lemaitre and Hoffmann, 2007; Williams, 2007). AMP gene 
expression is regulated by signal transduction pathways, such as the Toll and Imd 
pathways in D. melanogaster (Choe et al., 2002; De Gregorio et al., 2002; Lemaitre et al., 
1995; Lemaitre et al., 1996; Ramet et al., 2002). The Drosophila Toll-Spz signaling 
pathway controls dorsal-ventral patterning in the embryonic development and also retains 
a common function in stimulating expression of AMP genes. Although Toll and Spz 
genes have been identified in different insect species (An et al., 2010; Ao et al., 2008b; 
Christophides et al., 2002; Evans et al., 2006; Imamura and Yamakawa, 2002; Kanzok et 
al., 2004; Luna et al., 2002; Wang et al., 2007), the role of Toll-Spz pathway in 
regulating AMP gene expression in other insect species has not been well studied. 
Progress in understanding the Toll-Spz pathway that operates in the innate immune 
system requires more investigation of molecular and biochemical functions of Toll and 
Spz in diverse taxa. In this study, we have identified a Toll-Spz signaling pathway in a 
lepidopteran insect, M. sexta. 
In M. sexta, Toll and Spz have been identified (An et al., 2010; Ao et al., 2008b), 
but interaction between M. sexta Toll and Spz and direct evidence for a Toll-Spz pathway 
have not been demonstrated. In D. melanogaster, it has been shown that proteolytic 
processing of DmSpz releases the active DmSpz-C106, which is required for interaction 
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with DmToll (Arnot et al., 2010). The binding of two active DmSpz-C106 dimers to one 
DmToll receptor and the formation of Toll-Spz heterodimers are also essential (Hu et al., 
2004). We showed by co-immunoprecipitation (Co-IP) assay that MsToll
ecto
 could 
interact with MsSpz-C108, but not with full-length MsSpz (Fig. 9), a result consistent 
with that of DmToll
ecto
 and DmSpz-C106 (Fig. 10), suggesting that proteolytic activation 
of MsSpz is required for interaction of active MsSpz-C108 with MsToll. We also showed 
that MsSpz could be processed to active MsSpz-C108 by proteinases in the hemolymph 
of M. sexta larvae (Fig. 8C and D), and these hemolymph proteinases are also induced by 
microorganisms. One interesting result is that DmToll
ecto
 was differentially post-
translationally modified in S2 cells (Fig. 7D) and different modified forms of DmToll
ecto
 
could all interact with DmSpz-C106 (Fig. 10), while only one form of MsToll
ecto
 was 
detected (Fig. 7C). 
 
Co-expression of MsToll-MsSpz-C108 activate drosomycin expression in S2 cells 
To test whether MsToll-MsSpz-C108 complex can activate AMP genes, both in 
vitro experiments in Drosophila S2 cells (since no M. sexta cell line is available) and in 
vivo experiments in M. sexta larvae were performed. Over-expression of MsTIR and 
DmTIR in S2 cells both could activate drosomycin (a target gene of the Toll pathway) but 
not diptericin (a target gene of the Imd pathway) (Fig. 11), suggesting that MsToll can 
activate the Toll pathway in S2 cells. Co-expression of MsToll-MsSpz-C108 and DmToll-
DmSpz-C106 could activate drosomycin to similarly high levels (Figs. 12 and 13), but 
did not activate diptericin, further confirming that MsToll-MsSpz-C108 complex can 
activate the Toll signaling pathway in S2 cells. It has been shown that Bombyx mori Spz 
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can activate AMP genes in M. sexta larvae (Wang et al., 2007), but we showed that co-
expression of MsToll-DmSpz-C106 or DmToll-MsSpz-C108 did not activate drosomycin 
(Figs. 12 and 13). MsSpz is 44% and 23% identical to B. mori and D. melanogaster Spz-1, 
respectively; together these results suggest that Toll and Spz binding may be specific and 
only the correct pair of Toll-Spz can activate the Toll pathway. D. melanogaster contains 
nine Toll and six Spz genes; it would be interesting to know whether other Toll-Spz pairs 
can trigger signaling pathways in D. melanogaster.   
 
Injection of MsSpz-C108 activated AMP genes in M. sexta larvae 
In D. melanogaster, expression of AMP genes is regulated by the Toll and 
immune deficiency (Imd) pathways (De Gregorio et al., 2002; Lemaitre et al., 1995; 
Lemaitre et al., 1996). The Toll pathway is activated by fungi and Lys-type 
peptidoglycan (PG) of Gram-positive bacteria via peptidoglycan recognition protein 
(PGRP)-SA, PGRP-SD and Gram-negative binding protein 1 (GNBP1) (Bischoff et al., 
2004; Gobert et al., 2003; Michel et al., 2001), while the Imd pathway is activated by 
meso-diaminopimelic acid (DAP)-type PG of Gram-negative bacteria and some Bacilli 
species via PGRP-LC (Choe et al., 2002; Gottar et al., 2002; Kaneko et al., 2004). In M. 
sexta, several AMP genes, including cecropin, attacin, moricin, lebocin and gloverin, as 
well as lysozyme have been identified (Kanost et al., 2004), and they can be activated by 
different bacterial cell wall components (Rao and Yu, 2010). Among these M. sexta AMP 
genes, cecropin and attacin are common AMP genes found in most insect species, but 
moricin, lebocin and gloverin are only found in lepidopteran species (Axen et al., 1997; 
Chowdhury et al., 1995; Hara and Yamakawa, 1995; Kanost et al., 2004). It is not clear 
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whether M. sexta AMP genes, particularly lepidoptera-specific moricin, lebocin and 
gloverin genes, are regulated by the Toll and/or Imd pathways. Injection of MsSpz-C108 
activated AMP genes (cecropin, attacin, lebocin and moricin) in M. sexta larvae to 
significantly higher levels than the control (water-injection) (Fig. 14), suggesting that 
these M. sexta AMP genes are regulated by the Toll-Spz pathway. MsSpz-C108 activated 
lysozyme mRNA expression to much lower level compared to other AMP genes (Fig. 14), 
but Lysozyme protein is highly induced by MsSpz-C108 in hemolymph (An et al., 2010).  
 
MsToll antibody blocks the activity of MsSpz-C108 
In Drosophila, though Lys-type and DAP-type PGs can activate the Toll and Imd 
pathways, respectively, PGRP-SD can bind to DAP-type PG and may be responsible for 
activation of the Toll pathway by Gram-negative bacteria (Leone et al., 2008), and 
Anopheles gambiae PGRP-LC is responsible for activation of AMP genes stimulated by S. 
aureus but not by E. coli (Meister et al., 2009). In M. sexta, it is not clear whether Lys-
type and DAP-type PGs can activate the Toll-Spz and/or Imd pathways. We tried to 
silence MsToll by RNA interference (RNAi) in order to further confirm the Toll-Spz 
pathway and activation of AMP genes by S. aureus and E. coli PGs in M. sexta larvae, 
but all our attempts using siRNA and dsRNA failed. We then used antibody to the ecto-
domain of MsToll to block MsToll in M. sexta larvae from binding to the injected MsSpz-
C108. Our antibody blocking assay showed that activation of AMP genes in both 
hemocytes and fat body of M. sexta larvae by MsSpz-C108 and S. aureus PG (PG-SA, 
Lys-type PG) was significantly inhibited when larvae were pre-injected with antibody to 
MsToll but not the control antibody (Fig. 15). These results further confirm that MsToll-
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MsSpz-C108 can form a complex in M. sexta larvae to mediate the Toll-Spz signaling 
pathway and regulate AMP genes expression. E. coli PG (PG-K12, DAP-type PG) 
activated expression of some AMP genes (moricin in hemocytes and fat body, and 
lebocin-b/c in fat body) was also suppressed by pre-injection of antibody to MsToll. 
These results suggest that both the Lys-type PG-SA and DAP-type PG-K12 can activate 
the Toll-Spz pathway in M. sexta, but PG-K12 is a weaker elicitor than PG-SA in 
stimulation of the Toll-Spz pathway. Expression of lebocin-b/c in hemocytes was 
stimulated after MsToll Toll was blocked by antibody, suggesting that lebocin-b/c 
expression in hemocytes is not regulated by the Toll-Spz pathway. It is not clear why 
expression of lebocin-b/c in hemocytes and fat body is regulated differently. Expression 
of gloverin in hemocytes and fat body was also regulated in a similar pattern like lebocin-
b/c (Xu et al., 2012). This may be related to expression pattern of M. sexta Spz, as it is 
expressed and induced in hemocytes but not induced in fat body (An et al., 2010). 
Activation of lysozyme by MsSpz-C108, PG-SA and PG-K12 was always lower than that 
of other M. sexta AMP genes, and the activation was not blocked by pre-injection of Toll 
antibody. In addition, PG-K12 is a stronger elicitor than MsSpz-C108 or PG-SA in 
activation of lysozyme. Thus, lysozyme is also not regulated by the Toll-Spz pathway. 
Expression of lebocin-b/c in hemocytes and lysozyme in both hemocytes and fat body 
may be regulated by other signaling pathways, such as the Imd pathway since Rel genes 
similar to Drosophila Relish have been identified in M. sexta. 
In summary, we used a biochemical assay to show that MsToll
ecto
 and DmToll
ecto
 
could interact with MsSpz-C108 and DmSpz-C106, respectively, but not with full-length 
Spz (Figs. 9 and 10), used in vitro assays to show that MsToll-MsSpz-C108 and DmToll-
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DmSpz-C106 complexes could activate drosomycin but not diptericin gene in S2 cells 
(Figs. 12 and 13), used in vivo assays to show that activation of M. sexta AMP genes by 
MsSpz-C108 was significantly inhibited by pre-injection of antibody to MsToll (Fig. 15). 
Our results together demonstrated a Toll-Spz signaling pathway in a lepidopteran insect, 
M. sexta. This study may help better understand signaling pathways in lepidopteran 
insects, and the origin and evolution of animal innate immune signaling pathways. 
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CHAPTER 3 
A TOLL-ML-LPS PATHWAY IN THE TOBACCO HORNWORM, MANDUCA SEXTA 
 
Abstract 
In mammals, Toll-like receptor 4 (TLR4) is the receptor that recognizes 
lipopolysaccharide (LPS). MD2 (Myeloid differentiation protein 2) is required for the 
recognition of LPS and binding to TLR4. In insects, there are two signaling pathways in 
the innate immunity system: the Imd (immune deficiency) and Toll pathways. However, 
receptors that can recognize LPS have not been identified in invertebrates. Our aims are 
to investigate whether insects have a Toll-ML-LPS pathway. A Toll receptor (MsToll) 
and an MD2-related lipid-recognition protein (MsML-1) have been identified in the 
tobacco hornworm, Manduca sexta. We constructed S2 cell lines expressing MsToll, a 
Chimeric Toll (ChiToll with the ecto-domain of MsToll, transmembrane and TIR 
domains of Drosophila Toll) and MsML-1. We showed that LPS could activate 
drosomycin gene expression in S2 cells only when both Toll and MsML-1 or ChiToll and 
MsML-1 were co-expressed, indicating that a Toll-ML-LPS pathway is present in insects.  
 
Introduction 
In mammals, Toll-like receptors (TLRs) can recognize a variety of pathogen-
associated molecular patterns (PAMPs) to activate the NF-κB pathway. LPS released 
from Gram-negative bacteria is immediately captured by the LPS-binding protein (LBP), 
a specific lipid transfer protein, and binds to CD14 present on the surfaces of 
mononuclear phagocytes. CD14 is also a leucine-rich repeat protein and lacks a 
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transmembrane domain, and is, thus, incapable of transducing signals (An et al., 2010). 
Then LPS will be delivered to TLR4, the receptor that recognizes LPS. MD2 is required 
for the recognition of LPS and binding to TLR4. TLR4/MD2/LPS complex induces 
dimerization of TLR4 and subsequent activation of cytoplasmic signaling molecules 
(Poltorak et al., 1998). TLR4-mediated signaling through IκB and NF-κB leads to the 
robust induction of the genes involved in proinflammatory responses, which connects 
between innate and adaptive immunity. TLR4 resembles Toll receptor of insects, for 
example Drosophila melanogaster. Both receptors look alike in their extracellular 
domains as well as intracellular domains. Insects have multiple Toll and ML proteins 
resulting from gene duplication. However, there is no direct connection between Toll and 
ML. The Drosophila Toll-Spätzle pathway is similar to mammalian TLR-mediated 
signaling pathways, but also differs from TLR pathways in the recognition process 
(Valanne et al., 2011). LPS signaling pathway or receptors for LPS has not been 
identified in insects and other invertebrates. Thus, it is likely that there might be a Toll-
ML-LPS signaling pathway in insects. A M. sexta Toll (MsToll) (Ao et al., 2008b) and a 
MD2-like protein (MsML-1) (Ao et al., 2008a) have been identified previously in our 
laboratory. Recombinant MsML-1 protein specifically binds to LPS from several Gram-
negative bacteria (Ao et al., 2008a). The TIR domain of MsToll also has high similarity 
to that of vertebrate TLR4. These results suggested that there might be a Toll-ML-LPS 
pathway in M. sexta. 
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Materials and Method 
 
D. melanogaster Schneider S2 cell line 
D. melanogaster Schneider S2 cells were purchased from American Type Culture 
Collection (ATCC). 
 
Construction of recombinant pMT⁄BiP⁄V5-His A expression vectors 
cDNA fragments encoding MsToll, MsToll
ecto
, ChiToll, and MsML-1 were 
amplified by PCR using forward and reverse primers. Forward primer for MsML-1 
contains codons for an in-frame Flag sequence and a NotI site, while reverse primer 
contains a stop codon followed by a PmeI site. Forward primers for MsToll, MsToll
ecto
, 
and ChiToll contain a KpnI site, while reverse primers contain an ApaI site. PCR 
reactions were performed with the following conditions: 94°C for 3 min, 35 cycles of 
94°C for 30 s, Tm-5°C for 30 s, 72°C for 45 s to 4 min, followed by a final extension at 
72°C for 10 min. The PCR products were recovered by agarose gel electrophoresis-
Wizard® SV Gel and PCR Clean-Up System (A9285, Promega) and digested with 
NotI/PmeI or KpnI/ApaI, DNA fragments were recovered and inserted into NotI/PmeI or 
KpnI/ApaI digested pMT⁄BiP⁄V5-His A vector (V413020, Invitrogen) using T4 DNA 
ligase (M0202L, New England Biolabs). Recombinant expression vectors were then 
purified and sequenced by an Applied Biosystems 3730 DNA Analyzer in the DNA 
Sequencing and Genotyping Facility at University of Missouri – Kansas City, and used to 
generate stable S2 cell lines.  
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Cell culture and establishment of stable S2 cell lines 
D. melanogaster Schneider S2 cells were maintained at 27°C in Insect Cell 
Culture Media (SH30610.02, Hyclone), supplemented with 10% heat-inactivated fetal 
bovine serum (#10082063, Invitrogen) containing 1% penicillin-streptomycin solution 
(G6784, Sigma-Aldrich). For DNA transfection, cells were seeded overnight in serum-
free medium (SH30278.01, Hyclone). GenCarrier-1
TM
 transfection reagent (#31-00110, 
Epoch Biolabs) was used for transient transfection based on the manufacturer’s 
instructions. Cells in culture dishes or plates were grown to 70% confluence prior to 
transfection. DES
®–Inducible⁄Secreted Kit with pCoBlast (K5130-01, Invitrogen) was 
used to construct stable S2 cell lines.  
 
Western blot analysis and immunoprecipitation (Co-IP) assay 
For Western blot analysis, copper sulfate (final concentration of 250 μM) was 
added to the stable S2 cell lines (2×10
6
 cells/well) in 6-well plates, and protein expression 
was induced for 48 h. Cell culture medium (2 ml each) was collected, stable S2 cells were 
homogenized in 400 μl lysis buffer [50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM 
EDTA, 1% NP-40, 0.5 mM PMSF, protease inhibitor cocktail (P8340, Sigma-Aldrich)]. 
After removing the cell debits, the supernatants were collected as cell extracts for 
Western blot analysis. The cell culture media (10 μl each) and cell extracts (10 μl each, 
equivalent to ~5×10
4
 cells) were separated on 10%, 12%, or 15% SDS-PAGE and 
proteins were transferred to nitrocellulose membranes (162-0097, Bio-Rad). Anti-Flag 
M2 antibody (F-1804, Sigma-Aldrich, 1:5000 dilution) and anti-V5 antibody (V-8012, 
Sigma-Aldrich, 1:5000 dilution) were used as primary antibodies, horseradish 
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peroxidase-conjugate anti-mouse antibody (SC-2005, Santa Cruz Biotechnology, 
1:10,000) was used as secondary antibody for chemiluminescence, and alkaline 
phosphatase-conjugate anti-mouse antibody (A4312, Sigma-Aldrich, 1:10,000) was used 
as secondary antibody for color development. The signal was developed by using the 
ECL Chemiluminescence Detection Kit (RPN2134, GE Healthcare) or alkaline 
phosphatase (AP)-conjugate color development Kit (#170-6432, Bio-Rad).  
Immunoprecipitation (Co-IP) assay was performed by using 300 μl of cell extract, 
which is equivalent to approximately 10
6
 cells, or equivalent cell culture medium 
containing recombinant proteins. The cell extracts or cell culture media were pre-cleared 
for 30 min with 30 μl Protein G Sepharose (50% slurry, No.17-0618-01, GE Healthcare) 
in a total volume of 500 μl. After centrifugation, the supernatant was incubated with anti-
Flag M2 or anti-V5 antibody (final concentration of 10 μg/ml) at 4°C for 10 h with gentle 
rocking. LPS or PG (peptidoglycan) (10 μg/ml final concentration) was also included in 
the cell lysates to test whether it can promote co-precipitation of MsToll
ecto
 with MsML-1. 
Then, 30 μl Protein G Sepharose (50% slurry) in lysis buffer was added to the protein-
antibody mixture and incubated at 4°C overnight with gentle rocking. The Sepharose 
beads containing immunoprecipitated proteins were collected after centrifugation, 
washed three times with lysis buffer, re-suspended in 50 μl of 1×SDS sample buffer, 
boiled at 95°C for 5 min, and used for subsequent immunoblotting analysis. 
 
Dual-Luciferase Reporter Assay 
Stable Drosophila S2 cell lines expressing MsML-1, MsToll
ecto
 and ChiToll were 
established. Drosomycin (a readout antimicrobial peptide gene in the Drosophila Toll 
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pathway) promoter-luciferase reporter was constructed. Cell lines were transfected with 
the reporter alone or along with MsML-1 (for co-expression of MsToll
ecto
 or ChiToll with 
MsML-1). After protein expression for 48 h, cells were stimulated with LPS (10 μg/ml 
final concentration) for 7 h, and luciferase activity in cell lysates was determined using a 
dual luciferase assay kit. All results were expressed as the ratio of relative luciferase 
activity with and without LPS stimulation. 
 
Data analysis 
One representative set of data was used to make figures using the Graphpad Prism 
software, and the significance of difference was determined by an unpaired t-test or by 
one way ANOVA followed by a Tukey’s multiple comparison test with the Graphpad 
InStat software (GraphPad, San Diego, CA). 
 
Results 
 
Expression of recombinant M. sexta Toll, ML, and Chimeric Toll proteins in S2 cells 
The TLR4-MD2-LPS signaling pathway is well understood in mammals; however 
the receptor recognizing LPS is not characterized in invertebrates. In M. sexta, Toll and 
Ml genes have been identified (Ao et al., 2008a; Ao et al., 2008b). In order to investigate 
a Toll-ML-LPS pathway in M. sexta, we constructed a recombinant ChiToll receptor, 
with the ecto-domain of MsToll, transmembrane and TIR domains of Drosophila Toll 1 
(Fig. 16). We established stable S2 cell lines expressing MsToll receptor and its ecto-
domain MsToll
ecto
, as well as ChiToll receptor and MsML-1. Immunoblotting results 
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showed that MsToll
ecto
 (the ecto-domain) and ChiToll (Fig. 17C and D) were detected 
only in S2 cells but not in cell culture media. For the MsML-1, a single protein band was 
detected in the cells and the cell culture media (Fig. 17A). But MsML-1, a typically 
secreted protein, could not be secreted into the medium when co-expressed with 
MsToll
ecto
. Furthermore, the size of MsML-1 was smaller, suggesting differences in post-
translational modification of MsML-1 when co-expressed with Toll receptor (Fig. 17A). 
Comparing to the native MsML-1, the size of recombinant MsML-1 co-expressed with 
MsToll is similar as native protein (Fig. 17B). These results imply that there may be an 
interaction between MsToll and MsML-1. 
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Figure 16. Schematic diagram of the ChiToll. 
The ecto-domain (LRRs) of M. sexta Toll is fused to the transmembrane region and 
intracellular TIR domain of Drosophila Toll-1.  
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Figure 17. Expression of MsML-1 (A), MsToll
ecto
 (C), and ChiToll (D) in S2 cells. 
Proteins in cell culture media and cell lysates were detected by Western blotting using 
monoclonal antibody against FLAG-tag (MsML-1) or V5-tag (Toll), or polyclonal 
antibody against M. sexta ML-1 (B). Panels A, C and D: lanes 1 (culture medium) and 2 
(cell lysate) from individual expression; lanes 3 (culture medium) and 4 (cell lysate) from 
co-expression. Panel B: lane 1, native MsML-1 purified from M. sexta hemolymph; lane 
2, co-expressed MsML-1; lane 3: single-expressed MsML-1. 
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LPS enhances the interaction between MsToll
ecto
 and MsML-1 
In mammals, membrane-bound CD14 accepts LPS captured by LBP and transfers 
LPS to MD2, which is a co-receptor for TLR4 (Shimazu et al., 1999). MD2 is required 
for the recognition of LPS and binding to TLR4. The binding of MD2 to LPS triggers a 
conformation change, which induces the formation of LPS-MD2-TLR4 complex 
(Schromm et al., 2001). The multimer triggers TLR4 dimerization to initiate the 
intracellular siganling (Poltorak et al., 1998). To determine whether MsML-1 can bind to 
MsToll receptor, we over-expressed the ecto-domian of MsToll (MsToll
ecto
) with a V5-
His-tag to the C-terminus, and MsML-1 with a Flag-tag to the N-terminus in S2 cells 
(Figure 17). Co-immunoprecipitation (Co-IP) assays were performed by mixing 
individual cell lysates or using co-expression cell lysates. For MsML-1, single 
transfection and co-expressing with MsToll
ecto
 were separated because the size of MsML-
1 was different when co-expressed with Toll receptor. Our results showed that when cell 
lysates containing MsML-1 and MsToll
ecto
 were mixed, Flag antibody could pull down 
both MsML-1-Flag and MsToll
ecto
-V5 (Fig.18 and B, lane 4-6), whereas V5 antibody 
could precipitate both MsToll
ecto
-V5 and MsML-1-Flag (Fig. 18C and D, lane 4-6). 
Similar results were obtained when cells co-expressing MsToll
ecto
-V5 and MsML-1-Flag 
were used for the Co-IP assay and showed that difference in the post-translational 
modification did not have an effect on the interaction between MsToll and MsML-1 (Fig. 
18A-D, lane 5-8). These results suggest that MsToll
ecto
 can interact with MsML-1. In 
order to detect the role of LPS and PG in the interaction, LPS or PG (10 μg/ml final 
concentration) was included in the cell lysates. The results showed that LPS, but not PG, 
86 
 
could enhance the interaction between MsToll
ecto
 and MsML-1 (Fig. 18B and D, lane 5-6 
and 8-9).  
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Figure 18. Co-IP of MsToll
ecto
 with MsML-1. 
Stable Drosophila S2 cell lines expressing the MsToll
ecto
 and MsML-1 were established, 
and cell lysates were prepared individually. MsML-1 was also co-expressed with 
MsToll
ecto
 using stable cell line expressing MsToll
ecto
 for the transfection, and cell lysates 
were also prepared. Cell lysates containing MsML-1 (FLAG-tagged) or MsToll
ecto
 (V5-
tagged) and co-expressed cell lysates were used for Co-IP assays using monoclonal 
antibody (mAb) to FLAG- or V5-tag. LPS or PG (peptidoglycan) was also included in 
the cell lysates to test whether it can promote co-precipitation of MsToll
ecto
 with MsML-1. 
Lanes 1-3 contain only cell lysates without mAb. * indicates that LPS, but not PG, can 
enhance the interaction between MsToll
ecto
 and MsML-1.  
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Co-expression of MsToll or ChiToll with MsML-1 in S2 cells can activate drosomycin 
promoter stimulated by LPS 
In mammals, the TLR4-MD2-LPS pathway mediates the activity of several NF-
κB transcription factors, leading to robust induction of proinflammatory cytokines, 
interferon (IFN), or IFN-inducible genes. In D. melanogaster, the Toll-Spz pathway 
activates NF-κB factors Dorsal and Dif to induce expression of drosomycin gene, while 
the Imd pathway activates NF-κB factor Relish to induce diptericin gene expression 
(Tanji and Ip, 2005). To investigate whether co-expression of Toll with MsML-1 can 
activate expression of drosomycin or diptericin gene stimulated by LPS, Drosophila S2 
cell line was applied because no M. sexta cell line is available. A recombinant ChiToll 
(the ecto-domain of MsToll combined with the transmembrane and TIR domains of 
Drosophila Toll 1) is designed for Drosophila S2 cell. Cell lines were transfected with 
the reporter alone or along with MsML-1 (for co-expression with MsToll
ecto
, MsToll or 
ChiToll). After protein expression for 48 h, cells were stimulated with LPS (10 μg/ml 
final concentration) for 7 h, and activation of drosomycin or diptericin gene promoter 
activity was determined by dual luciferase reporter assays. The results showed that LPS 
could significantly increase the relative luciferase activity of drosomycin reporter (~4-
fold), but not diptericin reporter, in S2 cells co-expressing ChiToll-MsML-1 (Fig. 19). 
Similarly, LPS also stimulated drosomycin reporter activity to a significantly higher level 
(~2.5-fold) in cells co-expressing MsToll-MsML-1 compared to the control cells (Fig. 19). 
These results suggest that there might be a Toll-ML-LPS pathway in M. sexta. 
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Figure 19. LPS activates drosomycin luciferase reporter in S2 cells co-expressing ChiToll 
or MsToll with MsML-1. 
Stable Drosophila S2 cell lines expressing MsML-1, MsToll
ecto
, MsToll and ChiToll were 
established. Drosomycin and Diptericin promoter-luciferase reporters were constructed. 
Cell lines were transfected with the reporter alone or along with MsML-1 (for co-
expression with MsToll
ecto
, MsToll, or ChiToll). After protein expression for 48 h, cells 
were stimulated with LPS (10 μg/ml final concentration) for 7 h, and luciferase activity in 
cell lysates was determined using a dual luciferase assay kit. All results were expressed 
as the ratio of relative luciferase activity with and without LPS stimulation. Bars 
represent the mean of three individual measurements ± SEM. Identical letters are not 
significant difference (p>0.05), while different letters indicate significant difference 
among groups (p<0.05) determined by one way ANOVA followed by a Tukey’s multiple 
comparison test. 
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Summary 
 
In mammals, Toll-like receptor 4 (TLR4) is the receptor that recognizes LPS. 
MD2 is required for the recognition and binding between TLR4 and LPS. However, in 
invertebrates, receptors that can recognize LPS and trigger signaling pathways have not 
been identified. We used co-immunoprecipitation experiments to show that MsToll 
ectodomain could directly interact with MsML-1, and LPS could enhance the interaction. 
In dual-luciferase reporter assay, we also confirmed that LPS could stimulate drosomycin 
promoter in S2 cells co-expressing MsToll and MsML-1 or ChiToll and MsML-1. Our 
results for the first time showed a conserved Toll-ML-LPS pathway from insects to 
mammals, and provided better insight into the evolution of the TLR4-MD2-LPS pathway. 
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CHAPTER 4 
DORSAL-REL2 HETERODIMERS NEGATIVELY REGULATE ANTIMICROBIAL 
PEPTIDE EXPRESSION IN MANDUCA SEXTA 
 
Abstract 
NF-κB transcription factors play essential roles in regulation of innate immune 
responses. Here we report the identification and functional analysis of a Dorsal 
homologue (MsDorsal) and two short Relish isoforms (MsRel2A and MsRel2B) from the 
tobacco hornworm, Manduca sexta. The Rel homolog domain (RHD) of MsDorsal is 
similar to that of many Dorsal proteins in Arthropods. MsRel2A and MsRel2B have an 
identical RHD region and differ only in a few residues at the C-terminus. RT-PCR 
analysis showed that MsDorsal and MsRel2A transcripts were detected in all tissues 
tested, including fat body, hemocytes, midgut and testis; however, MsRel2B mRNA was 
detected only in the midgut and testis. Overexpression of the RHD domains from 
MsDorsal and MsRel2 in S2 cells could activate antimicrobial peptide (AMP) gene 
promoters from M. sexta, D. melanogaster and B. mori. MsDorsal-RHD specifically 
bound to an NF-κB site of M. sexta lysozyme promoter, while MsRel2-RHD bound to an 
NF-κB site of M. sexta moricin promoter. Interestingly, co-immunoprecipitation (Co-IP) 
analysis showed that MsDorsal-RHD could interact with MsRel2-RHD. More importantly, 
co-expression of MsDorsal-RHD with MsRel2-RHD abolished the activation of several 
M. sexta antimicrobial peptide gene promoters. These results suggest that the short 
MsRel2 isoforms may form heterodimers with MsDorsal to negatively regulate 
expression of antimicrobial peptides in M. sexta.  
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Introduction 
Insects rely solely on the innate immune system to control or eliminate invading 
pathogens (Hoffmann, 2003; Lemaitre and Hoffmann, 2007). Pathogen-associated 
molecular patterns (PAMPs) from various pathogens are recognized by germ-line 
encoded pattern recognition receptors (PRRs) to trigger different cellular and humoral 
immune responses (Kumar et al., 2009; Mogensen, 2009). Synthesis of antimicrobial 
peptides (AMPs) is one of the major defense mechanisms in insects (Imler and Bulet, 
2005; Yi et al., 2014; Yount et al., 2006) and expression of AMPs is regulated by the Toll 
and Imd (immune deficiency) pathways (De Gregorio et al., 2002; Tanji et al., 2007). The 
Toll pathway mediates the recognition of gram-positive bacteria and fungi (Valanne et al., 
2011) , while the Imd pathway is activated by most gram-negative bacteria (Georgel et al., 
2001). 
The nuclear factor κB (NF-κB) family of transcription factors plays essential roles 
in regulating the expression of immune-related genes (Ganesan et al., 2011; Li and 
Verma, 2002). These factors contain an N-terminal Rel homology domain (RHD) that 
interacts with DNA. In mammals, there are two classes of NF-κB factors. Class I factors 
include p105 and p100, which contain an N-terminal RHD and a C-terminal long 
inhibitory ankyrin repeats that must be cleaved off to release the N-terminal RHD for 
activation of gene expression. Class II factors include RelA (p65), RelB and c-Rel that 
contain an N-terminal RHD and a C-terminal transactivation domain (Silverman and 
Maniatis, 2001). NF-κB factors can form homo- and hetero-dimers in the nucleus, which 
bind to NF-κB elements in the promoter regions of many immune-related genes (Ganesan 
et al., 2011). In Drosophila melanogaster, three NF-κB factors, Dorsal, Dorsal-related 
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immunity factor (Dif) and Relish, have been identified (Hetru and Hoffmann, 2009). 
Dorsal and Dif belong to the Class II NF-κB factors and they are involved in the Toll 
pathway to regulate dorsal-ventral patterning in embryonic development (Anderson et al., 
1985) or expression of AMPs such as drosomycin in Drosophila larvae and adults (Tian 
et al., 2008; Uttenweiler-Joseph et al., 1998; Whalen and Steward, 1993). Relish is a 
member of the Class I NF-κB factors and is cleaved to release the N-terminal fragment 
(Relish-N) containing RHD upon activation of the Imd pathway (Silverman et al., 2000; 
Stoven et al., 2000). Relish also regulates expression of AMPs including diptericin 
(Wicker et al., 1990). It has been suggested that Drosophila Dif and Relish may form 
heterodimers in in vivo to synergistically increase AMP production (Tanji et al., 2007; 
Tanji et al., 2010). 
M. sexta is a popular lepidopteran model organism to study insect immunity 
(Jiang et al., 2010). Various immune-related genes have been identified and characterized 
(Kanost et al., 2004), including AMP genes moricin, lebocin and gloverin (Dai et al., 
2008; Rao et al., 2012; Xu et al., 2012); C-type lectins (immulectins) (Yu et al., 1999; Yu 
and Kanost, 2000; Yu et al., 2006; Yu et al., 2005); beta-1,3-glucan recognition proteins 
and so on (Jiang et al., 2004; Ma and Kanost, 2000; Rao et al., 2014; Wang et al., 2006). 
A Toll-Spätzle pathway has been confirmed in M. sexta and it plays an important role in 
immune responses (Zhong et al., 2012). Previously, we reported that M. sexta moricin is 
activated by both NF-κB and GATA factors (Rao et al., 2011). 
NF-κB factors have been identified in the phylum of Arthropoda (Antonova et al., 
2009; Fan et al., 2008; Huang et al., 2010; Huang et al., 2009; Li et al., 2010; Li et al., 
2009; Montagnani et al., 2004; Shin et al., 2002; Shin et al., 2005; Tanaka et al., 2007; 
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Tanaka et al., 2005; Wang et al., 2013; Yu et al., 2013). In the mosquito Aedes aegypti, 
two Dorsal isoforms, AaREL1-A and AaREL1-B, can cooperatively enhance activation 
of immune genes (Shin et al., 2005), and three alternatively spliced isoforms of Relish are 
generated from a single inducible relish gene. The 3.9 kb relish transcript contains both 
the RHD domain and the inhibitor κB (IκB)-like domain, while the other two short 
transcripts lack either the RHD or the IκB domain. The Anopheles gambiae REL2 gene 
produces two spliced forms: a full-length (REL2-F) and a shorter (REL2-S) (Meister et 
al., 2005). In the silkworm Bombyx mori, two Rel (Dorsal) proteins, BmRelA and 
BmRelB, activate antimicrobial peptide genes differentially (Tanaka et al., 2005) , and 
two Relish homologs (BmRelish1 and 2) have been identified (Tanaka et al., 2007). 
BmRelish2 lacks the acidic and hydrophobic amino acids (AHAA) rich regions and 
ankyrin (ANK) repeats, and it serves as a dominant negative factor of BmRelish1 active 
form (Tanaka et al., 2007). In the pacific white shrimp Litopenaeus vannamei, LvRelish 
and its short isoform (sLvRelish) have been identified (Huang et al., 2009). However, no 
NF-κB transcription factors and their functions have been reported in M. sexta so far.  
Here we report cloning and functional studies of three NF-κB homologs from M. 
sexta. Interestingly, we cloned two short isoforms of M. sexta Relish, named MsRel2A 
and MsRel2B, which differed in tissue-specific expression patterns but both could 
activate AMP gene promoters. More importantly, we confirmed formation of MsDorsal-
MsRel2 heterodimers, and showed for the first time that MsDorsal-MsRel2 heterodimers 
could suppress expression of AMP gene promoters. Our results suggest that relish active 
isoforms such as MsRel2 may activate AMP genes as homodimers, and may also 
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negatively regulate AMP gene expression as heterodimers with dorsal to prevent over-
activation of AMPs. 
 
Materials and Method 
 
Insect rearing and Drosophila S2 and Spodoptera frugiperda Sf9 cell lines 
M. sexta eggs were originally purchased from Carolina Biological Supplies 
(Burlington, NC, USA). Larvae were reared on an artificial diet at 25°C (Dunn, 1983), 
and the fifth instar larvae were used for the experiments. D. melanogaster Schneider S2 
cells were purchased from American Type Culture Collection (ATCC). Spodoptera 
frugiperda Sf9 cells were purchased from Invitrogen. 
 
Cloning and sequence analysis of M. sexta Dorsal and Rel2 cDNAs 
After analyzing the M. sexta EST library 
(http://entoplp.okstate.edu/profiles/jiang.htm), two EST fragments were predicted to 
encode RHD-containing proteins (manduca.Contig2427 and manduca.Contig7025). We 
designed primers based on the EST sequence to clone the full-length cDNA. Briefly, total 
RNA was prepared from the fat body of day 3 naïve larvae using TRIzol
®
 Reagent 
(T9424, Sigma–Aldrich). For reverse transcription, total RNA was treated with RQ1 
RNase-free DNase I (Promega) at 37°C for 30 min to remove contaminated genomic 
DNA, and DNase was inactivated by heating to 65°C for 20 min. Reverse transcription 
was performed using oligo(dT) primer (Promega) and ImProm-II reverse transcriptase 
(Promega) following the manufacturer’s instructions. M. sexta Rel2 and Dorsal cDNA 
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were cloned using forward and reverse primers listed in Table 7. 5’and 3’ RACE 
reactions were performed using smarter race kit (Clontech). The opening reading frame 
(ORF) was predicted from the nucleotide sequence using DNAMAN (Lynnon 
Corporation, Quebec, Canada). BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was 
used to search homologous RHD sequences. Figures were made from means of three 
independent biological replicates with the GraphPad Prism software (GraphPad, CA). 
Significance of difference was determined by one way ANOVA followed by a Tukey’s 
multiple comparison test using GraphPad Prism. 
 
Construction of luciferase reporter plasmids 
To construct different promoter mutants, site-directed mutagenesis was performed 
using the wild-type M. sexta lysozyme promoter (1203 bp) and moricin deletion promoter 
(240 bp) as templates (Rao et al., 2011). Primers with specific mutation sites were 
designed for each mutant and listed in Table 7. PCR program was 3 min at 95°C, and then 
17 cycles of 95°C for 1 min, 55°C for 2 min, 68°C for 15 min, followed by a final 
extension at 68°C for 30 min. The PCR products were recovered by agarose gel 
electrophoresis-Wizard® SV Gel and PCR Clean-Up System (A9285, Promega) and 
digested by DpnI and then transformed into competent Escherichia coli XL1 Blue cells. 
The mutant reporter plasmids were then purified and sequenced by an Applied 
Biosystems 3730 DNA Analyzer in the DNA Sequencing and Genotyping Facility at 
University of Missouri – Kansas City, and used for transient transfection in S2 or Sf9 cell 
lines.  
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Tissue distribution and induced expression of M. sexta Rel2A, Rel2B, and Dorsal 
To determine tissue distribution of M. sexta two Relish isoforms and Dorsal, day 
2 fifth instar M. sexta naïve larvae were dissected. Hemocytes, fat body, midgut, 
epidermis, and testis were collected and washed 3 times in anti-coagulant (AC) saline (4 
mM NaCl, 40 mM KCl, 8 mM EDTA, 9.5 mM citric acid-monohydrate, 27 mM sodium 
citrate, 5% sucrose, 0.1% polyvinylpyrrolidone, 1.7 mM PIPES). cDNAs were prepared 
as described previously (Zhong et al., 2012). Briefly, 1 μg total RNAs extracted with 
TRIzol
®
 Reagent (T9424, Sigma-Aldrich) and digested by RQ1 RNase-free DNase I 
(Promega) to remove contaminated DNA were used for cDNA preparation. cDNA was 
prepared in a 25 μl reaction using moloney murine leukemia virus (M-MLV) reverse 
transcriptase (M1701, Promega) with an anchor-oligo(dT)18 primer following the 
manufacturer’s instructions. To determine induced expression of MsRel2A, MsRel2B, and 
MsDorsal, day 2 fifth instar larvae were injected with distilled deionized (ddH2O), heat-
killed E. coli strain XL1-blue (5×10
7
 cells/larva), S. aureus (5×10
7
 cells/larva), or C. 
neoformans (10
7
 cells/larva). Twenty-four hours after injection, hemocytes, fat body and 
midgut were collected separately. Total RNA and cDNA were prepared as described 
above. The RT-PCR was performed in 20 μl reactions containing 2.2 μl Advantage® 
cDNA Polymerase Mix (No. 639105, Clontech), 15.2 μl dH2O, 1 μl cDNA, 0.4 μl ultra-
pure dNTP and 0.6 μl each reverse and forward diluted primer (10 pmol/μl). The 
ribosomal protein S3 (rpS3) gene was used as internal control, and the forward and 
reverse primers for MsRel2A and MsRel2B with 508 Base Pair (bp), MsRel2B with 468 
bp, MsDorsal with 553bp, and rpS3 with 317 bp genes listed in Table 7. RT-PCR 
program was 2 min at 95°C, followed by 28 cycles of 95°C for 30 s, 55°C for 30 s, 68°C 
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for 30 s, followed by a final extension at 68°C for 10 min. The products from three 
replicates of each sample were analyzed with 1% agarose gel electrophoresis and these 
experiments were repeated with 3 different biological samples.  
 
Expression and purification of M. sexta Dorsal in bacteria and preparation of polyclonal 
rabbit antiserum 
Recombinant MsDorsal was expressed in E. coli and purified for production of 
polyclonal antibody in rabbit. RT-PCR was performed to obtain cDNA sequence 
encoding M. sexta Dorsal-RHD domain (residues 92-263), using forward and reverse 
primers listed in Table 7. PCR fragment was purified by agarose gel electrophoresis, 
digested with NcoI and XhoI enzymes, ligated into the NcoI/ XhoI digested expression 
vector pGEX-5X, and then transformed into competent E. coli BL21 (DE3) cells. 
Recombinant plasmids were prepared from positive clones and confirmed by restriction 
enzyme digestion and DNA sequencing. A single bacterial colony was inoculated into LB 
medium containing ampicillin (100 μg/ml) and grown at 37°C overnight. The overnight 
culture was diluted 1:100 in LB medium and incubated at 37°C to OD600=0.8 and then 
isopropyl-D-thiogalactoside (IPTG) was added (at 0.5 mM final concentration) to induce 
protein expression. After overnight incubation at 16°C, bacterial cells were harvested by 
centrifugation and lyzed with the lysis solution (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 
0.5% Triton X-100), and recombinant protein was purified using Ni-NTA agarose beads 
(Qiagen) under native conditions following the manufacturer’s instructions. The purified 
recombinant GST-MsDorsal fusion protein was cleaved by thrombin, and the cleavage 
products were separated on 12% SDS-PAGE. The gel slice containing recombinant 
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MsDorsal was used as an antigen to produce rabbit polyclonal antiserum at Cocalico 
Biologicals, Inc (Pennsylvania, USA). 
 
Construction of recombinant pAC5.1⁄V5-His A and pIZ/V5-His expression vectors 
cDNA fragments encoding MsRel2A (residues 1-397), MsRel2B (residues 1-422), 
MsRel2-RHD (residues 58-227 of MsRel2B or Rel2A), and MsDorsal-RHD (residues 92-
263), were amplified by PCR using forward and reverse primers listed in Table 7. For 
pAC5.1⁄V5-His A vector, forward primers of MsRel2A, Rel2B, and Dorsal contain 5’ 
non-coding region recognized by Drosophila ribosome, followed by a start codon and a 
KpnI site, while reverse primers contain an ApaI site. Forward primer of Rel RHD 
contains a start codon and an EcoRI site and reverse primer contains NotI site followed 
by an in-frame Flag sequence and a stop codon. For pIZ/V5-His vector, forward primers 
contains 5’ non-coding region suitable for Spodoptera frugiperda 9 (SF9) cell expression, 
followed by a start codon and a KpnI site, while reverse primer of Dorsal RHD contains 
an XbaI site and primer for Rel RHD contains an XbaI site followed by an in-frame Flag 
sequence and a stop codon. The primers listed in Table 7. PCR reactions were performed 
with the following conditions: 94°C for 3 min, 35 cycles of 94°C for 30 s, Tm-5°C for 30 
s, 72°C for 45 s to 1 min 30 s, followed by a final extension at 72°C for 10 min. The PCR 
products were recovered by agarose gel electrophoresis-Wizard® SV Gel and PCR 
Clean-Up System (A9285, Promega) and subcloned into KpnI/ApaI or KpnI/XbaI 
digested pAC5.1⁄V5-His A or PIZ vector (V413020, Invitrogen) using T4 DNA ligase 
(M0202L, NEB). Recombinant expression vectors were then purified and sequenced by 
an Applied Biosystems 3730 DNA Analyzer in the DNA Sequencing and Genotyping 
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Facility at University of Missouri – Kansas City, and used for protein expression in S2 or 
SF9 cell lines.  
 
Insect cell culture and transient transfection 
S2 cells or SF9 cells were maintained at 27°C in Insect Cell Culture Media 
(SH30610.02, Hyclone), supplemented with 10% heat-inactivated fetal bovine serum 
(#10082063, Invitrogen) containing 1% penicillin-streptomycin solution (G6784, Sigma-
Aldrich). For DNA transfection, cells were placed overnight to 70% confluence prior to 
transfection in serum-free medium (SH30278.01, Hyclone). GenCarrier-1
TM
 transfection 
reagent (#31-00110, Epoch Biolabs) was used for transient transfection based on the 
manufacturer’s instructions. After 7 h transfection, S2 or SF9 cells were centrifuged and 
resuspended in complete growth medium to induce protein expression for 48 h. The cell 
culture medium and cell lysate were analyzed by Western blot.  
 
Western blot analysis and immunoprecipitation (Co-IP) assay 
The Western blot analysis was performed as described previously (Zhong et al., 
2012). Briefly, cell culture medium was collected, S2 or SF9 cells (2×10
6
 cells/well) were 
homogenized in lysis buffer [50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% 
NP-40, 0.5 mM PMSF, protease inhibitor cocktail (P8340, Sigma-Aldrich)]. The cell 
debits were removed and the supernatants were collected as cell extracts for Western blot 
analysis. The cell culture media (10 μl each) and cell extracts (10 μl each, equivalent to 
~5×10
4
 cells) were separated on 10% or 12% SDS-PAGE and proteins were transferred 
to nitrocellulose membranes (162-0097, Bio-Rad). Anti-Flag M2 antibody (F-1804, 
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Sigma-Aldrich, 1:5000 dilution) and anti-V5 antibody (V-8012, Sigma-Aldrich, 1:5000 
dilution) were used as primary antibodies and alkaline phosphatase-conjugate anti-mouse 
antibody (A4312, Sigma-Aldrich, 1:10,000) was used as secondary antibody for color 
development. The signal was developed by alkaline phosphatase (AP)-conjugate color 
development Kit (#170-6432, Bio-Rad). 
For co-immunoprecipitation (Co-IP) assay, 300 μl of cell extract containing 
recombinant proteins, which is equivalent to approximately 5x10
6
 cells, was blocking for 
30 min with 30 μl Protein G Sepharose (50% slurry, No.17-0618-01, GE Healthcare). 
The protein G Sepharose was removed by briefly centrifugation and the supernatant was 
incubated with anti-Flag M2 or anti-V5 antibody (final concentration of 10 μg/ml) at 4°C 
for 10 h with gentle rocking. Then, 30 μl Protein G Sepharose (50% slurry) in lysis buffer 
was added to the protein-antibody mixture and incubated at 4°C overnight with gentle 
rocking. The Sepharose beads containing immunoprecipitated proteins were collected 
after centrifugation, washed four times with lysis buffer and analyzed by subsequent 
immunoblotting (Zhong et al., 2012). 
 
Dual-Luciferase Reporter Assay 
For Dual-luciferase reporter assays, S2 or SF9 cells were seeded in 96-well 
culture plates (10
4
 cells/well) overnight in serum-free medium. These cells were then 
transiently co-transfected with recombinant pAC5.1⁄V5-His A or pIZ/V5-His expression 
plasmid (0.3 μg), pGL3B (empty vector) or different pGL3B firefly luciferase reporter 
plasmids from the promoters of M. sexta or D. melanogaster antimicrobial peptide (AMP) 
genes, and several mutants of M. sexta lysozyme or moricin promoters (0.15 μg) (Rao et 
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al., 2011), and renilla luciferase reporter plasmid (0.015 μg) (as an internal standard) 
(pRL-TK, Promega). After overnight transfection, serum-free medium was replaced with 
complete growth medium for protein expression, and firefly luciferase and renilla 
luciferase activities were measured 48 h after protein expression using the Dual-
Luciferase Reporter Assay System (E1980, Promega) in the GloMax
®
 Multi Microplate 
Luminometer (Promega). Relative luciferase activity (RLA) was obtained as the ratio of 
firefly luciferase activity to renilla luciferase activity. RLA from S2 or SF9 cells co-
transfected with empty pAC5.1⁄V5-His A or pIZ/V5-His and different reporter vectors 
was used as the calibrator. These experiments were repeated at least three times (three 
independent biological samples, or three independent cell cultures), and a representative 
set of data was used to make figures.  
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Table 7 PCR primers used in this study 
Primers Forward Primer (5’  3’)  Reverse Primer (5’  3’) 
For cloning 
Rel2-F1 ATTTAAATATAGTTAG
ACTGAAGTTTAGCGCT
CA 
Rel2-R1 CGTGAGCGCTAAACT
TCAGTCTAACTATATT
TA 
Dorsal-F1 CAATCGCAGCCAATTA
CGCACAAGGTAAC 
Dorsal-R1 GCTTCGCGTAAAATA
TCTTTTAGTTGTCGAT
TC 
For RT-PCR 
Rel2A-F AGTGTGCGTCTACGAA
TG 
Rel2A,2B-R TAGATTCGTCATGGGT
TG 
Rel2B-F GATCGCGGTTTCTCACGCACGA 
Dorsal-F CGGGGTACCCAAAATG
GCCCCGTACGTGGTCG
TCGTGCAGCAG 
Dorsal-R GAAGGGCCCCTTCTT
GTCGTAGATGACGTC
GGA 
RPS3-F GTTGCGAGGTGGTGGT
TTC 
RPS3-R CCGTTCTTGCCCTGTT
GGTC 
For protein expression 
Rel2A,2B-
pAC5.1-KpnI-N 
CGGGGTACC 
GGAATTTGCCAATTGGGTGCTACCAATTTAATAAACTCCACTGGC
GTTAGTTTCGGCGTTGCTAATGTCACCAGTTTTGGCAACCAAAAT
GGCCTCCTCTTGTCCAAGCGAC 
  Rel2A-pAC5.1-
ApaI-C 
GAAGGGCCCTAGATT
CGTCATGGGTTG 
  Rel2B-pAC5.1-
ApaI-C 
GAAGGGCCCAAGAAT
TCTTTTGACATAGTAT 
Dorsal-pAC5.1-
KpnI-N 
CGGGGTACCCAAAAT
GGCCCCGTACGTGGT
CGTCGTGCAGCAG 
Dorsal-pAC5.1-
ApaI-C 
GAAGGGCCCCTTCTT
GTCGTAGATGACGTC
GGA 
Dorsal-pIZ-
KpnI-N 
CTTGGTACCAATAAA
GTGCGATGGCGCCGT
ACGTGGTCGTCGTG 
Dorsal-pIZ-XbaI-
C 
CCCTCTAGAG 
TCTTCTTGTC 
GTAGATGAC 
 
Rel-pIZ-KpnI-N CTTGGTACCAATTGCC
CTTACCATGGAGAAA
AAAATCCCATATCTA
CAGATCAC 
Rel-pIZ-XbaI-
Flag-C 
CCCTCTAGATCACTA
TTACTTGTCATCGTCG
TCCTTGTAGTCCTTCA
AATTATAAATGGG 
Rel-RHD-
EcoRI-N 
CCGGAATTCATGCCA
TATCTACAGATCACA
GA 
Rel-RHD-NotI-
Flag-C 
GCGGTTTAAACTCAC
TTGTCATCGTCGTCCT
TGTAGTCAGCGGCCG
CCTTCAAATTATAAA
TGGGTTC 
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Primers Forward Primer (5’  3’)  Reverse Primer (5’  3’) 
For mutant reporter plasmids 
Lysozyme
Moricin-
κB5-rev
-N 
CTAAACTAATATTGG
GACTTTACTGCCAGT
ATCAACCTGGATT 
Lysozyme
Moricin-
κB5-rev
-C 
ATACTGGCAGTAAA
GTCCCAATATTAGTT
TAGGTACCTATCG 
Lysozyme
Moricin-
κB5-GATA-rev
-N 
CTAAACTAATATTCA
GATAACGATAGGGAC
TTTACTGCCAGTATC 
Lysozyme
Moricin-
κB5-GATA-rev
-C 
GTAAAGTCCCTATCG
TTATCTGAATATTAG
TTTAGGTACCTATCG 
Lysozyme
Moricin-
κB5
 -N 
CTAAACTAATATTGT
AAAGTCCCTGCCAGT
ATCAACCTGGATT 
Lysozyme
Moricin-
κB5
-C 
ATACTGGCAGGGACT
TTACAATATTAGTTT
AGGTACCTATCG 
Lysozyme
Moricin-
κB5-GATA
-N 
ATTGTAAAGTCCCTAT
CGTTATCTGTGCCAGT
ATCAACCTGGAAT 
Lysozyme
Moricin-
κB5-GATA
-C 
ATACTGGCACAGATA
ACGATAGGGACTTTA
CAATATTAGTTTAG 
Moricin
Lysozyme-
κB-rev
-N 
GCCTTTGTAAATTAG
AAAGTCCCTATCGTT
ATCTGAGAGTATAAA 
Moricin
Lysozyme-κB-
rev
-C 
GATAACGATAGGGA
CTTTCTAATTTACAA
AGGCCCGGAATTAC 
Moricin
Lysozyme-
κB
 -N 
GCCTTTGTAAATTGG
GACTTTCTTATCGTTA
TCTGAGAGTATAAA 
Moricin
Lysozyme-κB
 -
C 
GATAACGATAAGAA
AGTCCCAATTTACAA
AGGCCCGGAATTAC 
Moricin
Lysozyme-
κB-rev- △GATA-N 
GCCTTTGTAAATTAG
AAAGTCCCTATAATT
ATATTAGAGTATAAA 
Moricin
Lysozyme-κB-
rev- △GATA-C 
TATAATTATAGGGAC
TTTCTAATTTACAAA
GGCCCGGAATTAC 
Moricin
Lysozyme-
κB-△GATA-N 
GCCTTTGTAAATT 
GGGACTTTCTTATAAT
TATATTAGAGTATAA
A 
Moricin
Lysozyme-κB-
△GATA-C 
TATAATTATAAGAAA
GTCCCAATTTACAAA
GGCCCGGAATTAC 
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Results 
 
Cloning and sequence analysis of M. sexta Dorsal and Rel2 
Based on the partial sequences from the M. sexta EST database, we performed 
PCR amplification and RACE to obtain the full-length cDNA of two M. sexta Relish 
isoforms Rel2A (GenBank accession no. HM363513) and Rel2B (GenBank accession no. 
HM363514), and a Dorsal homologue (GenBank accession no. HM363515). MsRel2A 
cDNA is 1677 bp long with an open reading frame (ORF) of 1191 bp, which encodes a 
putative protein of 397 amino acids. MsRel2B cDNA is 2057 bp with an ORF of 1326 bp 
encoding a putative protein of 442 residues (Fig. 21). MsRel2A and MsRel2B have an 
identical RHD domain and only differ at the C-terminal regions. MsRel2A and MsRel2B 
share 91.7% identity, but MsRel2B is about 45 amino acids longer at the C-terminus. 
Sequence analysis showed that MsDorsal-RHD is most similar to RHDs of invertebrate 
species and it belongs to the class II NF-κB, while MsRel2-RHD is most similar to RHDs 
of Relish proteins, and thus MsRel2A and MsRel2B belong to the class I NF-κB.  
 
The expression profile of M. sexta Dorsal and Rel2 
Tissue distribution profile of MsDorsal, MsRel2A and MsRel2B in M. sexta naïve 
larvae was determined by RT-PCR. The results showed that MsDorsal mRNA was 
expressed at high levels in hemocytes and testis, at relatively high levels in fat body and 
midgut, and at a lower level in epidermis (Fig. 20A). MsRel2A transcript was expressed 
at high levels in all the tissues tested, but MsRel2B mRNA was only detected at high 
levels in the midgut and testis. These results suggest that MsDorsal and MsRel2A may be 
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ubiquitously expressed in tissues, while MsRel2B is more restricted to certain tissues 
(midgut and testis). To determine whether these NF-κB factors are induced by microbial 
infection, M. sexta larvae were injected with S. aureus, E. coli and S. cerevisiae, and 
MsDorsal and MsRel2 transcripts were measured by RT-PCR. Compared to the naïve or 
water injected larvae, the expression of MsDorsal, MsRel2A and MsRel2B mRNAs in the 
hemocytes, fat body and midgut didn’t change significantly after microbial injection (Fig. 
20B and 20C), suggesting that expression of NF-κB factors in M. sexta larvae is not 
induced in response to microbial infection.  
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Figure 20. Expression profile of M. sexta Dorsal, Rel2A and Rel2B transcripts in different 
tissues by RT-PCR. 
A, total RNA samples were prepared from different tissues of naïve larvae and cDNA 
was prepared by reverse transcription. RT-PCR was carried out using primers specific for 
MsDorsal, MsRel2A, MsRel2B and ribosomal protein S3. B and C, total RNA samples 
were prepared from different tissues of naïve larvae or larvae injected with water, S. 
aureus, E. coli , or S. cerevisiae. RT-PCR analysis was carried out as described above. 
The sizes of bands are: MsDorsal (553 bp), MsRel2A (508 bp), MsRel2B (468 bp), rps3 
(317 bp). Hc, hemocyte; Fb, fat body; Mg, midgut; Epi, epidermis; Te, testis; M, DNA 
size ladders. 
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MsRel2 and MsDorsal activate promoter activity of M. sexta AMP genes. 
D. melanogaster and M. sexta AMP genes can be significantly upregulated by 
various microbial components (Rao and Yu, 2010). Since NF-κB transcription factors 
play central roles in the activation of AMP expression, we carried out dual-luciferase 
reporter assays to determine if MsDorsal and MsRel2 could activate different AMP gene 
promoters (Rao et al., 2011). Recombinant MsDorsal-RHD (Dl-RHD) and MsRel2-RHD 
(Rel2-RHD) (only the RHD domains), as well as MsRel2A and MsRel2B (full length 
proteins) were successfully expressed in both Drosophila S2 cells and S. frugiperda Sf9 
cells (Fig. 21) and could be detected in both the cytoplasm (Fig. 21, lanes 1 and 3) and 
the nucleus (Fig. 21, lanes 2 and 4). Over-expression of recombinant Dl-RHD and Rel2-
RHD in S2 cells could significantly activate promoter activity of several M. sexta AMP 
gene promoters and B. mori lebocin-4 promoter (Fig. 22A). Most AMP gene promoters, 
including M. sexta moricin, defensin-1 and two attacins and B. mori lebocin-4, were 
activated to significantly higher levels by Rel2-RHD than by Dl-RHD, while M. sexta 
cecropin promoter was activated to an equally high level by Dl-RHD and Rel2-RHD, but 
M. sexta lysozyme promoter was activated to a significantly higher level by Rel2-RHD 
than by Dl-RHD (Fig. 22A). Similarly, over-expression of the full length Rel2A and 
Rel2B could also significantly stimulate the activity of AMP gene promoters, and Rel2A 
and Rel2B could activate the activity of most AMP gene promoters (except M. sexta 
attacin-2 and lysozyme) to similar high levels (Fig. 22B).  
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Figure 21. Western blot analysis of recombinant MsDorsal-RHD, MsRel2A, MsRel2B 
and MsRel2-RHD in S2 and SF9 cells. 
Expression plasmids of V5-tagged MsDorsal-RHD, Flag-tagged MsRel2-RHD and V5-
tagged MsRel2A and MsRel2B were used to transfect S2 or SF9 cells, respectively. 
Cytoplasmic or nuclear lysate was prepared separately for Western blot analysis using 
monoclonal V5 or Flag antibody. Odd lanes: cytoplasmic proteins; Even lanes: nuclear 
proteins; A and B: Lanes 1 & 2: S2 cells; lanes 3 & 4: Sf9 cells; C: lanes 1 & 2, Rel2A; 
lanes 3 & 4, Rel2B in Sf2 cells. 
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Figure 22. MsRel2 and MsDorsal activate expression of M. sexta and B. mori AMP gene 
promoters. 
A, Activation of AMP gene promoters by MsDorsal-RHD and MsRel2-RHD in S2 cells. 
B, Activation of AMP gene promoters by MsRel2A and MsRel2B in S2 cells. The S2 
cells were transfected with 0.3 μg of NF-κB plasmid, 0.15 μg of reporter gene plasmid 
together with 0.015 μg pRL-TK Renilla reniformis luciferase vector as the internal 
control. 48 hours after transfection, cells were harvested and analyzed with Dual-
Luciferase Reporter Assay System (E1980, Promega). Bars represent the mean of three 
individual measurements ± SEM. Asterisks indicate significant difference (p<0.05) 
determined by one-way ANOVA. 
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Activation of moricin and lysozyme promoters by MsDorsal and MsRel2 
We have previously characterized a moricin promoter (1400 bp) and also cloned a 
lysozyme promoter (1203 bp) in M. sexta (Rao et al., 2011). Five NF-κB sites were 
predicted in the MsMoricin promoter, but only the proximal NF-κB5 (Mor-NF-κB5) was 
activated in Sf9 cells by peptidoglycan from E. coli (Rao et al., 2011). To test whether 
MsMoricin can be activated by MsDorsal and/or MsRel2 and whether the five predicted 
NF-κB sites are all functionally active, reporter luciferase assays were performed with 
MsMoricin promoter and its deletion and mutation promoters in Sf9 cells since 
MsMoricin promoter showed low activity in S2 cells but high activity in Sf9 cells (Rao et 
al., 2011). All the MsMoricin promoters showed almost no activity in Sf9 cells after 
overexpression of MsDorsal-RHD (Fig. 23A), indicating that MsMoricin is not activated 
by Dorsal. MsMoricin (1400 bp), MsMoricin-725 (725 bp) and MsMoricin-242 (242 bp) 
promoters were activated to similar high levels by MsRel2-RHD, but MsMoricin-40 (40 
bp) promoter did not have any activity (Fig. 23A). Deletion of the predicted NF-κB1, NF-
κB2, NF-κB3 or NF-κB4 site did not have an effect on the activity of MsMoricin 
promoter stimulated by MsRel2-RHD, but deletion or mutation of NF-κB5 significantly 
decreased the activity of MsMoricin promoter (Fig. 23B), indicating that MsMoricin is 
activated by Rel2 and only the NF-κB5 site is functionally active.  
We showed that MsLysozyme promoter was activated by MsDorsal-RHD (Fig. 
22A), and only one NF-κB site was predicted in the lysozyme promoter, which differs 
from moricin NF-κB5 site only at the two 3’-end nucleotides but the two NF-κB sites 
have opposite direction (Fig. 23C). To test whether the consensus sequence and direction 
of NF-κB site as well as other transcription factor binding sites are required for activation 
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of AMP promoters by Dorsal and Rel2, we made several mutations in the Mor-242 
promoter (242 bp) by replacing NF-κB5 site with lysozyme NF-κB site (Lyz-κB, with an 
opposite direction to NF-κB5) or reversed lysozyme NF-κB site (Lyz-κB-Rev, with the 
same direction to NF-κB5) and with or without GATA-1 site (Fig. 23E), since GATA-1 
is required for NF-κB5 to activate moricin promoter (Rao et al., 2011). It has also been 
reported that Drosophila Dif and Relish can form heterodimers to activate AMPs (Tanji 
et al., 2010). Thus, we also test whether co-expression of MsDorsal-RHD and MsRel2-
RHD has an effect on the activity of the moricin promoters. Our results showed that 
among the five moricin promoters, only Mor-242 promoter (containing both NF-κB5 and 
GATA-1 sites) was activated by MsRel2-RHD, and only Mor
Lyz-κB-Rev
 promoter 
(containing both the reversed lysozyme NF-κB site that has the same direction to NF-κB5 
and GATA-1) was activated by MsDorsal-RHD, but none of the five promoters was 
activated by co-expression of MsRel2-RHD and MsDorsal-RHD (Fig. 23D).       
To determine activation of MsLysozyme promoter by Doral and Rel2, we 
constructed four deletion promoters and also four mutation promoters by replacing 
lysozyme NF-κB with moricin NF-κB5 (opposite direction to lysozyme NF-κB) or 
reversed NF-κB5 (same direction to lysozyme NF-κB) with or without GATA-1 site (Fig. 
24C). Since lysozyme promoter showed similar high activities in both Drosophila S2 and 
S. frugiperda Sf9 cells (Rao et al., 2011), activation of lysozyme promoters was 
performed in S2 cells. The results showed that only the lysozyme promoter (1203 bp) but 
not the four deletion promoters was activated by MsDorsal-RHD, and all five lysozyme 
promoters showed low basal activities when MsRel2-RHD was overexpressed (Fig. 24A), 
indicating that the distal lysozyme NF-κB is functional active and it binds to Dorsal but 
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not Rel2. Among the lysozyme promoter and the four mutated promoters, only lysozyme 
promoter was activated by MsDorsal-RHD, and only Lyz
Mor-κB5-GATA
 promoter 
(containing moricin NF-κB5 and GATA-1 sites) was activated by MsRel2-RHD, and 
none of the five lysozyme promoters was activated by co-expression of MsDorsal-RHD 
and MsRel2-RHD (Fig. 24B). 
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Figure 23. Moricin promoter is regulated by MsRel2-RHD but not by MsDorsal-RHD. 
A, the empty vector (PIZ) or expression vector (Dl-RHD or Rel2-RHD) was used to 
transfect SF9 cells along with different truncated Moricin promoter-driven luciferase 
reporters. The relative induction of Moricin promoter was determined by dual-luciferase 
assays. B, the empty vector (PIZ) or expression vector (Dl-RHD or Rel2-RHD) was used 
to transfect SF9 cells along with different NF-κB-deleted or the NF-κB-mutated reporter. 
The relative induction of each reporter was determined. C, DNA sequence of Moricin 
NF-κB5 and Lysozyme NF- κB binding site. D, the empty vector (PIZ), or expression 
vector (Dl-RHD, Rel2-RHD or Dl-RHD+Rel2-RHD) was used to transfect SF9 cells 
along with the MsMoricin, Mor
Lyz-κB
, Mor
Lyz-κB-ΔGATA
, Mor
Lyz-κB-Rev
, or Mor
Lyz-κB-Rev-
ΔGATA
 reporter. The relative induction of each reporter was determined. Bars represent the 
mean of three individual measurements ± SEM. Identical letters are not significant 
difference (p>0.05), while different letters indicate significant difference among groups 
(p<0.05) determined by one way ANOVA followed by a Tukey’s multiple comparison 
test. E, Schematic representation of different mutations in the Mor-242 promoter.
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Figure 24. Lysozyme promoter is regulated mainly by MsDorsal-RHD. 
A, the empty vector (pAC5.1A) or the expression vector (pAC-Dorsal-RHD or pAC-
Rel2-RHD) was used to transfect S2 cells along with the full-length MsLysozyme 
promoter (Lyz-1203) or the truncated forms (Lyz-888, Lyz-596, Lyz-345 and Lyz-67) and 
the pRL-TK internal control. The relative induction of Lysozyme promoter activity was 
determined by dual-luciferase assays. B, the relative induction of Lyz-1203, Lyz
Mor-κB5-Rev
, 
Lyz
Mor-κB5-GATA-Rev
, Lyz
Mor-κB5
, or Lyz
Mor-κB5-GATA
 by Dorsal-RHD, Rel2-RHD or 
Rel2+Dorsal was determined. Bars represent the mean of three individual measurements 
± SEM. Identical letters are not significant difference (p>0.05), while different letters 
indicate significant difference among groups (p<0.05) determined by one way ANOVA 
followed by a Tukey’s multiple comparison test. C, Schematic representation of different 
mutations in the Lyz-1203 promoter. 
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Interaction of MsDorsal with MsRel2 
It has been reported that Drosophila Dif and Relish can form heterodimers and 
expression of peptide linked Dif-Relish-N (the N-terminal domain of Relish) can activate 
AMP genes in the Toll and IMD pathways (Tanji et al., 2010). We showed above that co-
expression of MsDorsal-RHD and MsRel2-RHD abolished activation of moricin 
promoter by MsRel2-RHD (Fig. 23C) and lysozyme promoter by MsDorsal-RHD (Fig. 
24B). To test interaction between MsDorsal and MsRel2, we over-expressed MsRel2-
RHD-Flag and MsDorsal-RHD-V5 in S2 cells and performed co-immunoprecipitation 
(Co-IP) experiments. Expression of MsRel2-RHD-Flag and MsDorsal-RHD-V5 in S2 
cells was confirmed by Western blot analysis with monoclonal anti-Flag or anti-V5 
antibody (Fig. 25A, B, D and E, lanes 2 and 3 for input), and expression of MsDorsal-
RHD-V5 was also confirmed by polyclonal rabbit anti-Dorsal antibody (Fig. 25C, lane 3). 
Results from the Co-IP experiments showed that anti-Flag antibody could pull down 
MsRel2-RHD-flag (Fig. 25A, lane 4), and co-precipitated MsDorsal-RHD-V5, which was 
recognized by anti-V5 antibody (Fig. 25B, lane 4) and anti-Dorsal antibody (Fig. 25C, 
lane 4). Likewise, anti-V5 antibody could pull down MsDorsal-RHD-V5 (Fig. 25D, lane 
4), and co-precipitated MsDRel2-RHD-Flag, which was recognized by anti-Flag antibody 
(Fig. 25E, lane 4). These results suggest that M. sexta Dorsal and Rel2 may form 
heterodimers in vivo.  
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Figure 25. M. sexta Rel2 interacts with Dorsal. 
MsRel2-RHD and MsDorsal-RHD were expressed in Drosophila S2 cells for 48 h. 
Proteins in cell lysates were used for co-immunoprecipitation (Co-IP) assays as described 
in the Materials and Methods. MsDorsal-RHD contained a V5-tag, while MsRel2-RHD 
contained a Flag-tag. Monoclonal antibody (anti-FLAG or anti-V5) was added to 
combined cell lysates and immunoprecipitated (IP) proteins or Co-IP proteins were 
detected by immunoblotting using anti-Flag (A and E), anti-V5 (B and D), anti-Dorsal 
antibody (C) as the primary antibody, alkaline phosphatase-conjugate anti-mouse or anti-
rabbit antibody as the secondary antibody and alkaline phosphatase (AP) conjugate color 
development kit. Lanes 1-3 from A-E were cell lysates alone (protein inputs).  
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Dorsal-Rel2 heterodimers as negative regulators in AMP gene expression 
We showed that co-expression of MsDorsal-RHD and MsRel2-RHD abolished 
activation of moricin promoter by MsRel2-RHD (Fig. 23C) and lysozyme promoter by 
MsDorsal-RHD (Fig. 24B), respectively, and MsDorsal-RHD and MsRel2-RHD could 
interact with each other to form heterodimers (Fig. 25). To test whether Dorsal-Rel2 
heterodimers may also have an effect on activation of other AMP gene promoters, 
luciferase assays were performed in S2 cells for Drosophila AMP gene promoters and in 
Sf9 cells for M. sexta AMP gene promoters after overexpression of MsDorsal-RHD or 
MsRel2-RHD alone, or co-expression of MsDorsal-RHD and MsRel2-RHD. 
Overexpression of MsDorsal-RHD or MsRel2-RHD alone could activate all the 
Drosophila and M. sexta AMP gene promoters to certain levels (Fig. 26). Co-expression 
of MsDorsal-RHD and MsRel2-RHD in S2 cells stimulated Drosophila cecropin, 
diptericin and metchnikowin promoters to significantly higher levels than by MsDorsal-
RHD or MsRel2-RHD alone, but inhibited activation of attacin (Fig. 26A). However, co-
expression of MsDorsal-RHD and MsRel2-RHD in Sf9 cells abolished activation of all 
the AMP gene promoters tested, including M. sexta defensin-1, attacin-1, attacin-2, 
cecropin, and B. mori lebocin-4 (Fig. 26B). These results suggest that in M. sexta, 
Dorsal-Rel2 heterodimers may serves as negative regulators in activation of AMPs.  
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Figure 26. MsDorsal-MsRel2 heterodimer negatively regulates M. sexta AMP expression. 
Dl-RHD and Rel2-RHD were expressed separately or together in S2 (A) or SF9 (B) cells. 
The induction of Drosophila or M. sexta AMP gene promoters were measured, 
respectively. Drs: Drosomycin; Def: Defensin; Cec: Cecropin; Att: Attacin; Dpt: 
Diptericin; Dro: Drosocin; Met: Metchnikowin; Leb: Lebocin. Bars represent the mean of 
three individual measurements ± SEM. Identical letters are not significant difference 
(p>0.05), while different letters indicate significant difference among groups (p<0.05) 
determined by one way ANOVA followed by a Tukey’s multiple comparison test. 
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Discussion 
In this study, we identified a Dorsal homolog (MsDorsal) and two short isoforms 
of Relish (MsRel2A and MsRel2B) in M. sexta, and investigated their roles in activation 
of AMP gene promoters. We found that MsDorsal and MsRel2A and 2B were functional 
active NF-κB factors that could activate M. sexta and D. melanogaster AMP gene 
promoters differently. We also showed that MsDorsal could interact with MsRel2 and 
may form Dorsal-Rel2 heterodimers, which served as negative regulators in activation of 
M. sexta AMP genes.   
In Drosophila, Dorsal, Dif and Relish have been identified and characterized 
(Hetru and Hoffmann, 2009), and homo- and hetero-dimers among the three NF-κB 
factors have been observed in the flies (Ganesan et al., 2011). Peptide linked Dif-Relish-
N (N-terminal fragment of Relish) heterodimers can activate AMPs regulated by both the 
Toll and IMD pathways (Tanji et al., 2010). Since the covalent linked Dif-Relish-N 
heterodimers may form dimers of heterodimers, in which Dif-Dif homodimers can be on 
one end and Relish-N-Relish-N homodimers can be on the other end, thus such dimers of 
heterodimers may still function as Dif-Dif and Relish-Relish homodimers. In addition, it 
is not clear how Dif-Relish heterodimers are form in vivo in flies as both the Toll and 
IMD pathways must be activated to release Dif and generate Relish-N for formation of 
heterodimers. Interestingly, alternative splice forms of Relish have been identified in the 
mosquito Ae. Aegypti (Shin et al., 2002; Shin et al., 2005), and two isoforms of Relish 
have also been identified in the silkworm B. mori (Tanaka et al., 2007). In vitro assays 
show that the short isoform of Relish containing the N-terminal fragment alone can serve 
as transcription activator in Ae. aegypti, but the BmRelish2 isoform is a dominant 
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negative regulator of the active BmRelish1 (Shin et al., 2002; Shin et al., 2005). The 
biological roles of short Relish isoforms in insects are not clear. 
M. sexta Rel2A and Rel2B contain an identical RHD domain and only differ in 
the C-terminal residues. This might be a result of alternative splicing. Alternative splicing 
occurs frequently in insects. In mosquito Aedes aegypti, there are three spliced forms of 
Relish homolog (Shin et al., 2002). The 3.9 kb transcript contains both the RHD domain 
and the inhibitor kappa B (I kappa B)-like domain, while the other two shorter transcripts 
lack either the RHD or the I kappa B domain. The Anopheles gambiae REL2 gene 
produces two spliced forms: a full-length REL2-F and a shorter REL2-S (Meister et al., 
2005). In B. mori, two transcripts BmRelA and BmRelB differ only in the 5’ region, 
BmRelB could activate the Attacin gene strongly, whereas BmRelA activated Lebocin 4 
gene strongly (Tanaka et al., 2007). Both M. sexta Rel2A and Rel2B were functionally 
active NF-κB factors with different tissue distribution, Rel2B was more restricted to the 
midgut and testis. 
We showed that MsDorsal and MsRel2 could form heterodimer to negatively 
regulate AMP expression. In Drosophila melanogaster, Dif and Relish can form 
heterodimers to activate AMP production (Tanji et al., 2010). Dimerization of NF-κB 
factors has been reported in both vertebrates and invertebrates. p65 and p50 can form 
heterodimers to bind NF-κB sites (Urban et al., 1991). p65/c-Rel dimer is related to neuro 
protection through activation of metabotropic glutamate receptors type 5 (Sarnico et al., 
2008). In Drosophila, homodimers and heterodimers can form among Dorsal, Dif and 
Relish with different degrees of efficiency (Tanji et al., 2010). Therefore, further study is 
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needed to reveal NF-κB sites recognized by homo- and hetero-dimers of NF-κB factors in 
insects. 
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CHAPTER 5 
CHARACTERIZATION OF A NOVEL MANDUCA SEXTA BETA-1, 3-GLUCAN 
RECOGNITION PROTEIN-3 (ΒGRP3) WITH MULTIPLE FUNCTIONS 
 
Any questions about whether a particular use is authorized and any requests for 
permission to publish, reproduce, distribute, display or make derivative works from any 
Elsevier published works, images or other material should be directed to the Elsevier 
Rights Department.  
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Abstract 
Recognition of pathogens by insect pattern recognition receptors is critical to 
mount effective immune responses. In this study, we reported a new member (βGRP3) of 
the β-1, 3-glucan recognition protein (βGRP) family from the tobacco hornworm 
Manduca sexta. Unlike other members of the M. sexta βGRP family proteins, which 
contain an N-terminal small glucan binding domain and a C-terminal large glucanase-like 
domain, βGRP3 is 40-45 residues shorter at the N-terminus and lacks the small glucan 
binding domain. The glucanase-like domain of βGRP3 is most similar to that of M. sexta 
microbe binding protein (MBP) with 78% identity. βGRP3 transcript was mainly 
expressed in the fat body, and both its mRNA and protein levels were not induced by 
microorganisms in larvae. Recombinant βGRP3 purified from Drosophila S2 cells could 
bind to several Gram-negative and Gram-positive bacteria and yeast, as well as to 
laminarin (β-1, 3-glucan), mannan, lipopolysaccharide (LPS), lipoteichoic acid (LTA), 
and meso-diaminopimelic acid (DAP)-type peptidoglycan (PG), but did not bind to 
Lysine-type PG. Binding of βGRP3 to laminarin could be competed well by free 
laminarin, mannan, LPS and LTA, but almost not competed by free PGs. Recombinant 
βGRP3 could agglutinate Bacillus cereus and Escherichia coli in a calcium-dependent 
manner and showed antibacterial (bacteriostatic) activity against B. cereus, novel 
functions that have not been reported for the βGRP family proteins before. M. sexta 
βGRP3 may serve as an immune surveillance receptor with multiple functions.  
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Introduction 
The innate immune system is the first line of defense against pathogenic invaders 
in animals (Mogensen, 2009; Sukhithasri et al., 2013) and relies on surveillance 
molecules, named pattern recognition receptors (PRRs), to recognize pathogen-associated 
molecular patterns (PAMPs) present in pathogens but not in the hosts (Charroux et al., 
2009; Charroux and Royet, 2010; Kanost et al., 2004; Lemaitre and Hoffmann, 2007). 
PRRs include C-type lectins, β-1,3-glucan recognition/binding proteins (βGRPs/BGRPs) 
and Gram-negative bacteria binding proteins (GNBPs), peptidoglycan recognition 
proteins (PGRPs), Toll-like receptors (TLRs), retinoic acid-inducible gene 1 (RIG-I)-like 
receptors, nucleotide-binding oligomerization domain (NOD) receptors, and Dectin 
receptors (Pal and Wu, 2009; Takeuchi and Akira, 2010). Examples of PAMPs include 
lipopolysaccharide (LPS), lipoteichoic acid (LTA) and peptidoglycans (PG) from bacteria 
and β-1,3-glucan from fungi (Rao and Yu, 2010). Upon binding to PAMPs, PRRs can 
stimulate humoral and cellular immune responses, such as phagocytosis, nodule 
formation, encapsulation and melanization, synthesis of antimicrobial peptides and 
activation of the prophenoloxidase (proPO) system (Jiang et al., 2010; Kanost et al., 2004; 
Thompson et al., 2011). In insect hemolymph, activation of serine proteinase cascade 
leads to the proteolytic activation of proPO to active phenoloxidase (PO) (Gupta et al., 
2005; Jiang et al., 2010). PRRs such as C-type lectins, βGRPs/BGRPs and PGRPs can 
stimulate proPO activation in hemolymph when binding to various PAMPs (Jiang et al., 
2010; Lee et al., 2004; Ma and Kanost, 2000; Rao et al., 2010; Wang et al., 2011).  
Gram-negative bacteria binding protein (GNBP) was first characterized as a 50-
kDa hemolymph protein from the silkworm Bombyx mori that can bind to Escherichia 
128 
 
coli (Lee et al., 1996). GNBPs actually belong to the β-1, 3-glucan recognition protein 
(βGRP/BGRP) family, which is one of the major pattern recognition receptors that can 
bind to β-1, 3-glucans on bacteria and fungi (Hughes, 2012; Jiang et al., 2004; Lee et al., 
1996; Ma and Kanost, 2000; Wang et al., 2011). Members of the βGRP family proteins 
contain a small (~100 residues) N-terminal glucan binding domain and a large (~350 
residues) C-terminal glucanase-like domain that lacks key residues in the active sites for 
glucanase activity (Ma and Kanost, 2000; Ochiai and Ashida, 2000). The small glucan 
binding domains of βGRPs bind to β-1, 3-glucan with a mechanism different from that of 
glucanase-like domains (Dai et al., 2013; Kanagawa et al., 2011; Mishima et al., 2009; 
Takahasi et al., 2009). βGRPs have been identified in invertebrates, including insects and 
crustaceans, and they can bind to microbial cell wall components, leading to activation of 
proPO (Cerenius et al., 1994; Duvic and Soderhall, 1990; Vargas-Albores et al., 1996; 
Vargas-Albores et al., 1997; Zheng and Xia, 2012). In the tobacco hornworm Manduca 
sexta, βGRP1 and βGRP2 have been identified and they can greatly stimulate proPO 
activation after binding to laminarin (β-1, 3-glucan) (Jiang et al., 2004; Ma and Kanost, 
2000). M. sexta microbe binding protein (MBP), a β-1, 3-glucanase related protein, binds 
to bacteria and fungi, and MBP alone weakly stimulates proPO activation, but can 
significantly activate proPO when combined with different microbial elicitors (Wang et 
al., 2011). An inducible GNBP was purified from the silkworm, Bombyx mori (Hughes, 
2012; Lee et al., 1996), and silkworm βGRP can bind to β-1, 3-glucan to initiate 
activation of the proPO cascade (Ochiai and Ashida, 2000). Drosophila DGNBP-1 can 
bind to LPS and β-1, 3-glucan and enhance immune gene expression induced by LPS and 
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β-1, 3-glucan (Kim et al., 2000). Anopheles gambiae GNBPs are involved in anti-
Plasmodium responses (Warr et al., 2008). 
In this paper, we reported the characterization and functional analysis of βGRP3, 
a new member of the M. sexta βGRP family. We investigated tissue distribution of 
βGRP3 transcript and induced expression of βGRP3 mRNA in fat body, hemocytes and 
midgut as well as βGRP3 protein in hemolymph by immune challenge. We also 
expressed and purified recombinant βGRP3 from Drosophila S2 cells and studied 
binding of βGRP3 to microorganisms and to various microbial cell wall components, 
including laminarin (β-1, 3-glucan), mannan, LPS, LTA, meso-diaminopimelic acid 
(DAP)-type and Lysine-type PGs. Interestingly, we found that βGRP3, which is 40-45 
residues shorter at the N-terminus and lacks the small glucan binding domain, possessed 
novel properties with calcium-dependent agglutinating activity against Bacillus cereus 
and E. coli and strong antibacterial (bacteriostatic) activity against B. cereus. 
 
Materials and Methods 
 
Insect rearing and Drosophila S2 cell line 
M. sexta eggs were purchased from Carolina Biological Supply (Burlington, NC). 
Larvae were reared on artificial diet at 25°C (Dunn, 1983), and the fifth instar larvae 
were used for the experiments. D. melanogaster Schneider S2 cells were purchased from 
American Type Culture Collection (ATCC). 
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cDNA cloning of βGRP3 and sequence analysis 
An M. sexta EST sequence was predicted to encode a partial BGRP-like protein 
(Accession number: GR922389.1). We then designed primers based on the EST sequence 
to clone the full-length cDNA. Briefly, total RNA was prepared from the fat body of day 
3 naïve larvae using TRIzol
®
 Reagent (T9424, Sigma–Aldrich). For reverse transcription, 
total RNA was treated with RQ1 RNase-free DNase I (Promega) at 37°C for 30 min to 
remove contaminated genomic DNA, and DNase was inactivated by heating to 65°C for 
20 min. Reverse transcription was performed using oligo(dT) primer (Promega) and 
ImProm-II reverse transcriptase (Promega) following the manufacturer’s instructions. M. 
sexta βGRP3 full-length cDNA was cloned using the forward primer βGRP3-F1: 5’-ACG 
ACT CGA TCA CAA GCA AC-3’ and the reverse primer βGRP3-R1: 5’-CAG AAC 
TTG AGC ATG GCT TT-3’. 5’and 3’ RACE reactions were performed using smarter 
race kit (Clontech). The ORF of βGRP3 was predicted from the nucleotide sequence 
using DNAMAN (Lynnon Corporation, Quebec, Canada). BLASTP 
(http://www.ncbi.nlm.nih.gov/) was used to search homologous βGRP, BGRP or GNBP 
protein sequences. Multiple sequence alignment was performed by ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) with protein sequences retrieved from the 
NCBI database using default settings, and the phylogenetic tree was generated from the 
conserved regions of 18 proteins (not including the N-terminal regions) by Neighbor-
Joining method with bootstrap of 1,000 replications using MEGA5 (Tamura et al., 2011). 
Figures were made from one representative set of data with the GraphPad Prism software 
(GraphPad, CA). Significance of difference was determined by one way ANOVA 
followed by a Tukey’s multiple comparison test using the same software (GraphPad, CA). 
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Expression and purification of recombinant βGRP3 and GFP 
Recombinant βGRP3 was expressed in E. coli and purified for production of 
polyclonal antibody in rabbit. The cDNA sequence encoding mature βGRP3 (residues 24-
441) was obtained by PCR using primers βGRP3-F2 (5’-CAT GCC ATG GTT TAT 
CGG TCC CGT TCC ACG TCTTTG-3’) and βGRP3-R2 (5’-CCC AAG CTT TTA CAG 
CGC GAC TAC TTT GAC ATAGTC-3’). The PCR fragment was purified by agarose 
gel electrophoresis, digested with NcoI and HindIII enzymes, ligated into the 
NcoI/HindIII-digested expression vector H6pQE-60 (Lee et al., 1994) and then 
transformed into competent E. coli XL1-Blue cells. Recombinant plasmids were prepared 
from positive clones and confirmed by restriction enzyme digestion and DNA sequencing. 
Single bacterial colony on petri dish plates containing recombinant plasmid DNA was 
inoculated into LB medium containing ampicillin (100 μg/ml) and incubated at 37°C 
overnight. The overnight culture was diluted 1:100 in LB medium and incubated at 37°C 
to OD600=0.8 and then isopropyl-D-thiogalactopyranoside (IPTG) (0.5 mM final 
concentration) was added to induce protein expression for another 6 h at 37°C. Bacterial 
cells were harvested by centrifugation and lyzed with the lysis buffer (50 mM Tris-HCl, 
pH 8.0, 50 mM NaCl, 0.5% Triton X-100, 2 mg/ml lysozyme), and recombinant protein 
was purified using Ni-NTA agarose beads (Qiagen) following the manufacturer’s 
instructions. The purified protein was further separated on 12% SDS-PAGE and the gel 
slice containing recombinant βGRP3 was used as an antigen to produce rabbit polyclonal 
antiserum at Cocalico Biologicals, Inc (Pennsylvania, USA). Recombinant βGRP3 was 
also expressed in Drosophila S2 cells and purified. The cDNA sequence encoding mature 
βGRP3 (residues 24-441) was amplified by PCR using primers βGRP3-F3 (5’-GGA 
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AGA TCT TAT CGG TCC CGT TCC ACG TCT TTG A-3’) and βGRP3-R3 (5’-CCG 
CTC GAG CAG CGC GAC TAC TTT GAC ATA GTC-3’). The PCR product was 
recovered by agarose gel electrophoresis-Wizard® SV Gel and PCR Clean-Up System 
(A9285, Promega), subcloned into T-Easy vector (A1360, Promega), and recombinant 
plasmid was isolated. After digested with BglII/XhoI, cDNA fragment was recovered and 
inserted into BglII/XhoI digested expression vector pMT/BiP/V5-His A (V413020, 
Invitrogen) using T4 DNA ligase (M0202L, NEB). Green fluorescent protein (GFP) in 
the expression vector pMT/Bip/V5-His/GFP (V413020, Invitrogen) was used as a control 
protein. Recombinant expression vectors were purified using PureYield™ Plasmid 
Miniprep System (A1222, Promega) according to the manufacturer’s instruction and the 
insert sequences were confirmed by DNA sequencing. These plasmids were used to 
transfect S2 cells and generate stable S2 cell lines following the manufacturer’s 
instructions. To purify recombinant βGRP3 and GFP, copper sulfate (final concentration 
of 250 μM) was added to stable S2 cells to induce expression of βGRP3 or GFP. Cell 
culture medium was collected starting at 24 h after protein expression for several days by 
collecting culture medium very day and re-suspending the cells with fresh medium, and 
recombinant βGRP3 and GFP were purified by affinity chromatography using anti-V5 
agarose beads (A7345, Sigma–Aldrich) as described previously (Xu et al., 2012; Zhong 
et al., 2012). Fractions were analyzed by 10% SDS-PAGE, and those containing 
recombinant βGRP3 or GFP were combined and desalted using D-salt™ Excellulose™ 
GF-5 desalting column (#1851850, Pierce) pre-equilibrated with dH2O. Recombinant 
βGRP3 or GFP was eluted with water, and fractions containing βGRP3 or GFP were 
pooled and concentrated for the following assays. 
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Tissue distribution and expression of βGRP3 mRNA in response to immune challenge 
To determine tissue distribution of βGRP3 mRNA, day 2 fifth instar M. sexta 
naïve larvae were used in the following experiments. Larvae were injected with 50 μl of 
heated-killed E.coli DH5α, Serratia marcescens, Staphylococcus aureus, Bacillus subtilis 
(5 × 10
7
 cells/larva) or yeast (Saccharomyces cerevisiae) (10
7
 cells/larva), or ddH2O (as a 
control), hemocytes, fat body, midgut, epidermis and testis were collected at 24 h post-
injection and washed 3 times in anti-coagulant (AC) saline (4 mM NaCl, 40 mM KCl, 8 
mM EDTA, 9.5 mM citric acid monohydrate, 27 mM sodium citrate, 5% sucrose, 0.1% 
polyvinyl pyrollidone, 1.7 mM PIPES). Total RNAs were isolated from these tissues 
using TRIzol
®
 Reagent, and cDNAs were prepared from total RNAs (1 μg from each 
tissue) in a 25 μl reaction as described above. Real-time PCR was performed with SYBR 
Premix (Takara) on a 7500 system (Applied Biosystems) using primers βGRP3-F4 (5’-
AAG AAG CGA CGG CTC TGC TTG G-3’) and βGRP3-R4 (5’-TGGACA GCC AGG 
AGT TGG TGC-3’) for βGRP3 gene, and RPS3-F (5’-GTT GCG AGG TGGTGG TTT 
C-3’) and RPS3-R (5’-CCG TTC TTG CCC TGT TGG TC-3’) for the control ribosomal 
protein S3 (rpS3) gene, and the reaction conditions were: 95°C for 10 min, followed by 
40 cycles of 95°C for 15 s and 60°C for 1 min. Then dissociation curve analysis was 
performed. Data from three replicates of each sample were analyzed with SDS software 
(ABI) using a comparative method (2
-ΔΔCt
 ) with the rpS3 gene as an internal control gene. 
Expression in naïve or water-injected larvae was set to 1. 
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Time-course induction of βGRP3 protein in hemolymph 
To determine time-course induction of βGRP3 protein in hemolymph by Western 
blot analysis, day 2 fifth instar naïve larvae were injected with E. coli, Micrococcus 
luteus or S. cerevisiae as described above. Hemolymph (～50 μl) was collected every 2 h 
after injection (at least 4 larvae in each group). Hemolymph samples were centrifuged at 
3000 g for 10 min and cell-free plasma samples were collected. Equal volumes of plasma 
samples (from at least 4 larvae) were mixed and 0.5 μl mixed plasma samples were 
analyzed by 10% SDS-PAGE. Western blot was performed using rabbit anti-βGRP3 
antiserum (1:2000 dilution) and goat anti-rabbit IgG conjugated to alkaline phosphatase 
(1:10,000 dilution) (Sigma-Aldrich). To determine the concentration of βGRP3 protein in 
hemolymph, cell-free plasma samples from fifth instar naïve or E. coli-injected larvae 
were collected and pooled (from at least 30 larvae in each group). The amounts of βGRP3 
in plasma samples were estimated by comparing the intensity of endogenous βGRP3 in 
the plasma samples with that of recombinant βGRP3 purified from Drosophila S2 cells 
by Western blot analysis using myImage AnalysisV1.1 (Thermo Scientific). 
 
Binding of βGRP3 to microbial cell wall components 
To test binding of βGRP3 to microbial cell wall components, plate ELISA assays 
were performed. Ultrapure TLR grade lipopolysaccharide (LPS) and peptidoglycan (PG) 
from E. coli K12 (LPS-K12 and PG-K12), lipoteichoic acid (LTA) and PG from B. 
subtilis (LTA-BS and PG-BS) and S. aureus (LTA-SA and PG-SA) were from Invivogen. 
Mannan and laminarin (β-1,3-glucan) were from Sigma-Aldrich. Briefly, wells of a flat 
bottom 96-well plate (Costar, Fisher) were coated with different microbial components (2 
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μg/well) as described previously (Yu and Kanost, 2000; Yu et al., 2005). The plates were 
placed overnight at room temperature until the water evaporated completely, heated to 
60°C for 30 min, and then blocked with 200 μl/well of 1 mg/ml BSA in Tris buffer (TB) 
(50 mM Tris-HCl, 50 mM NaCl, pH 8.0) for 2 h at 37°C. The plates were rinsed and 
increasing concentrations of purified recombinant βGRP3 or GFP (a control protein) in 
TB containing 0.1 mg/ml BSA were added to the coated plates (50 μl/well). For 
competitive binding assay, recombinant βGRP3 (diluted to 2 μg/ml) was pre-incubated 
with increasing concentrations of free microbial components for 1 h at room temperature 
as described previously (Yu et al., 2005) and then added to the laminarin-coated plates. 
Binding of recombinant proteins to microbial components was for 3 h at room 
temperature. Then, the plates were incubated with monoclonal anti-polyhistidine 
antibody (Sigma-Aldrich) (1:2,000 in TB containing 0.1 mg/ml BSA) (100 μl/well) 
overnight at 4°C, followed by incubation with goat anti-mouse IgG conjugated to alkaline 
phosphatase (Sigma–Aldrich; 1:3,000 in TB containing 0.1 mg/ml BSA) (100 μl/well) for 
2 h at 37°C. The plates were rinsed, p-nitro-phenyl phosphate (1 mg/ml in 10 mM 
diethanolamine, 0.5 mM MgCl2) was added (50 μl/well), and absorbance at 405 nm of 
each well was determined every minute for 30 min using a microtiter plate reader (Bio-
Tek Instrument, Inc.). The data were analyzed by the GraphPad Prism software. 
 
Binding of βGRP3 to microorganisms 
Binding of recombinant βGRP3 to microorganisms was performed using a 
published method (Du et al., 2009) with slight modifications. Briefly, Gram-negative E. 
coli, Pseudomonas aeruginosa, Serratia marcescens, Gram-positive S. aureus, B. subtilis, 
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M. luteus and Bacillus cereus, as well as S. cerevisiae were cultured overnight. The 
microorganisms were pelleted, washed twice with Tris-buffered saline (TBS) (25 mM 
Tris-HCl, 2.7 mM KCl, 137 mM NaCl, pH 7.5), then thoroughly resuspended in TBS 
containing 2 mM CaCl2 and 1 mM MgCl2. Purified recombinant βGRP3 or GFP (as a 
control) (each at 2 μg in 50 μl) were added to 50 μl bacteria (4x108 cells/ml) or yeast 
(4x10
7
 cells/ml) with rotation for 1 h at room temperature. The microorganisms were 
pelleted and the supernatants were collected as unbound proteins. These microorganisms 
were washed four times with TBS, subjected to elution with 7% SDS (100 μl) for 10 min, 
washed in 1 ml TBS four times, and finally lyzed in lysis buffer. Samples of the unbound 
proteins, TBS wash, 7% SDS elution and microbial lysates (to detect tightly bound 
proteins) were subjected to immunoblotting analysis using monoclonal anti-V5 antibody 
(V8012, Sigma-Aldrich). 
 
Agglutination of microorganisms by βGRP3 
E. coli, S. marcescens, P. aeruginosa, S. aureus, B. subtilis, B. cereus, M. luteus, 
and S. cerevisiae were used for the agglutination assays. Aliquots (3.5 μl) of bacteria 
(3x10
9
 cells/ml) and yeast (2.5x10
8
 cells/ml) suspensions were mixed with purified 
recombinant βGRP3 or GFP protein (final concentration of 8 μg/ml) in a total of 25 μl 
TBS containing 2 mM CaCl2 and 1 mM MgCl2 or 5 mM EDTA. The mixtures were 
incubated at room temperature for 1 h and then observed by microscopy as described 
previously (Yu et al., 1999; Yu et al., 2006). 
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Antimicrobial activity assay 
The antimicrobial inhibition zone assay was performed according to a published 
protocol (Hultmark, 1998). A single colony of E. coli, S. marcescens, B. cereus, B. 
subtilis, or S. cerevisiae was grown overnight in LB broth (for bacteria) or YPD medium 
(for S. cerevisiae) at 37°C. Overnight bacterial cultures were then sub-cultured in LB 
medium and S. cerevisiae culture was sub-cultured in YPD medium until mid-log phase 
(OD600=～0.6). Fifteen micro liters (15 μl) of log-phase cultures were diluted into 20 ml 
LB or YPD medium containing 1.5% agarose (kept in a 45°C heating block), mixed well 
and spread immediately on a petri dish. After the medium was solidified, 5-mm wells 
were punched in the agarose. Buffer, ampicillin, or purified βGRP3 was added into each 
well. The plates were incubated at 37°C overnight, and the diameters of inhibition zones 
were measured and recorded. B. cereus growth curves were also determined in the 
presence of recombinant βGRP3 and various microbial components as described 
previously (Rao et al., 2012). Briefly, overnight B. cereus culture was sub-cultured in LB 
medium until mid-log phase, centrifuged at 1000 g for 10 min at 4°C, washed once in 10 
mM Tris–HCl, pH 7.5, 0.1 mM EDTA, and diluted to OD600 =10-3 with LB medium. 
The diluted B. cereus cultures (75 μl/well) was mixed with purified βGRP3 alone (final 
concentration of 2 μg/ml), βGRP3 mixed with different microbial components (final 
concentration of 20 μg/ml), or water (Control) in 96-well plates, and the total volume was 
adjusted to 100 μl with LB medium. B. cereus cultures were incubated at 37°C with 220 
rpm shaking. OD600 was measured every hour by PowerWave XS plate reader (Bio-Tek, 
USA). Bacterial growth curves were generated using the Graphpad Prism software 
(GraphPad, CA). 
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Results 
 
cDNA cloning and sequence analysis of M. sexta βGRP3 
An M. sexta EST sequence was found to encode a partial BGRP-like protein 
(Accession number: GR922389.1), which is different from M. sexta βGRP1 and βGRP2 
proteins reported previously (Jiang et al., 2004; Ma and Kanost, 2000). To clone the new 
βGRP/BGRP homologue, we designed gene-specific primers based on the EST sequence. 
The full-length cDNA sequence of M. sexta βGRP3 was obtained by 5’ and 3’ RACE. 
The complete ORF of βGRP3 is 1323 nucleotides long encoding a protein of 441 amino 
acids with a putative signal peptide of 23 residues. The calculated molecular mass of 
mature βGRP3 is 48.9 kDa with an isoelectric point (pI) of 8.33. There are four potential 
N-linked glycosylation sites in βGRP3 (Asn46, Asn79, Asn124 and Asn177), and the 
glycosyl hydrolase like domain is located close to the C-terminus of βGRP3. βGRP3 is 
~40-45 residues shorter at the N-terminus compared to M. sexta βGRP1 (487 residues), 
βGRP2 (482 residues), and microbe binding protein (MBP) (482 residues), and it lacks 
the small glucan binding domain. The N-terminal region (~57 residues, not including the 
23-residues putative signal peptide) of βGRP3 shows no similarity to any sequence in the 
NCBI database (data not shown).   
BLASTP search showed that the glucanase-like domain of M. sexta βGRP3 
protein is most similar to M. sexta MBP, a β-1, 3-glucanase related protein (Wang et al., 
2011), Hyphantria cunea β-1, 3-glucan binding protein (BGRP) (Shin et al., 1998), and 
Bombyx mori BGRP-2 (Lee et al., 1996) with 63% identity, followed by Helicoverpa 
armigera BGRP-3 (59% identity) (Pauchet et al., 2009), Ostrinia furnacalis BGRP (60% 
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identity), Papilio xuthus Gram-negative bacteria binding protein-3 (GNBP-3) (58% 
identity). M. sexta βGRP3 also shows similarity to M. sexta βGRP1 (36% identity) (Ma 
and Kanost, 2000), βGRP2 (35% identity) (Jiang et al., 2004) and β-1,3-glucanase (36% 
identity), but lacks the four key residues (W, E, D, E) required for glucanase activity (Fig. 
27A) (Ma and Kanost, 2000). Therefore, βGRP3 may serve as a pattern recognition 
receptor in the immune system of M. sexta.  
The BGRP family proteins have been identified in different invertebrate species. 
The phylogenetic tree constructed based on the glucanase-like domains of 17 
BGRP/βGRP related proteins and M. sexta beta-1, 3-glucanase showed that M. sexta 
βGRP3 and microbe binding protein (Ms-MBP) are clustered in the same clade, βGRP1 
and βGRP2 are in a different clade, while M. sexta β-1,3-glucanase is in a distant clade 
(Fig. 27B). These results suggest that the common ancestor of M. sexta βGRP family 
proteins diverged into three clades with possible functional variances. 
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Figure 27. Multiple sequence alignment of the active sites of glucanases and some 
BGRP/βGRP/GNBP proteins and phylogenetic tree of BGRP/βGRP/GNBP proteins. 
Glucanase-related proteins and BGRP/βGRP/GNBP proteins were retrieved from the 
NCBI database, multiple sequence alignment was performed by ClustalW2, and only 
residues around the active site of glucanase were shown (A). The Glycine residue 
conserved in all sequences and the two highly conserved hydrophobic residues are shaded. 
Residues corresponding to the active site (W, E, D and E) of the Bacillus macerans 
glucanase are shown in bold. A phylogenetic tree of 17 BGRP/βGRP/GNBP proteins and 
M. sexta beta-1, 3-glucanase was constructed by MEGA5 using the Neighbor-Joining 
method with bootstraps of 1,000. Ms-βGRP1, M. sexta beta-1, 3-glucan recognition 
protein 1 (AF177982); Ms-βGRP2, M. sexta beta-1, 3-glucan recognition protein 2 
(Q8ISB6); Ms-βGRP3, M. sexta beta-1, 3-glucan recognition protein 3 (ADK39022); Ms-
MBP, M. sexta microbe binding protein (GNBP-like) (ADT82662); Ms-Glucanase, M. 
sexta beta-1, 3-glucanase (AEV66276); Af-BGRP, Apis florea beta-1, 3-glucan-binding 
protein (XP_003694585); Hc-BGRP, Hyphantria cuneabeta-1, 3-glucan-binding protein 
(O96363.1); Bm-GNBP, Bombyx mori beta-1, 3-glucan recognition protein 2 precursor 
(NP_001037450); Ha-BGRP3, Helicoverpa armigera beta-1,3-glucan recognition protein 
3 (ACI32828.1); Px-GNBP3, Papilio xuthus Gram-negative bacteria binding protein 3 
(BAM19646.1); Dp-BGRP, Danaus plexippus beta-1,3-glucan-binding protein 
(EHJ65186.1); Pr-BGRP3, Pieris rapae beta-1, 3-glucan recognition protein 3 
(ACI32823.1); Sl-BGRP2, Spodoptera littoralis beta-1, 3-glucan recognition protein 2 
(ACI32819.1); Cq-GRP, Culex quinquefasciatus beta-1, 3-glucan recognition protein 
(XP_001850624.1); Dw-GK12242, Drosophila willistoni GK12242 (XP_002068068.1); 
Gm-GNBP, Glossina morsitans Gram-negative binding protein 1-like protein 
(ABC25063.1); Aa-GRP, Aedes aegypti AAEL007626-PA (EAT40654.2); Ad-GRP, 
Anopheles darling hypothetical protein (EFR19153.1). 
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Expression profiles of βGRP3 mRNA and protein 
We expressed M. sexta βGRP3 in E. coli and purified the recombinant protein for 
production of a rabbit polyclonal antibody. We also expressed and purified V5-tagged 
βGRP3 and GFP from Drosophila S2 cells for functional study. Recombinant βGRP3 
purified from S2 cells migrated close to 58 kDa, which is larger than the calculated mass 
of 48.9 kDa, probably due to the addition of V5-His tag and post-translational 
modifications (Fig. 28). Recombinant βGRP3 could be recognized by both monoclonal 
anti-V5 and polyclonal anti-βGRP3 antibodies (Fig. 28B and C). 
The mRNA level of βGRP3 in different tissues of M. sexta naïve larvae was 
determined by real-time PCR, and the results showed that βGRP3 transcript was mainly 
expressed in fat body at a significantly higher level than in hemocytes, midgut and other 
tissues (Fig. 29A). Expression of βGRP3 mRNA in fat body, hemocytes and midgut was 
not significantly up-regulated in response to microbial challenges (Fig. 29B-D), which is 
similar to that of M. sexta βGRP1 (Ma and Kanost, 2000). We also determined βGRP3 
protein concentration in hemolymph by Western blot. The results showed that βGRP3 
protein concentration in the hemolymph of larvae injected with E. coli, M. luteus or S. 
cerevisiae did not change significantly from 0 to 12 h post-injection (Fig. 30A-C). To 
estimate the concentration of endogenous βGRP3 protein in hemolymph, Western blot 
was performed with increasing volumes of hemolymph from naïve and E. coli-injected 
larvae along with increasing amounts of purified recombinant βGRP3: endogenous 
βGRP3 protein was estimated at ~ 260 μg/ml in the hemolymph of naïve larvae and~255 
μg/ml in the hemolymph of E. coli-injected larvae (Fig. 30D and E). These results 
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suggest that both βGRP3 transcript and protein levels were not induced by immune 
challenges. 
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Figure 28. Analysis of recombinant GFP and βGRP3 purified from Drosophila S2 cells. 
V5-tagged recombinant GFP and βGRP3 proteins were purified from Drosophila S2 cells 
and analyzed by SDS-PAGE (1.5 μg each protein) (A) and Western blot (0.2 μg each 
protein) using monoclonal anti-V5 (B) or polyclonal anti-βGRP3 (C) antibody. (A-C): 
GFP (lane 1) and βGRP3 (lane 2). 
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Figure 29. Tissue distribution and expression of βGRP3 mRNA in response to immune 
challenge 
(A) Tissue distribution of βGRP3 mRNA in hemocytes, fat body, midgut, epidermis and 
testis of the 5th instar M. sexta naïve larvae was determined by real-time PCR and 
normalized to rpS3 gene. (B-D): Expression of βGRP3 mRNA in fat body (B), 
hemocytes (C), and midgut (D) after immune challenge Expression of βGRP3 mRNA in 
hemocytes, fat body and midgut of the 5th instar M. sexta naïve larvae or larvae injected 
with ddH2O, E. coli, S. marcescens, S. aureus, B. subtilis, or S. cerevisiae at 24 h post-
injection was determined by real-time PCR. The bars represent the mean of three 
individual measurements ±SEM. Relative expression of βGRP3 mRNA in naïve larval 
hemocytes (A) or in tissues of naïve larvae (B-D) was set as 1. Comparing expression of 
βGRP3 mRNA in different tissues (A) or after microbial injections, identical letters 
among tissues or treatments indicate not significant difference (p>0.05), while different 
letters indicate significant difference (p<0.05) determined by one way ANOVA followed 
by a Tukey’s multiple comparison test. 
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Figure 30. Expression of βGRP3 protein in hemolymph in response to immune challenge 
The 5th instar M. sexta naïve larvae were injected with E. coli (A), M. luteus (B), or S. 
cerevisiae (C), and hemolymph samples were collected at 0, 2, 4, 6, 8, 10 and 12 h post-
injection as described in the Materials and Methods. Cell-free mixed plasma samples (0.5 
μl each) were subjected to Western blot analysis using rabbit anti-βGRP3 antibody. (D) 
and (E): Concentration of endogenous βGRP3 in hemolymph Increasing amounts of 
purified recombinant βGRP3 (lanes 1-4) or increasing volumes of mixed plasma samples 
(lanes 5-8) from naïve larvae (D) or E.coli-injected larvae (E) were analyzed by Western 
blot using rabbit anti-βGRP3 antibody. Lanes 1-4: 10, 25, 50 and 75 ng purified 
recombinant βGRP3, respectively; lanes 5-8: 0.1, 0.2, 0.3 and 0.4 μl cell-free mixed 
plasma samples, respectively. 
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Binding of βGRP3 to microbial cell wall components and microorganisms 
To determine whether recombinant βGRP3 can bind to different microbial cell 
wall components, plate ELISA assay was performed. Compared to the control GFP 
protein, βGRP3 could bind to LPS-K12 and PG-K12 from E. coli K12, LTA-BS and PG-
BS from B. subtilis, mannan and laminarin from fungi, and LTA-SA from S. aureus (Fig. 
31), but did not bind to PG-SA from S. aureus (Fig. 31D). To confirm binding of βGRP3 
to microbial components is specific, a competitive binding assay was performed. Binding 
of βGRP3 to laminarin was well competed by free laminarin, mannan, LPS-K12, LTA-
SA and LTA-BS, but only slightly competed by PG-K12 and PG-BS (Fig. 31I), 
indicating that βGRP3 has broad binding spectra to microbial cell wall components with 
different affinities.  
To further confirm broad binding spectra of βGRP3, a direct binding of βGRP3 to 
different microorganisms was performed. We first tested binding of GFP and βGRP3 to E. 
coli and found that GFP did not bind to E. coli and remained in the unbound fraction (Fig. 
32A), but βGRP3 bound tightly to E. coli since only a small fraction of βGRP3 was 
eluted by 7% SDS and more βGRP3 remained in the E. coli lysates (Fig. 32D). We then 
tested binding of GFP and βGRP3 to several Gram-negative and Gram-positive bacteria 
as well as yeast. GFP did not bind to any of the microorganisms tested (Fig. 32B and C), 
but βGRP3 bound to all eight microorganisms tested (Fig. 32E and F). More βGRP3 
protein bound to E. coli, P. aeruginosa, S. aureus and B. subtilis than to the other four 
microorganisms (Fig. 32E and F). Binding of βGRP3 to S. marcescens, S. aureus, B. 
subtilis, M. luteus, and S.cerevisiae seems to be stronger since little or no βGRP3 was 
eluted by 7% SDS and more βGRP3 remained in microbial lysates (comparing Fig. 32E 
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and F). These results suggest that βGRP3 is able to bind to multiple types of PAMPs on 
various microorganisms. 
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Figure 31. Binding of βGRP3 to microbial cell wall components 
Increasing concentrations of recombinant βGRP3 or GFP purified from Drosophila S2 
cells were added to 96-well plates coated with LPS-K12 (A), PG-K12 (B), LTA-SA (C), 
PG-SA (D), LTA-BS (E), PG-BS (F), mannan (G) or laminarin (H), and binding of 
recombinant proteins to microbial components was determined by plate ELISA using 
anti-V5 antibody. Recombinant βGRP3 (2 μg/ml) was pre-incubated with increasing 
amounts of free microbial components and then added to the laminarin-coated 96-well 
plates (I), and binding of βGRP3 to laminarin was determined by plate ELISA assay. The 
figures showed total binding of recombinant proteins to microbial components. Each 
point represents the mean of three individual measurements ± SEM, and the lines in (A-H) 
represent nonlinear regression calculation of one-site binding curves for βGRP3 (solid 
line) and GFP (dotted line). 
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Figure 32. Binding of βGRP3 to microorganisms 
Microorganisms were incubated with recombinant GFP (A-C) or βGRP3 (D-F) at room 
temperature for 1 h, washed with TBS, and bound proteins were eluted with 7% SDS. 
The remaining microorganisms were lyzed in lysis buffer. Recombinant proteins in each 
fraction were detected by Western blot using anti-V5 antibody. (A) and (D): Binding of 
recombinant GFP (A) and βGRP3 (D) to E. coli. Lane 1: purified recombinant proteins 
(0.2 μg each); lane 2: unbound proteins; lane 3: the fourth TBS wash; lane 4: 7% SDS 
elution; lane 5: E. coli lysates In lanes 2-5, equivalent volumes to lane 1 were loaded in 
each lane. (B, C, E and F): Binding of GFP and βGRP3 to various microorganisms Only 
SDS elution fractions (B and E) and microbial lysates after SDS eluting (C and F) were 
analyzed by Western blot using anti-V5 antibody. Ec: E. coli, Pa: P. aeruginosa, Sm: S. 
marcescens, Sa: S. aureus, Bs: B. subtilis, Ml: M. luteus, Bc: B. cereus, Sc: S. cerevisiae. 
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Agglutination of E. coli and B. cereus by βGRP3 
To test whether βGRP3 also has agglutinating activity against microorganisms, 
purified recombinant βGRP3 or GFP was incubated with eight microorganisms, and 
agglutination of microbial cells was observed under microscope. GFP did not agglutinate 
any of the eight microorganisms tested (Fig. 33A-C and data not shown), but βGRP3 
could agglutinate E. coli and B. cereus (Fig. 33D and E), but not S. cerevisiae (Fig. 33F) 
and the other five bacteria (data not shown), and agglutination of E. coli and B. cereus 
was calcium-dependent (Fig. 33G and H). In addition, E. coli cells formed aggregates in 
the presence of βGRP3 (Fig. 33D), while B. cereus cells were cross-linked by βGRP3 to 
form large networks (Fig. 33E). 
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Figure 33. Agglutination of microorganisms by βGRP3 
Purified recombinant GFP or βGRP3 was incubated with E. coli, B. cereus or S. 
cerevisiae in TBS containing 2 mM CaCl2 and 1 mM MgCl2 (A-F) or 5 mM EDTA (G 
and H) at room temperature for 60 min, samples of microbial cells were examined by 
microscopy. Bar = 20 μm. 
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Antibacterial activity of βGRP3 against B. cereus 
Since βGRP3 could bind to microorganisms (Fig. 32) and agglutinate E. coli and 
B. cereus (Fig. 33), it may have antimicrobial activity and an inhibition zone assay was 
performed. Ampicillin and buffer were used as positive and negative controls. Ampicillin 
showed high activity against E. coli and relatively high activity against B. subtilis, but 
recombinant βGRP3 did not show activity against E. coli or B. subtilis (Fig. 34A and B). 
Interestingly, ampicillin was not active against B. cereus, but βGRP3 showed strong 
activity against B. cereus in a dose-dependent manner (Fig. 34C). Both ampicillin and 
βGRP3 did not have activity against S. cerevisiae (Fig. 34D). To test whether binding of 
microbial components to βGRP3 may inhibit its activity against B. cereus, bacterial 
growth curves were determined in presence of βGRP3 alone or βGRP3 mixed with 
microbial components. The results showed that βGRP3 alone almost completely inhibited 
B. cereus growth (OD600 = 0.104 compared to OD600 = 1.013 in the control group 
(water) at 20 h after incubation). LPS-K12, LTA-BS, LTA-SA, laminarin, mannan and 
PG-BS could all completely block the antibacterial activity of βGRP3 against B. cereus 
(OD600 =0.998 – 1.087 compared to OD600 = 1.013 in the control group) (Fig. 34E). 
PG-K12 also significantly blocked the activity of βGRP3 against B. cereus growth 
(OD600 = 0.805 vs. OD600 =0.104) (p<0.001), but B. cereus growth was still 
significantly inhibited compared to the control group (OD600 = 0.805 vs. OD600 = 1.013) 
(p<0.001) (Fig. 34E). 
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Figure 34. Antibacterial activity of βGRP3 against B. cereus 
Antibacterial activity of recombinant βGRP3 was determined by inhibition zone assay 
(A-D) and broth micro-dilution assay (E) as described in the Materials and Methods. 
Buffer and different amounts of ampicillin (Amp) were used as controls in the inhibition 
zone assay, the plates were incubated at 37°C overnight, and the diameters of inhibition 
zones were measured and recorded (A-D). Diluted B. cereus culture was incubated with 
recombinant βGRP3 alone (2 μg/ml) or βGRP3 (2 μg/ml) mixed with different free 
microbial components (20 μg/ml each) in 96-well plates at 37°C, and OD600 was 
recorded every hour up to 22 h. The points represent the mean of four individual 
measurements ± SEM. Asterisks indicate significant difference in OD600 values at 20 h 
among the control, βGRP3, and βGRP3+PG-K12 groups (p<0.001) determined by one 
way ANOVA followed by a Tukey’s multiple comparison test. 
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Discussion 
 
M. sexta βGRP3, a novel β-1, 3-glucan recognition proteins 
Invertebrates lack the adaptive immune system and rely on pattern recognition 
receptors (PRRs) as surveillance molecules to detect microorganisms and mount immune 
responses. These surveillance molecules circulate in the animal body to recognize 
pathogen-associated molecular patterns (PAMPs) (Mogensen, 2009; Pal and Wu, 2009; 
Sukhithasri et al., 2013). β-1, 3-glucan recognition proteins (BGRPs/βGRPs) are a family 
of proteins containing a glycosyl hydrolase like domain, but lack key residues for 
glucanase activity (Fig. 27A). In this study, we have cloned a new member (βGRP3) of 
the M. sexta βGRP family, and investigated functions of βGRP3 in innate immunity.  
M. sexta βGRP1 and βGRP2 transcripts are mainly expressed in fat body. βGRP1 
mRNA is expressed in both feeding and wandering stages of larvae, while βGRP2 
transcript is only expressed in the wandering stage larvae (Jiang et al., 2004; Ma and 
Kanost, 2000). We found that βGRP3 mRNA was predominantly expressed in fat body of 
naïve larvae (Fig. 29A). Expression of βGRP3 transcript in fat body, hemocytes and 
midgut as well as βGRP3 protein in hemolymph was not induced by different immune 
challenges (Figs. 29B-D and 30), which is similar to that of M. sexta βGRP1 but different 
from that of βGRP2 (Jiang et al., 2004; Ma and Kanost, 2000). M. sexta MBP mRNA is 
mainly expressed in fat body and is significantly induced by immune challenge, and MBP 
protein concentration in hemolymph also increases after immune stimulations (Wang et 
al., 2011). These results indicate that the βGRP family proteins are differentially 
regulated by development and immune challenge.  
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M. sexta βGRP3 had a broad binding ability 
Recombinant βGRP3 had a broad binding spectrum to microbial components (Fig. 
31) and microorganisms (Fig. 32). Broad binding spectra of insect PRRs, including 
BGRPs/βGRPs, GNBPs, PGRPs and C-type lectins, have been reported. For example, 
two beetle 1,3-β-D-glucan-binding proteins can recognize β-1, 3-D-glucan and 
peptidoglycan (Lee et al., 2004). M. sexta C-type lectins can bind to several different 
microbial components, including LPS, LTA and PG (Yu et al., 1999; Yu and Kanost, 
2000; Yu et al., 2006; Yu et al., 2005). Drosophila GNBP-1 can bind to LPS and β-1, 3-
glucan (Kim et al., 2000). M. sexta βGRP1 can bind to E. coli, M. luteus and S. cerevisiae 
(Ma and Kanost, 2000), βGRP2 can bind to laminarin and LTA but not LPS (Jiang et al., 
2004), and MBP can bind to LPS, LTA and DAP-type PG (Wang et al., 2011). Thus, the 
BGRP/βGRP family proteins may have broad binding spectra for various pathogens but 
differ in binding affinities. Less M. sexta βGRP3 bound to DAP-type PGs than to LPS, 
LTA and laminarin (Fig. 31), which is consistent with the results of competitive binding 
assay that binding of βGRP3 to laminarin was only slightly competed by PGs but well 
competed by LPS, LTA and laminarin (Fig. 31I).  
 
M. sexta βGRP3 agglutinates E. coli and B. cereus, and inhibits the growth of B. cereus 
The βGRP family proteins are mainly involved in activation of the proPO system 
(Fabrick et al., 2003; Jiang et al., 2004; Ma and Kanost, 2000; Ochiai and Ashida, 2000), 
and some βGRPs can also aggregate microorganisms (Fabrick et al., 2003; Jiang et al., 
2004; Beschin et al., 1998). Like most βGRP proteins, M. sexta βGRP3 could activate 
proPO in plasma (Zhong X and Yu X, unpublished results), more importantly, it possess 
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some unique properties that have not been reported for the BGRP/βGRP family proteins: 
1) calcium-dependent agglutination of E. coli and B. cereus (Fig. 33), which is similar to 
that of C-type lectins (Yu et al., 1999; Yu and Kanost, 2000; Yu et al., 2006; Yu et al., 
2005), and 2) direct antibacterial activity against B. cereus that is resistant to ampicillin 
(Fig. 34C). Compared to M. sexta βGRP1, βGRP2 and MBP, βGRP3 is ~40-45 residues 
shorter at the N-terminus and lacks the small glucan binding domain. BlastP search 
showed that the shorter N-terminal domain (~57 residues) of M. sexta βGRP3 does not 
have a hit in the NCBI database (data not shown), indicating that the N-terminus of 
βGRP3 is not a truncated form of the small glucan binding domain but a new sequence 
that may have unknown functions. We speculate that the shorter N-terminal domain of 
βGRP3 may be involved in protein-protein interactions for formation of dimers or 
oligomers, which are required for agglutination of bacterial cells, since βGRP3 only 
contains a glucanase domain. Such a protein-protein interaction may also be calcium-
dependent. The coelomic cytolytic factor 1 (CCF-1) of earthworm Eisenia fetida, which 
is a member of the βGRP family, also lacks the small N-terminal glucan binding domain, 
but it can still agglutinate Gram-negative bacteria, indicating that the N-terminal glucan 
binding domain is not absolutely required for agglutination (Beschin et al., 1998). 
Antibacterial activity of βGRP3 is probably due to bacteriostatic effect but not 
bactericidal effect as the activity of βGRP3 was completely blocked by laminarin, 
mannan, LPS, LTA and PG-BS, and significantly blocked by PG-K12 (Fig. 34E). Future 
work is to understand how βGRP3 agglutinates bacterial cells and exerts antibacterial 
activity. 
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CHAPTER 6 
MANDUCA SEXTA GLOVERIN BINDS MICROBIAL COMPONENTS AND IS 
ACTIVE AGAINST BACTERIA AND FUNGI 
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Elsevier published works, images or other material should be directed to the Elsevier 
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Abstract 
Gloverin is a glycine-rich and heat stable antimicrobial protein with activity 
mainly against Escherichia coli. However, Spodoptera exigua Gloverin is active against a 
Gram-positive bacterium but inactive against E. coli. In this study, we investigated 
expression profile, binding ability and antimicrobial activity of Manduca sexta Gloverin 
(MsGlv). Msglv transcript was detected in several tissues of naïve larvae with higher 
levels in the midgut and testis. Expression of Msglv mRNA in larvae was up-regulated by 
the active form Spätzle-C108, E. coli and Staphylococcus aureus peptidoglycans (PGs), 
and the activation was blocked by pre-injection of antibody to M. sexta Toll receptor, 
suggesting that Msglv expression is regulated by the Toll-Spätzle pathway. Recombinant 
MsGlv bound to lipopolysaccharide (LPS) to the O-specific antigen and outer core 
carbohydrate moieties, Gram-positive lipoteichoic acid (LTA) and PG, and laminarin, but 
did not bind to E. coli PG or mannan. MsGlv was active against Bacillus cereus, 
Saccharomyces cerevisiae and Cryptococcus neoformans, but had low activity against E. 
coli and S. aureus. Our results suggest that Gloverins may have various activities against 
different microorganisms.  
 
Introduction 
Insects rely on the innate immune system to fight against microbial infections. 
The insect innate immune system shares similarities to the innate immune system of 
vertebrates, and is also composed of humoral and cellular responses (Ferrandon et al., 
2007; Lemaitre and Hoffmann, 2007; Muller et al., 2008). Insect cellular immune 
responses include hemocyte (blood cell) mediated nodule formation, phagocytosis and 
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encapsulation, while synthesis of antimicrobial peptides/proteins (AMPs) and activation 
of proteinase cascades are major components of humoral immune responses (Bulet and 
Stocklin, 2005; Bulet et al., 2004; Chae et al., 2012; Ferrandon et al., 2007; Jiang et al., 
2010; Lemaitre and Hoffmann, 2007). Insects can synthesize a variety of AMPs with 
activities against bacteria, fungi, viruses and some parasites (Bulet and Stocklin, 2005; 
Bulet et al., 2004). Some AMPs, such as Cecropin, Attacin and Defensin, are common 
and present in most insect species, while some other AMPs like Moricin, Gloverin and 
Lebocin have been identified only in lepidopteran insects so far. 
Gloverin was first isolated from the hemolymph of immunized Hyalophora 
gloveri pupae (Axen et al., 1997). H. gloveri Gloverin (HgGlv) is a heat-stable, glycine-
rich and basic antibacterial protein (~14kDa) that is active against Escherichia coli (Axen 
et al., 1997). Homologous Gloverin proteins or cDNAs have also been isolated in other 
lepidopteran species, including Helicoverpa armigera (Mackintosh et al., 1998), 
Trichoplusia ni (Lundstrom et al., 2002; Seitz et al., 2003), Galleria mellonella (Seitz et 
al., 2003), Bombyx mori (Cheng et al., 2006; Kaneko et al., 2007; Kawaoka et al., 2008; 
Mrinal and Nagaraju, 2008), Diatraea saccharialis (Silva et al., 2010), Plutella xylostella 
(Etebari et al., 2011), Spodoptera exigua (Hwang and Kim, 2011), and Manduca sexta 
(Abdel-latief and Hilker, 2008; Zhu et al., 2003). H. armigera Gloverin is active against 
Gram-negative bacteria but inactive against Gram-positive bacteria and the fungus 
Candida albicans (Mackintosh et al., 1998). Recombinant T. ni pro-Gloverin (containing 
the pro-segment) is active against E. coli, and its activity is comparable to that of mature 
HgGlv protein (Lundstrom et al., 2002). B. mori has four gloverin genes, and all four 
recombinant Gloverins are active against E. coli (Kawaoka et al., 2008; Mrinal and 
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Nagaraju, 2008). Gloverins have been reported to be active almost exclusively against 
Gram-negative bacteria, however, recombinant S. exigua Gloverin (SeGlv) is active 
against a Gram-positive bacterium (Flavobacterium sp.) but inactive against E. coli, and 
knockdown expression of Seglv by RNA interference (RNAi) increases susceptibility of S. 
exigua larvae to Gram-positive Bacillus thuringiensis infection (Hwang and Kim, 2011). 
A recent report also shows that T.ni Gloverins have anti-viral activity (Moreno-Habel et 
al., 2012). 
HgGlv has a random-coil conformation in aqueous solution, but can convert to a 
more α-helical structure in a hydrophobic membrane-like environment (Axen et al., 1997). 
HgGlv can inhibit synthesis of E. coli outer membrane proteins to increase the 
permeability of bacterial outer membrane (Axen et al., 1997). Pre-incubation of Rd 
mutant LPS with HgGlv can inhibit its activity against E. coli, suggesting that Gloverin 
may interact with the lipid A moiety of LPS, since lipid A is negatively charged, which 
may interact with basic Gloverin through electrostatic interaction (Axen et al., 1997). But 
the isoelectric point (pI) of Gloverins from different insect species varies from slightly 
acidic to neutral (pI 5.5-7 for four B. mori Gloverins), basic (pI ~8.3) to highly basic 
(pI>9.3). In addition, direct binding of Gloverin to lipid A or LPS has not been 
demonstrated, and it is not known whether Gloverin can also bind to other microbial 
components such as bacterial lipoteichoic acid (LTA) and peptidoglycan (PG), or fungal 
β-1, 3-glucan and mannan. In this study, we investigate expression profile of M. sexta 
gloverin (Msglv), binding of recombinant MsGlv to microbial components and 
antimicrobial activity of MsGlv against Gram negative and Gram-positive bacteria as 
well as fungi. 
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Materials and Methods 
 
Insect rearing and Drosophila S2 cell line 
M. sexta eggs were purchased from Carolina Biological Supplies (Burlington, NC, 
USA). Larvae were reared on an artificial diet at 25°C (Dunn, 1983), and the fifth instar 
larvae were used for the experiments. D. melanogaster Schneider S2 cells were 
purchased from American Type Culture Collection (ATCC). 
 
Microorganisms and microbial components 
Escherichia coli strain XL1-blue was purchased from Strata gene (CA, USA). 
Serratia marcescens and Bacillus thuringiensis were from American Type Culture 
Collection (ATCC). Staphylococcus aureus and Bacillus cereus were kindly provided by 
Professor Brian Geisbrecht, Saccharomyces cerevisiae (strain BY4741) and Cryptococcus 
neoformans (KN99alpha) were provided by Professor Alexander Idnurm, Bacillus subtilis 
was provided by Professor Michael O’Connor, School of Biological Sciences at 
University of Missouri-Kansas City.  
Smooth lipopolysaccharide (LPS) from Salmonella enterica, S. marcescens, E. 
coli 055:B5, E. coli 026:B6 and E. coli 0111:B4, rough mutants of LPS from E. coli 
EH100 (Ra mutant), E. coli J5 (Rc mutant), E. coli F583 (Rd mutant) and S. enterica 
serotype minnesota Re 595 (Re mutant), lipid A monophosphoryl from E. coli F583 (Rd 
mutant) and lipid A diphosphoryl from E. coli F583 (Rd mutant), laminarin, mannan, and 
zymosan were from Sigma-Aldrich (MO, USA), TLR grade LPS and PG from E. coli 
K12 (LPS-K12 and PG-K12), peptidoglycan (PG) and lipoteichoic acid (LTA) from B. 
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subtilis (LTA-BS and PG-BS) and S. aureus (LTA-SA and PG-SA) were from Invivogen 
(CA, USA). 
 
Sequence analysis 
Sequence similarity search was carried out using blast biological software 
(http://www.ncbi.nlm.nih.gov/blastp). Multiple sequence alignments were performed 
using ClustalW (http://www.ch.embnet.org/software/ClustalW.html). A phylogenetic tree 
of the mature gloverin proteins from some insect species was constructed by MEGA 5.05 
software (Tamura et al., 2011). Signal peptide sequences were predicted with SignalP 3.0 
Server (http://www.cbs.dtu.dk/services/SignalP/) (Bendtsen et al., 2004). Figures were 
made with the GraphPad Prism software (GraphPad, San Diego, CA) with one 
representative set of data. Significance of difference was determined by an unpaired t-test 
or by one way ANOVA followed by a Tukey’s multiple comparison test using the same 
software (GraphPad, San Diego, CA). 
 
Tissue distribution and induced expression of M. sexta gloverin 
To determine tissue distribution of M. sexta gloverin (Msglv), day 2 fifth instar M. 
sexta naïve larvae were dissected, hemocytes, fat body, midgut, epidermis and testis were 
collected and washed 3 times in anti-coagulant (AC) saline (4 mM NaCl, 40 mM KCl, 8 
mM EDTA, 9.5 mM citric acid-monohydrate, 27 mM sodium citrate, 5% sucrose, 0.1% 
polyvinylpyrrolidone, 1.7 mM PIPES). Total RNAs from these tissues were extracted 
with TRIzol
®
 Reagent (T9424, Sigma-Aldrich). cDNA was prepared from 1 μg total 
RNA in a 25 μl reaction using moloney murine leukemia virus (M-MLV) reverse 
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transcriptase (M1701, Promega) with an anchor-oligo(dT)18 primer following the 
manufacturer’s instructions. To determine induced expression of Msglv, day 2 fifth instar 
larvae were injected with ddH2O, heat-killed E. coli strain XL1-blue (5×10
7
 cells/larva), 
S. marcescens (5×10
7
 cells/larva), S. aureus (5×10
7
 cells/larva), B. subtilis (5×10
7
 
cells/larva) or C. neoformans (10
7
 cells/larva). Twenty-four hours after injection, 
hemocytes, fat body and midgut were collected separately. Total RNA and cDNA were 
prepared as described above. The real-time PCR was performed in 20 μl reactions 
containing 10 μl 2×SYBR® GreenERTM qPCR SuperMix Universal (No. 204141, Qiagen), 
4 μl dH2O, 4 μl diluted (1:50) cDNA, and 1 μl each reverse and forward diluted primer 
(10 pmol/μl). For Msglv gene, primers MsGlv-F (5’-CCC GCA ATA CGC TCA GAT A-
3’) and MsGlv-R (5’-TGC TGG AAG AGA CCT TGG A-3’) were used, for the control 
ribosomal protein S3 (rpS3) gene, primers RPS3-F (5’-GTT GCG AGG TGG TGG TTT 
C-3’) and RPS3-R (5’- CCG TTC TTG CCC TGT TGG TC-3’) were used. Real-time 
PCR program was 2 min at 50°C, 10 min at 95°C, followed by 40 cycles of 95°C for 15 s, 
60°C for 1 min and the dissociation curve analysis. Data from three replicates of each 
sample was analyzed with SDS software (ABI) using a comparative method (2
-ΔΔCT
) and 
these experiments were repeated with 3 different biological samples.  
 
Activation of M. sexta gloverin by Spätzle and peptidoglycans 
Recombinant full-length M. sextaSpätzle-1A (MsSpz) and the C-terminal active 
domain of Spätzle-1A (MsSpz-C108) were expressed in Drosophila S2 cells and purified 
by affinity chromatography as described previously (Zhong et al., 2012). Day 1 fifth 
instar M. sexta larvae were injected with MsSpz (3 μg/larva), MsSpz-C108 (1 μg/larva), S. 
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aureus PG-SA or E. coli PG-K12 (1 μg/larva) (Zhong et al., 2012). Twenty hours later, 
fat body, hemocytes and midgut samples were collected for preparation of total RNA and 
cDNA, and expression of Msglv in these tissues was determined by quantitative RT-PCR 
as described above.  
For antibody blocking assay, day 1 fifth instar M. sexta naïve larvae were pre-
injected with purified IgG to the ecto-domain of M. sexta Toll (Toll Ab, 5 μg/larva) or 
IgG from pre-bleed rabbit serum (Control Ab, 5 μg/larva). One hour later, these larvae 
were injected with water, MsSpz (3 μg/larva), MsSpz-C108 (1 μg/larva), S. aureus PG-SA 
(1 μg/larva), E. coli PG-K12 (1 μg/larva), or without second injection (control) as 
described previously (Zhong et al., 2012). Twenty hours later, fat body, hemocyte and 
midgut samples were collected for quantitative RT-PCR analysis. M. sexta ribosomal 
protein S3 (rpS3) gene was used as an internal standard to normalize the amount of RNA 
template. The expression levels of Msglv were calculated by the 2
−∆∆CT 
methods as 
described above. 
 
Expression and purification of M. sexta Gloverin in bacteria and preparation of 
polyclonal rabbit antiserum 
RT-PCR was performed to obtain a cDNA encoding M. sexta pro-Gloverin (pro-
MsGlv, residues 23-177) using primers pro-MsGlv-F (5’-GGA CCA TGG CCC CGC 
AAT ACG CTC AGA T-3’) and pro-MsGlv-R (5’-CCA CTC GAG CCA TCT ATG CTG 
GAA GAG ACC-3’). The PCR fragment was purified by agarose gel electrophoresis, 
digested with NcoI and XhoI enzymes, ligated into the NcoI /XhoI-digested expression 
vector pET-32a (+) (Novagen), and then transformed into competent E. coli BL21 (DE3) 
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cells. A single positive bacterial colony, which was confirmed by restriction enzyme 
digestion and sequencing, was inoculated into LB medium containing Ampicillin (100 
μg/mL) and grown overnight. The overnight culture was diluted 1:100 in LB medium and 
grown at 37°C to OD600=0.8 and then isopropyl-D- thiogalactopyranoside (IPTG) (0.5 
mM) was added to induce protein expression. After 6 h incubation at 28°C, bacterial cells 
were harvested by centrifugation and lyzed with the lysis solution (50 mM Tris-HCl, pH 
8.0, 50 mM NaCl, 0.5% Triton X-100, 2 mg/mL lysozyme). Protein purification was 
performed with a His-Bind® Buffer Kit (Novagen). The purified protein was further 
separated on 15% SDS-PAGE and the gel slice containing recombinant pro-MsGlv was 
used as an antigen to produce rabbit polyclonal antiserum at Cocalico Biologicals, Inc 
(Pennsylvania, USA). 
 
Establishment of stable S2 cell lines expressing M. sexta mature Gloverin (MsGlv) and 
green fluorescent protein (GFP) 
The cDNA encoding mature MsGlv (residues 46-177) was amplified by PCR 
using primers MsGlvM-F (5’-GCG AGA TCT GAC GTG ACC TGG GAC AAG CAA 
G-3’) and MsGlvMF-R (5’-GGA CTC GAG CCA TCT ATG CTG GAA GAG ACC T-
3’). The forward primer contained a BglII site at the 5’ end and the reverse primer 
contained an XhoI site at the 3’ end. PCR product was recovered by agarose gel 
electrophoresis-Wizard® SV Gel and PCR Clean-Up System (A9285, Promega), 
subcloned into T-Easy vector (A1360, Promega), and recombinant plasmid was isolated. 
After digested with BglII/XhoI, cDNA fragment was recovered and inserted into the same 
restriction sites of the expression vector pMT/BiP/V5-His (V413020, Invitrogen) using 
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T4 DNA ligase (M0202L, NEB). Green Fluorescent Protein (GFP) in the expression 
vector pMT/Bip/V5-His/GFP (V413020, Invitrogen) was used as a control. Recombinant 
expression vectors were purified using PureYield™ Plasmid MiniprepSystem (A1222, 
Promega) according to the manufacturer’s instruction and used to generate stable S2 cell 
lines after the insert sequences were confirmed by DNA sequencing. Drosophila 
Schneider S2 cells were maintained at 27°C in Insect Cell Culture Media (SH30610.02, 
Hyclone) supplemented with 10% heat-inactivated fetal bovine serum (#10082063, 
Invitrogen) and 1% penicillin-streptomycin solution (G6784, Sigma-Aldrich). For 
transfection assay, S2 cells (in 6-well plates) were seeded overnight in serum-free 
medium (SH30278.01, Hyclone) and GenCarrier-1
TM
 transfection reagent (#31-00110, 
Epoch Biolabs) was used for transient transfection based on the manufacturer’s 
instructions. Culture dishes or plates were prepared to 70% confluence prior to 
transfection. DES
®–Inducible⁄Secreted Kit with pCoBlast (K5130-01, Invitrogen) was 
used to construct stable S2 cell lines as described previously (Zhong et al., 2012). For 
Western blot analysis, copper sulfate (250 μM) was added to stable S2 cells in a 6-well 
plate to induce protein expression for 48 h as described previously (Zhong et al., 2012). 
 
Purification of recombinant MsGlv and GFP from S2 cells 
To purify recombinant MsGlv and GFP, copper sulfate (final concentration of 250 
μM) was added to stable S2 cells expressing MsGlv or GFP in 75-cm2 flasks to induce 
protein expression. Cell culture medium was collected starting at 24 h after protein 
expression for 10 days by collecting culture medium every day and re-suspending the 
cells with fresh medium. Cell culture medium was combined, cell debris was removed by 
centrifugation, and cell-free medium was incubated overnight at 4°C with 500 μl of Anti-
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V5-agarose Affinity Gel (A7345, Sigma-Aldrich) equilibrated with initial buffer (50 mM 
Tris-HCl, 150 mM NaCl, pH 7.4). Purification of MsGlv and GFP by Anti-V5-agarose 
Affinity Gel was performed essentially the same as described previously for purification 
of M. sexta Spätzle proteins (Zhong et al., 2012). Recombinant MsGlv and GFP were 
sequentially eluted from the column with 1 ml aliquots of the elution buffer (0.1 M 
glycine-HCl, pH 3.5, 1% Triton X-100) into vials containing 100 μl of 1M Tris-base, pH 
8.0. Fractions were analyzed by 15% SDS-PAGE, and those containing recombinant 
MsGlv or GFP were combined and desalted using D-saltTM Excellulose
TM 
GF-5 
desalting column (#1851850, Pierce) pre-equilibrated with dH2O. Recombinant MsGlv or 
GFP was eluted with water, and fractions containing MsGlv or GFP were pooled and 
concentrated for the following binding and activity assays. 
 
Binding of MsGlv to microbial components 
To test binding of MsGlv to microbial cell wall components, plate ELISA assays 
were performed using different microbial components (LPS, LTA, PG, lipid A, laminarin, 
zymosan and mannan). Briefly, wells of a flat bottom 96-well plate (Costar, Fisher) were 
coated with different microbial components (2 μg/well) as described previously (Yu and 
Kanost, 2000; Yu et al., 2005). The plates were placed overnight at room temperature 
until the water evaporated completely, heated to 60°C for 30 min, and then blocked with 
200 μl/well of 1 mg/ml BSA in Tris buffer (TB) (50 mM Tris-HCl, 50 mM NaCl, pH 8.0) 
for 2 h at 37°C. Then, plates were rinsed four times with 200 μl/well of TB, and 
increasing concentrations or 120 nM of purified MsGlv or GFP (a control protein) diluted 
in TB containing 0.1 mg/ml BSA were added to the coated plates (50 μl/well), and 
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binding was allowed to occur for 3 h at room temperature. The plates were rinsed four 
times with 200 μl/well of TB, and monoclonal anti-polyhistidine antibody (Sigma-
Aldrich, USA) (1:2,000 in TB containing 0.1 mg/ml BSA) was added (100 μl/well) and 
incubated overnight at 4°C. The plates were rinsed four times with TB (200 μl/well), and 
alkaline phosphatase-conjugated goat anti-mouse-IgG (Sigma-Aldrich, USA) (1:3,000 in 
TB containing 0.1 mg/ml BSA) was added (100 μl/well) and incubated for 2 h at 37°C. 
The plates were rinsed, p-nitro-phenyl phosphate (1 mg/ml in 10 mM diethanolamine, 0.5 
mM MgCl2) was added (50 μl/well), and absorbance at 405 nm of each well was 
determined every minute for 30min using a microtiter plate reader (Bio-Tek Instrument, 
Inc.).  
 
Antimicrobial activity assays 
Antimicrobial activity of purified MsGlv was tested against six bacterial strains (B. 
cereus, E. coli DH5α, S. marcescens, B. subtilis, B. thuringiensis and S. aureus) and two 
fungal strains S. cerevisiae and C. neoformans. A broth micro dilution assay was used to 
generate growth curves as described previously (Rao et al., 2012). Briefly, overnight 
bacterial cultures were sub-cultured in LB medium and fungal cultures were sub-cultured 
in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) until mid-log phase. The 
bacterial and fungal cultures were centrifuged at 1,000 g for 10 min at 4°C and washed 
once with 10 m M Tris-HCl, pH7.5, 0.1 mM EDTA. The bacterial and fungal cells were 
diluted to OD600=10
-5
 in LB and YPD media, respectively, and the diluted cell cultures 
(75 μl) were mixed with purified MsGlv (25 μl of ~85 μg/ml) (final concentration of 21 
μg/ml or 1.5 μM) or water (Control) in 96-well plates. Bacteria were cultured at 37°C 
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with 220 rpm shaking, while fungi were cultured at 30°C with 220 rpm shaking. OD600 
was measured every hour by Powerwave XS plate reader (BioTek, VT, USA). Bacterial 
growth curves were generated using the Graphpad Prism version 4.0 for Windows 
(GraphPad Software, CA, USA). 
 
Results 
 
Sequence analysis of M. sexta Gloverin 
M. sexta Gloverin (MsGlv) (Genbank accession number: CAL25129) is 177-
residues long, with a predicted 19-residue signal peptide, 26-residue pro-segment, and 
132-residue mature protein (Fig. 35).  Mature MsGlv contains 28 glycines (21.2%) with a 
theoretical mass of 13986 Da and pI of 9.35. MsGlv is most similar to Gloverins from 
Antheraea mylitta (74.2% identity in the mature proteins), Antheraea pernyi (73.5%), B. 
mori (gloverin-4, 71.2%), H. gloveri (69.7%), and also has 48-69% identities to other 
mature Gloverins (Fig. 35).  
Among the four B. mori gloverin genes, Bmglv1 is the ancestral gene, whereas 
Bmglv2-4 are derived from duplication (Mrinal and Nagaraju, 2008). Phylogenetic 
analysis of mature Gloverin protein sequences showed that A. mylitta, A. pernyi and H. 
gloveri Gloverins clustered in one group, BmGlv2-4 clustered in one group, and H. 
virescens, S. exigua and T. ni (Glv-1) Gloverins clustered in one group (Fig. 36A). These 
Gloverins along with PxGlv and TnGlv2 may come from the same ancestral gene. 
However, MsGlv and BmGlv1 did not cluster with any of the three groups, thus Msglv 
may be an ancestral gene in M. sexta. 
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Expression and purification of recombinant MsGlv 
Pro-MsGlv (residues 23–177) was expressed in bacteria, purified by nickel 
affinity column (Fig. 36B, lane 1), and used as an antigen to generate polyclonal antibody 
in a rabbit. Mature MsGlv (residues 46–177) was expressed in Drosophila S2 cells and 
purified by affinity chromatography (Fig. 36B, lane 2) for binding and activity assays 
(see below). Polyclonal anti-pro-MsGlv antibody could recognize recombinant MsGlv 
(Fig. 36C, lane 1) and natural MsGlv in the cell-free hemolymph of larvae immunized 
with E. coli (Fig. 36C, lane 3). Western blot analysis showed that MsGlv protein was not 
detected in the cell-free hemolymph of naïve larvae (Fig. 36D, lane 1), but was present at 
relatively high levels in the hemolymph of larvae immunized with S. aureus, E. coli and S. 
cerevisiae (Fig. 36D, lanes 2–4). 
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Figure 35. Multiple sequence alignment of Gloverin proteins from some lepidopteran 
species. 
Gloverin protein sequences from M. sexta (CAL25129), Antheraea mylitta (ABG72699), 
Antheraea pernyi (ACB45565), B. mori (NP_001036930, NP_001037683, 
NP_001093312 and NP_001037684), Heliothis virescens (ACR78446), Plutella 
xylostella (ACM69342), Spodoptera exigua (ADL27731), Trichoplusia ni (ABV68856 
and AAG44367), and Hyalophora gloveri (Axen et al., 1997) were aligned by ClustalW 
and residues conserved in all 13 proteins are indicated by asterisks. Predicted signal 
peptide sequences are underlined, and identity between M. sexta Gloverin and a Gloverin 
from other species is indicated in the parenthesis. The box indicates a conserved endo 
peptidase cleavage site and the arrow indicates the beginning of mature Gloverins. 
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Figure 36. Phylogenetic analysis of mature Gloverin sequences and expression of M. 
sexta Gloverin. 
Thirteen mature gloverin protein sequences from some lepidopteran species from Fig. 35 
were used to construct the NJ tree by the MEGA5.05 software. Numbers above the nodes 
indicate percent support from bootstrap analysis. (A). Recombinant M. sexta pro-
Gloverin (pro-MsGlv) and mature Gloverin (MsGlv) were purified from bacteria and 
Drosophila S2 cells, respectively, and analyzed by SDS–PAGE (B). Lane 1: proMsGlv (2 
μg) and lane 2: MsGlv (0.5 μg). Western blot analysis of recombinant and hemolymph 
MsGlv (C). Purified recombinant MsGlv (lane 1, 0.2 μg), cell-free hemolymph (1 μl each) 
from naïve larvae (lane 2) and larvae immunized with E. coli (lane 3) were analyzed by 
Western blot using polyclonal rabbit antiserum against pro-MsGlv. Induced expression of 
MsGlv in hemolymph by Western blot (D). Cell-free hemolymph (1 μl each) from naïve 
larvae (lane 1) and larvae immunized with S. aureus (lane 2), E. coli (lane 3) and S. 
cerevisiae (lane 4) were analyzed by Western blot using polyclonal rabbit antiserum 
against pro-MsGlv. 
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Tissue distribution and induced expression of M. sexta gloverin 
Real-time PCR analysis showed that Msglv mRNA was detected in the epidermis, 
hemocytes, fat body, midgut and testis of M. sexta naïve larvae, with significantly higher 
expression levels in the midgut and testis (Fig. 37A). Expression of Msglv transcript was 
induced to a significantly higher level in the fat body by Gram-positive S. aureus than the 
other microorganisms tested (Gram-negative E. coli and S. marcescens, Gram-positive B. 
subtilis, and the fungus C. neoformans) (Fig. 37B, upper panel), and was induced to 
significantly higher levels in the hemocytes and midgut by Gram-negative E. coli than 
other microorganisms (Fig. 37C and D, upper panels), but Msglv mRNA was not induced 
by water injection (Fig. 37B–D, upper panels). Activation of Msglv gene by different 
microorganisms showed tissue-specific pattern, which is consistent with tissue-specific 
activation of some Drosophila AMP genes (Imler and Bulet, 2005). 
MsGlv protein was almost not detected in fat body, hemocytes and midgut of 
naïve larvae (Fig. 37B–D, low panels, lanes 1) and was present at very low levels in these 
tissues when larvae were injected with water (Fig. 37B–D, low panels, lanes 2). MsGlv 
protein in fat body, hemocytes and midgut was induced by Gram-negative and Gram-
positive bacteria as well as C. neoformans (Fig. 37B–D, low panels, lanes 3–7), a result 
consistent with the induction of Msglv mRNA by microorganisms in these tissues (Fig. 
37B–D, upper panels). MsGlv protein in hemolymph was also induced after larvae were 
injected with S. aureus, E. coli and S. cerevisiae (Fig. 36D). Together, these results 
suggest that M. sexta gloverin gene expression can be induced by different 
microorganisms at both the transcriptional and protein levels. 
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In B. mori, Bmglv1 gene is expressed in larval but not adult gonads, while Bmglv 
2–4 genes are expressed in adult but not larval gonads (Mrinal and Nagaraju, 2008), 
suggesting that Bmglv genes may be developmentally regulated. Knockdown expression 
of Bmglv2 gene by RNAi in B. mori embryos reduces hatching (Mrinal and Nagaraju, 
2008), and RNAi of Seglv gene in S. exigua larvae reduces pupation and prolongs larval 
period (Hwang and Kim, 2011). In the M. sexta eggs parasitized by Trichogramma 
evanescens, Msglv gene expression is suppressed at 2 days after parasitization, while 
expression of like-moricin (l-mor), leureptin and attacin-2 genes do not change 
significantly (Abdel-latief and Hilker, 2008). We showed that Msglv gene was expressed 
at a higher level in the testis of M. sexta naïve larvae (Fig. 37A). Altogether, these results 
suggest that Gloverin may play a role in development in addition to being an AMP. 
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Figure 37. Tissue distribution and expression of Msglv in M. sexta larvae after microbial 
infection. 
Day 2 fifth instar M. sexta naïve larvae were dissected, epidermis, hemocytes, fat body, 
midgut and testis were collected for preparation of total RNAs. Expression of Msglv 
mRNA in these tissues was determined by quantitative real-time PCR (A). Total RNAs 
were also prepared from fat body, hemocytes and midgut of fifth instar larvae immunized 
with different microorganisms at 24 h post-injection, and expression of Msglv mRNA 
was also determined by quantitative real-time PCR (B–D, upper panels). M. sexta 
ribosomal protein S3 (rpS3) gene was used as an internal control. The bars represent the 
mean of three individual measurements ± SEM. Relative expression of Msglv mRNA in 
epidermis (A), fat body (B), hemocytes (C) or midgut (D) of naïve larvae was set as 1. 
Comparing expression of Msglv mRNA in different tissues (A) or after microbial 
injections, identical letters among tissues or treatments indicate not significant difference 
(p > 0.05), while different letters indicate significant difference (p < 0.05) determined by 
one way ANOVA followed by a Tukey’s multiple comparison test. Protein extracts from 
fat body, hemocytes and midgut (B-D, lower panels) of naïve larvae (lane 1) and larvae 
injected with water (lane 2), E. coli (lane 3), S. marcescens (lane 4), S. aureus (lane5), B. 
subtilis (lane 6) and C. neoformans (lane 7) (60 μg total protein per lane), and cell-free 
hemolymph from larvae immunized with S. aureus (lane 8, 1 μg per lane) were also 
analyzed by SDS–PAGE, and MsGlv was detected by Western blot using polyclonal 
rabbit antiserum against pro-MsGlv. 
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Expression of M. sexta gloverin is regulated by the Toll pathway 
In Drosophila, expression of AMP genes is regulated by the Toll and Imd 
pathways. Drosophila Toll pathway is activated by Gram-positive Lys-type 
peptidoglycan (PG), while the Imd pathway is activated by Gram-negative meso-
diaminopimelic acid (DAP)-type PG (Ganesan et al., 2011; Lemaitre and Hoffmann, 
2007; Lemaitre et al., 1995; Lemaitre et al., 1996; Valanne et al., 2011). In M. sexta, both 
Lys-type and DAP-type PGs can activate expression of M. sexta AMP genes (Rao and 
Yu, 2010). To determine whether expression of Msglv is regulated by the Toll and/or Imd 
pathways in M. sexta, naïve larvae were injected with purified recombinant active 
MsSpz-C108 (a Toll pathway ligand) (Zhong et al., 2012), S. aureus and E. coli 
peptidoglycans (PGs), and expression of Msglv mRNA was determined. Real-time PCR 
results showed that expression of Msglv mRNA was up-regulated to significantly higher 
levels in the fat body (Fig. 38A) and hemocytes (Fig. 38B) by MsSpz-C108, S. aureus 
PG-SA (Lys-type) and E. coli PG-K12 (DAP-type) compared to the water-injection 
control. Msglv mRNA was also induced by MsSpz-C108 and PG-K12 in the midgut, but 
was not induced by PG-SA (Fig. 38C). MsSpz also activated Msglv in the fat body to a 
significantly higher level compared to water-injection (Fig. 38A), probably due to 
activation of MsSpz by hemolymph proteinases. In the fat body and hemocytes, MsSpz-
C108 activated Msglv expression to a significantly higher level than PG-SA and PG-K12 
did, and PG-SA and PG-K12 activated Msglv expression to a similarly high level (Fig. 
38A and B). However, in the midgut PG-K12 activated Msglv expression to a 
significantly higher level than MsSpz-C108 and PG-SA did (Fig. 38C). These results 
suggest that expression of Msglv in the fat body and hemocytes is mainly regulated by the 
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Toll pathway, and that PG-K12 (DAP-type) activated Msglv expression is regulated by 
the Toll-Spätzle pathways. 
To confirm that expression of Msglv is regulated by the Toll pathway and to 
determine whether PG-K12 activates the Toll or Imd pathway, an antibody blocking 
assay was performed. M. sexta naïve larvae were pre-injected with purified IgG from 
rabbit antiserum against the ecto-domain of M. sexta Toll (MsToll) or pre-bleed rabbit 
serum (Zhong et al., 2012), and then injected with MsSpz, MsSpz-C108, PG-SA or PG-
K12. Expression of Msglv in fat body, hemocytes and midgut was determined by real-
time PCR (Fig. 39). Our results showed that in the control IgG pre-injected larvae, 
expression of Msglv in the fat body, hemocyte and midgut was up-regulated by MsSpz-
C108 (Fig. 39), and PG-SA activated Msglv in the fat body and hemocytes (Fig. 39A and 
B), while PG-K12 activated Msglv in the midgut (Fig. 39C). However, in the MsToll IgG 
pre-injected larvae, MsSpz-C108-activated expression of Msglv in the fat body, 
hemocytes and midgut, PG-SA-activated Msglv expression in the fat body and hemocytes, 
and PG-K12 activated expression of Msglv in the fat body and midgut were all 
significantly suppressed (Fig. 39). In contrast, PG-K12-activated Msglv expression in the 
hemocytes was stimulated after pre-injection of MsToll antibody (Fig. 39B). These 
results suggest that pre-injection of larvae with IgG to MsToll blocks the Toll receptor 
from binding to MsSpz-C108, resulting in blocking the Toll pathway to activate Msglv 
gene expression.   
We have previously shown that a Toll–Spätzle pathway regulates expression of 
cecropin, attacin, moricin and lebocin genes in M. sexta (Zhong et al., 2012). Thus, our 
results suggest that systematic expression of AMP genes in fat body, hemocytes and 
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midgut of M. sexta larvae are mainly regulated by the Toll pathway. Interestingly, the 
Toll receptor is involved in regulation of Msglv gene in midgut (Figs. 38 and 39C), 
moricin gene in hemocytes and lebocinb/c genes in fat body (Zhong et al., 2012) of M. 
sexta larvae activated by PG-K12 (DAP-type PG), a result differing from D. 
melanogaster in that DAP-type PG activates the Imd pathway (Leulier et al., 2003). In 
addition, MsSpz-C108 was more potent than PG-SA and PG-K12 in activation of Msglv 
gene in fat body and hemocytes, but PG-K12 was more potent than MsSpz-C108 and PG-
SA in activation of Msglv gene in midgut (Fig. 38), suggesting that even though all three 
ligands can activate the Toll pathway, the recognition process at the cell surface may 
differ, and tissue-specific co-activators/receptors may also be involved. Activation of 
Msglv gene in hemocytes by PG-K12 was not blocked but stimulated after pre-injection 
of MsToll antibody (Fig. 39B), which is similar to activation of lebocin-b/c in hemocytes 
by PG-K12 (Zhong et al., 2012). These results suggest that PG-K12-activated expression 
of Msglv and lebocin-b/c genes in hemocytes may not be Toll-dependent and may be 
regulated by other pathways such as the Imd pathway. Thus, our results also suggest 
tissue-specific regulation of insect AMP genes. 
The promoter regions of insect AMP genes contain NF-κB binding sites for 
Rel/NF-κB factors such as Dorsal, Dif and Relish. In Drosophila, Dorsal and Dif regulate 
the Toll pathway, while Relish regulates the Imd pathway. Therefore, whether an AMP 
gene is regulated by the Toll, Imd or both pathways depends upon the NF-κB binding 
sites in the promoter regions. For example, D. melanogaster drosomycin gene is 
synergistically regulated by the Toll and Imd pathways, since drosomycin gene promoter 
contains NF-κB binding sites for both Dif/Dorsal and Relish (Ganesan et al., 2011; Tanji 
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et al., 2007; Tanji et al., 2010). On the other hand, diptericin gene promoter contains NF-
κB binding sites only for Relish and it is predominantly regulated by the Imd pathway 
(Ganesan et al., 2011). Some species/tissue-specific activators or suppressors may also 
contribute to regulation of AMP genes. M. sexta moricin gene promoter has high activity 
in Sf9 cells but has low or no activity in S2 cells, because the promoter region may 
contain a binding site for species-specific activator(s) (Rao et al., 2011). 
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Figure 38. Msglv expression in M. sexta larvae is activated by MsSpz-C108 and bacterial 
peptidoglycans. 
Day 1 fifth instar M. sexta naïve larvae were injected with purified recombinant MsSpz (3 
μg/larva), MsSpz-C108 (1 μg/larva), S. aureus PG (PG-SA) (1 μg/larva), E. coli PG (PG-
K12) (1 μg/larva), or water (control), or left untreated (naïve), fat body, hemocytes and 
midgut were then collected at 20 h post-injection for preparation of total RNAs. 
Expression of Msglv mRNA was determined by real-time PCR. Ribosomal protein S3 
(rpS3) gene was used as an internal control. The bars represent the mean of three 
individual measurements ± SEM. Relative expression of Msglv in naïve larvae was set as 
1. Identical letters are not significant difference (p>0.05), while different letters indicate 
significant difference (p<0.05) among different treatments determined by one way 
ANOVA followed by a Tukey’s multiple comparison test. 
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Figure 39. Activation of Msglv triggered by MsSpz-C108 and bacterial peptidoglycans is 
blocked by antibody to M. sexta Toll. 
Day 1 fifth instar M. sexta naïve larvae were pre-injected with purified IgG to the ecto-
domain of M. sexta Toll (Toll Ab, 5 μg/larva) or IgG from pre-bleed rabbit serum 
(Control Ab, 5 μg/larva). One hour later, these larvae were injected with purified 
recombinant MsSpz (3 μg/larva), MsSpz-C108 (1 μg/larva), S. aureus PG (PG-SA) (1 
μg/larva), E. coli PG (PG-K12) (1 μg/larva), or water (control), or without second 
injection (control), fat body, hemocytes and midgut were then collected at 20h after 
second injection for preparation of total RNAs. Expression of Msglv mRNA was 
determined by real-time PCR. Ribosomal protein S3 (rpS3) gene was used as an internal 
control. The bars represent the mean of three individual measurements ± SEM. Relative 
expression of Msglv mRNA after pre-injection of antibody but without second injection 
(control) was set as 1. Asterisks indicate significant difference (p<0.05) between Toll and 
Control antibody pre-injections for Msglv determined by an unpaired t-test. 
 
 
 
 
 
 
 
185 
 
MsGlv binds to microbial components and to the O-specific antigen and outer core 
moieties of LPS 
It was suggested that Gloverin can interact with LPS to inhibit synthesis of E. coli 
outer membrane proteins (Axen et al., 1997). To demonstrate direct binding of MsGlv to 
LPS and other microbial cell wall components, a plate ELISA assay was performed using 
recombinant MsGlv purified from Drosophila S2 cells. The results showed that MsGlv 
bound to E. coli LPS, Gram-positive (S. aureus and B. subtilis) lipoteichoic acid (LTA-
SA and LTA-BS) and peptidoglycan (PG-SA and PG-BS), and fungal laminarin (β-1, 3-
glucan), but did not bind to E. coli PG (PG-K12) or fungal mannan (Fig. 40). More 
MsGlv protein bound to LPS (Fig. 40A) compared to other microbial components, and 
more MsGlv protein bound to S. aureus LTA-SA and PG-SA (Fig. 40C and D) than to B. 
subtilis LTA-BS and PG-BS (Fig. 40E and F). Our results confirm direct binding of 
Gloverin to LPS and showed broad binding of MsGlv to other microbial components.   
LPS is composed of three moieties: the O-specific antigen, the core (outer and 
inner core) carbohydrate, and the lipid A (Raetz, 1990; Yu and Kanost, 2002). It was 
suggested that HgGlv may bind to the lipid A moiety because pre-incubation of HgGlv 
with Rd-LPS inhibits its activity against E. coli (Axen et al., 1997). To test binding of 
MsGlv to different moieties of LPS, several smooth LPS containing different O-specific 
antigens, different rough mutants of LPS, and lipid A were used in the binding assay. 
Plate ELISA results showed that various amounts of MsGlv bound to all five smooth LPS 
and Ra-LPS, but almost no binding of MsGlv to Rc-, Rd-, Re-LPS or lipid A was 
observed (Fig. 41). These results suggest that MsGlv can bind to the O-specific antigen 
and the outer core moieties of LPS. 
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HgGlv can interact with Rd-LPS and Re-LPS, but may not bind to Ra-LPS, since 
E. coli K12 D21 (with Ra-LPS) is less sensitive to HgGlv than E. coli K12 D21f2 (with 
Re-LPS) (Axen et al., 1997). Thus, MsGlv bound to both the O-specific antigen and the 
outer core carbohydrate of LPS (Fig. 41), while HgGlv may bind to the lipid A moiety of 
LPS. MsGlv has a pI of 9.35, while HgGlv has a pI of 8.23. The difference in the pI 
values of MsGlv and HgGlv may not completely account for the difference in binding to 
LPS. HgGlv has a random conformation in solution, but has a more defined structure in a 
membrane-like environment (Axen et al., 1997). Therefore, it is possible that differences 
in the defined structures of Gloverins after contacting microbial components or 
microorganisms account for the differences in binding to microbial components or 
activities against different microorganisms. A 3-dimentional structure of Gloverin may 
provide insight into the relationship between microbial binding and antimicrobial activity 
of Gloverin. So far, no structure of glycine-rich antimicrobial proteins is available. 
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Figure 40. Recombinant MsGlv binds to LPS, Gram-positive peptidoglycan (PG) and 
lipoteichoic acid (LTA), and laminarin. 
Wells of 96-well fat-bottom microtiter plates were coated with TLR grade E. coli LPS-
K12 (A) and PG-K12 (B), B. subtilis LTA-BS (E) and PG-BS (F), S. aureus LTA-SA (C) 
and PG-SA (D), laminarin (G) and mannan (H). Recombinant MsGlv and GFP purified 
from Drosophila S2 cells were diluted to different concentrations and added to the 
ligand-coated plates, and the binding assay was performed as described in the Materials 
and Methods. Each point represents the mean of four individual measurements ± SEM, 
and the lines represent nonlinear regression calculation of one-site binding curve.  
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Figure 41. Recombinant MsGlv binds to the O-specific antigen and out core carbohydrate 
moieties of LPS. 
Wells of 96-well fat-bottom microtiter plates were coated with smooth LPS from several 
bacteria, Ra-, Rc-, Rd- and Re-LPS, monophosphoryl and diphosphoryl lipid A. 
Recombinant MsGlv and GFP purified from Drosophila S2 cells were diluted to 120 nM 
and added to the ligand-coated plates, and the binding assay was performed as described 
in the Materials and Methods. The figure showed specific binding of recombinant MsGlv 
to LPS and lipid A after subtracting the total binding of the control GFP from the total 
binding of MsGlv. Each bar represent the mean of three individual measurements ± SEM. 
Identical letters are not significant difference (p>0.05), while different letters indicate 
significant difference (p<0.05) among different ligands determined by one way ANOVA 
followed by a Tukey’s multiple comparison test. 
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MsGlv is active against bacteria and fungi 
Gloverins are active almost exclusively against E. coli (Axen et al., 1997; 
Kawaoka et al., 2008; Lundstrom et al., 2002; Mackintosh et al., 1998). However, SeGlv 
is active against a Gram-positive bacterium (Flavobacterium sp.) but is inactive against E. 
coli (Hwang and Kim, 2011). Our binding assays showed that MsGlv could bind to 
Gram-negative LPS, Gram-positive LTA and PG, and fungal laminarin (Figs. 40 and 41), 
suggesting that Gloverin may be active against different microorganisms. To determine 
the activity of recombinant MsGlv against microorganisms, microbial growth curves 
were performed. Our results showed that MsGlv at low concentration (~1.5 μM or ~20 
μg/mL) could inhibit the growth of Gram-positive B. cereus (Fig. 42C), and fungi S. 
cerevisiae (Fig. 42G) and C. neoformans (Fig. 42H) even after long incubation time (over 
20h for bacteria and 30h for fungi). MsGlv also had activity against Gram-negative E. 
coli (Fig. 42A) and S. marcescens (Fig. 42B), and Gram-positive B. subtilis (Fig. 42D), B. 
thuringiensis (Fig. 42E) and S. aureus (Fig. 42E) when the incubation time was short 
(less than 10h, indicated by asterisks), but could not completely inhibit the growth of 
these microorganisms when incubation time was longer (over 15 h). In addition, when the 
initial CFU of S. cerevisiae or C. neoformans was increased, MsGlv could not completely 
inhibit their growth and the growth curves had a pattern similar to that of E. coli or S. 
aureus (data not shown). These results suggest that MsGlv is active against Gram-
negative and Gram-positive bacteria as well as fungi to some extent depending on the 
microorganism.     
MsGlv could bind to Gram-positive LTA and PG, as well as fungal laminarin (Fig. 
41), which may account for its activity against B. cereus, S. cerevisiae and C. neoformans. 
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MsGlv also bound to LPS (Figs. 40A and 41), but it was almost inactive against E. coli 
(Fig. 42A), while most Gloverins from other insect species are active against E. coli but 
inactive against Gram-positive bacteria (Axen et al., 1997; Kawaoka et al., 2008; 
Lundstrom et al., 2002; Mackintosh et al., 1998). We think that in vitro assay to test 
whether a Gloverin is active against Gram-negative, Gram-positive bacteria, and/or fungi 
may depend upon microbial strains, initial number (CFU) of microorganisms, incubation 
time, and the concentration of Gloverin. For example, B. mori Gloverins (BmGlvs) are 
active against E. coli in phosphate buffer within 6 h of incubation, but the activity is weak 
(Kawaoka et al., 2008). We observed that when the initial CFU of S. cerevisiae and C. 
neoformans was increased, MsGlv (at ~1.5 μM) was almost inactive against the two fungi 
with a growth curve similar to that of E. coli or S. aureus (data not shown). Thus, 
Gloverin may play a role in defense against initial infection in insects when the number 
of microbes is low. 
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Figure 42. Antimicrobial activities of recombinant MsGlv. 
Mid-log phase bacteria (Gram-negative E. coli and S. marcescens, Gram-positive B. 
cereus, B. subtilis, B. thuringiensis and S. aureus) and fungi (S. cerevisiae and C. 
neoformans) were diluted to OD600=10
-5
 and incubated with recombinant MsGlv purified 
from S2 cells (final concentration of ~21 μg/ml or 1.5 μM) or water (Control) in 96-well 
plates with 220 rpm shaking at 37°C (for bacteria) or 30°C (for fungi). OD600 was 
recorded every hour up to 20 h (for bacteria) or 30 h (for fungi) after incubation. The 
points represent the mean of four individual measurements ± SEM. The asterisks in the 
boxes indicate significant difference (p<0.05) between MsGlv and the control at the 
indicated time points determined by an unpaired t-test. 
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CHAPTER 7 
RESEARCH SUMMARY AND FUTURE DIRECTION 
 
The innate immune system is conserved from insects to humans. In insects, the 
Toll and IMD signaling pathways, PGRPs, and Dorsal, Dif and Relish NF-κB factors in 
regulation of immune genes have been well studied in the model organism D. 
melanogaster. However, signaling pathways and NF-κB factors in regulation of gene 
expression in other insect species have not been well characterized. Even in Drosophila, 
it is also debatable whether LPS can activate AMP gene expression. In some insect 
species including M. sexta, it has been reported that LPS can activate innate immune 
responses (Kawabata S, 2009; Rao and Yu, 2010; Zeidler et al., 2004); however, whether 
there is an LPS-triggered signaling pathway in insects or in invertebrates remains elusive.  
I have confirmed a Toll-Spz pathway in M. sexta, a Lepidopteran insect. We 
showed direct interaction between MsToll and MsSpz-C108 by Co-immunoprecipitation 
(CoIP), and demonstrated that co-expression of MsToll and MsSpz-C108 could activate 
AMP gene promoters in S2 cells by dual luciferase assays. In vivo assays showed that 
MsToll antibody could block stimulation of AMP genes by MsSpz-C108 in M. sexta 
larvae. This study may help better understand signaling pathways in lepidopteran insects, 
and the origin and evolution of animal innate immune signaling pathways. Since there are 
multiple Toll receptors and Spz proteins in insects, for example, there are nine Toll 
receptors and six Spz proteins in Drosophila, one future direction is to investigate 
whether there are multiple Toll-Spz pathways and their roles in innate immune response.  
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Mammalian TLR4-MD2-LPS signaling has been well studies. However, it is not 
known whether a similar LPS signaling pathway exists in invertebrates. I showed by in 
vitro assays that MsToll, MsML-1 and LPS could form a receptor complex. More 
importantly, I showed that co-expression of chimeric Toll (ChiToll by combining the 
ecto-domain of MsToll with the transmembrane and TIR domains of Drosophila Toll) 
with MsML-1 could up-regulate AMP genes activated by LPS. Our results for the first 
time showed that a Toll-ML-LPS signaling pathway is conserved from insects to humans. 
Drosophila has eight MD2-like proteins, and it is not clear which Toll receptor and/or 
MD2-like protein are involved in LPS signaling. Also, it is interesting to see whether 
MsToll-MsML-1 could replace TLR4-MD2 to sense LPS and activate NF-κB factors in 
mammalian cells. In human HEK293T cell line, NF-κB factors cannot be activated 
without co-expression of both human TLR4 and MD2. Thus, it is possible to test whether 
chimeric human TLR4 (ChiTLR4, combining the ecto-domain of MsToll with the 
transmembrane and TIR domains of human TLR4) can form a complex with MsML-1 to 
bind LPS and activate the NF-κB pathway in HEK293T cells. 
In Drosophila, Dorsal and Dif are activated by degradation of the inhibitor Cactus, 
while Relish is activated by cleavage off the C-terminal ankyrin repeats. Dorsal, Dif and 
Relish can form homo- and hetero-dimers (Ganesan et al., 2011; Tanji et al., 2007; Tanji 
et al., 2010). In order to form Dif-Relish heter-dimers, both the Toll and IMD pathways 
must be activated. I identified two short isoforms of Relish in M. sexta (Rel2A and 
Rel2B), which were functionally active NF-κB factors. More importantly, I showed that 
Dorsal and Rel2 could form heterodimers, which could negatively regulate AMP genes. 
This is a novel finding about NF-κB factors in regulation of gene expression. Both 
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MsDorsal and the short isoforms of MsRel2 may form homodimers to activate AMP gene 
expression. If the Toll pathway is over-activated, Dorsal-Rel2 heterodimers can be 
formed, thus Rel2 short isoforms not only can serve as activators but also may serve as 
dampen factors to prevent over-activation of the Toll pathway. It would be interesting to 
see whether Relish short isoforms are also present in Drosophila or not, whether they 
play a role similar to M. sexta Rel2 isoforms.  
β-1, 3-glucan recognition proteins (βGRPs) have been identified in several insect 
species and their main role is to stimulate PPO activation. I identified a novel member of  
the β-1, 3-glucan recognition proteins (βGRP3) in M. sexta. I found βGRP3 possesses 
novel properties, it has calcium-dependent agglutinating activity for B. cereus and E. coli, 
and bactericidal activity against B. cereus. These functions are new to the β-1, 3-glucan 
recognition proteins, and it is necessary to investigate the mechanisms underlying 
agglutination of bacteria and bactericidal activity, which have been observed for C-type 
lectins (immulectins) and AMPs in M. sexta and other insects.  
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